Search criteria | ||||
Assessing definitions and incentives adopted for innovation for pharmaceutical products in five high-income countries: a systematic literature review | ||||
Naohiko Wakutsu 1, Emi Hirose 2, Naohiro Yonemoto 3, Sven Demiya 4 (rwesheorj 4) | ||||
1) Graduate School of Economics, Nagoya City University, Nagoya, Japan 2) Health & Value, Pfizer Japan Inc., Tokyo, Japan. emi.hirose@pfizer.com 3) Health & Value, Pfizer Japan Inc., Tokyo, Japan 4) IQVIA Solutions Japan K.K., Tokyo, Japan | ||||
Pharmaceutical Medicine |
||||
, Article | ||||
, France, Germany, Japan, UK, USA | ||||
Abstract: https://link.springer.com/article/10.1007/s40290-022-00457-5 | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2023 | English | , Literature Review | |
The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making | ||||
Paul Cottu 1, Scott David Ramsey 2, Oriol Solà-Morales 3, Patricia A Spears 4, Lockwood Taylor 5 | ||||
1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr. 2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org. 3Health Innovation Technology Transfer Foundation, Aragó 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org. 48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com. 5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com. | ||||
Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015. |
||||
, Article | ||||
, France, Italy, USA | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34959093/ | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory | 2022 | English | , Review | |
Estimating the burden of influenza-related and associated hospitalizations and deaths in France: An eight-season data study, 2010-2018 | ||||
Magali Lemaitre 1, Fayssoil Fouad 1, Fabrice Carrat 2 3, Pascal Crépey 4, Jacques Gaillat 5, Gaëtan Gavazzi 6, Odile Launay 7 8, Anne Mosnier 9, Marie-Cécile Levant 10, Mathieu Uhart 10 | ||||
1 IQVIA, Courbevoie, France. 2 Sorbonne Université, Institut National de la Santé et de la Recherche Médicale (Inserm), Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France. 3 Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Unité de Santé Publique, Paris, France. 4 Université de Rennes, EHESP, REPERES-EA 7449, Rennes, France. 5 Centre Hospitalier Annecy-Genevois, Metz-Tessy, France. 6 CHU Grenoble Alpes, Clinique Universitaire de Gériatrie, Pavillon Elisée-Chatin, and GREPI EA 7408, Université Grenoble Alpes, Grenoble, France. 7 Faculté de Médecine Paris Descartes, Université de Paris, Paris, France. 8 Inserm, CIC 1417, F-CRIN I-REIVAC, Assistance Publique-Hôpitaux de Paris, CIC Cochin-Pasteur, Paris, France. 9 Open Rome & Réseau des GROG, Paris, France. 10 Sanofi Pasteur, Lyon, France. | ||||
Influenza Other Respir Viruses . 2022 Jan 10. doi: 10.1111/irv.12962. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/35014194/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2022 | English | , Methodology, Population Based Study | |
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 | ||||
Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina Isgrò 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca Trifirò 18, | ||||
Pharmacy Department, Mater Dei Hospital, Msida, Malta. 2Exeter College of Medicine and Health, Exeter, UK. 3Department of Medicine, University of Verona, Verona, Italy. 4Real World Solutions Department, IQVIA, Lisbon, Portugal. 5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy. 6Agenzia Regionale di Sanità della Toscana, Florence, Italy. 7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands. 8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy. 9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy. 10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy. 11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy. 12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. 13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy. 14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. 15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France. 16RTI Health Solutions, Barcelona, Spain. 17Democritus University of Thrace, Alexandroupolis, Greece. 18Department of Diagnostics and Public Health, University of Verona, Verona, Italy. 19Data Science Hub, Real World Solutions, IQVIA, London, UK. 20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands. | ||||
Pharmacoepidemiol Drug Saf . 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11. |
||||
, Article | ||||
, Denmark, France, Italy, Netherlands, Portugal, Spain, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/35092329/ | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study | 2022 | English | , Database Study, Review | |
Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus and Influenza Related Hospitalizations in Adults – A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study) | ||||
Ann R Falsey, Edward E Walsh, Stacey House, Yannick Vandenijck, Xiaohui Ren, Sofia Keim, Diye Kang, Pascale Peeters, James Witek, Gabriela Ispas | ||||
University Of Rochester School Of Medicine and Rochester Regional Health, Rochester, NY, United States; Washington University School of Medicine, St Louis, MO, United States; Janssen Infectious Diseases, Beerse, Belgium; IQVIA Real-World Solutions, Courbevoie, France; Janssen Research & Development, LLC, Titusville, NJ, United States | ||||
, Article | ||||
, Argentina, Australia, Brazil, Canada, France, Germany, Japan, Korea, Malaysia, Mexico, South Africa, USA | ||||
Abstract: https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofab491/6381446 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2021 | English | , Burden of illness, Clinical setting: hospital, Epidemiological study, Observational study, Patient questionnaire, Prospective study | |
Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS) | ||||
Stanislas Pol 1, Fayssoil Fouad 2, Magali Lemaitre 2, Ingrid Rodriguez 3, Olivier Lada 3, Pascaline Rabiega 2, Elias Benabadji 3, Françoise Roudot-Thoraval 4 | ||||
1Université de Paris, département d'hépatologie et d'addictologie, 75014 Cochin (AP-HP), Paris, France. 2IQVIA, 92400 Courbevoie, France. 3Gilead Sciences, 92100 Boulogne Billancourt, France. 4Service d'hépatologie, Henri-Mondor (AP-HP), 94010, Créteil, France. | ||||
Lancet Reg Health Eur . 2021 Dec 11;13:100281. doi: 10.1016/j.lanepe.2021.100281. eCollection 2022 Feb. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34950924/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2021 | English | , Observational study, Population Based Study, Predictive analytics | |
Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018 | ||||
C Demont 1, N Petrica 2, I Bardoulat 2, S Duret 2, L Watier 3, A Chosidow 4, M Lorrot 4, A Kieffer 5, M Lemaitre 2 | ||||
1Sanofi Pasteur, 14 Espace Henry Vallée, 69007, Lyon, France. Clarisse.Demont@sanofi.com. 2IQVIA, 92400, Courbevoie, France. 3Université Paris-Saclay, UVSQ, Inserm, CESP, 94807, Villejuif, France. 4Department of Pediatrics, Armand Trousseau Hospital (AP-HP), 75012, Paris, France. 5Sanofi Pasteur, 14 Espace Henry Vallée, 69007, Lyon, France. | ||||
BMC Infect Dis . 2021 Aug 2;21(1):730. doi: 10.1186/s12879-021-06399-8. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34340679/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2021 | English | , Observational study, Population Based Study | |
Monitoring outpatient antibiotic utilization using reimbursement and retail sales data: a population-based comparison in France, 2012-17 | ||||
Nhung T H Trinh 1 2, Martin Chalumeau 1 3, Tim A Bruckner 4, Corinne Levy 5 6, Antoine Bessou 2, Dejan Milic 2, Robert Cohen 5 7, Magali Lemaitre 2, Jérémie F Cohen 1 3 | ||||
1Université de Paris, Epidemiology and Statistics Research Center-CRESS, INSERM, Obstetrical, Perinatal and Pediatric Epidemiology research team, F-75004, Paris, France. 2IQVIA, La Défense, France. 3Department of General Pediatrics and Pediatric Infectious Diseases, AP-HP, Hôpital Necker-Enfants malades, Université de Paris, Paris, France. 4Program in Public Health, University of California, Irvine, CA, USA. 5Association Clinique et Thérapeutique Infantile du Val-de-Marne (ACTIV), Saint-Maur-des-Fossés, France. 6Clinical Research Centre, Centre Hospitalier Intercommunal de Créteil, Créteil, France. 7Université Paris Est, IMRB-GRC GEMINI, Créteil, France. | ||||
J Antimicrob Chemother . 2021 Aug 12;76(9):2446-2452. doi: 10.1093/jac/dkab185. |
||||
, Article | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34120188/ | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study | 2021 | English | , Population Based Study | |
Étude EPILYMIA – Étude rétrospective combinant trois sources de données pour l’estimation de l’incidence de la borréliose de Lyme en France entre 2015 et 2019 | ||||
AntoineBessou1 StéphanieDuret1 MagaliLemaître1 CharlesNuttens2 | ||||
1 IQVIA France, Courbevoie, France 2 Pfizer SAS France, Paris, France | ||||
https://doi.org/10.1016/j.respe.2021.05.024 |
||||
, Article | ||||
, France | ||||
Abstract: sciencedirect.com/science/article/abs/pii/S0398762021002595 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2021 | French | , Population Based Study | |
Refracture and mortality following hospitalization for severe osteoporotic fractures: The Fractos Study | ||||
Christian Roux 1, Thierry Thomas 2, Julien Paccou 3, Geoffray Bizouard 4, Anne Crochard 5, Emese Toth 5, Magali Lemaitre 4, Frédérique Maurel 4, Laure Perrin 5, Florence Tubach 6 | ||||
1 Department of Rheumatology Cochin Hospital, Assistance Publique - Hôpitaux de Paris Centre, Institut National de la Santé et de la Recherche Médicale (INSERM) Unités Mixtes de Recherche (UMR) 1153, Université de Paris Paris France. 2 Department of Rheumatology Hôpital Nord, Centre Hospitalier Universitaire (CHU) Saint-Etienne, INSERM U1059, Lyon University Saint-Etienne France. 3 Department of Rheumatology Lille University, CHU Lille, Marrow Adiposity and Bone Laboratory (MABlab) ULR 4490 Lille France. 4 IQVIA Courbevoie France. 5 UCB Pharma Colombes France. 6 Department of Public Health, Pharmacoepidemiology Center (Cephepi) Sorbonne University, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP Sorbonne University, Pitié-Salpêtrière Hospital, CIC-1422 Paris France. | ||||
JBMR Plus . 2021 May 14;5(7):e10507. doi: 10.1002/jbm4.10507. eCollection 2021 Jul. |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics | 2021 | English | , Population Based Study | |
Épidémiologie et mortalité de la pneumopathie interstitielle diffuse de forme progressive (hors fibrose pulmonaire idiopathique): données du Système National des Données de Santé–Étude PROGRESS | ||||
M.Nasser, P.Rabiega, L.Boussel, S.Si Mohamed, V.Barbet, S.Marque, J.Massol, F.Thivolet-Bejui, L.Chalabreysse, D.Maucort Boulch, E.Hachulla, S.Jouneau, K.Le La, V.Cottin | ||||
1 Hospices civils de Lyon, Lyon, France 2 IQVIA-RWS, La Défense, France 3 AIXIAL, Paris, France 4 CHU, Lille, France 5 CHU, Rennes, France 6 Boehringer Ingelheim France, Paris, France | ||||
https://doi.org/10.1016/j.rmra.2020.11.023 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1877120320302196 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2021 | French | , Methodology, Population Based Study | |
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study). | ||||
Mouhamad Nasser, Sophie Larrieu, Salim Si-Mohamed, Kaïs Ahmad, Loic Boussel, Marie Brevet, Lara Chalabreysse, Céline Fabre, Sébastien Marque, Didier Revel, Françoise Thivolet-Bejui, Julie Traclet, Sabrina Zeghmar, Delphine Maucort-Boulch, Vincent Cottin | ||||
1 Dept of Respiratory Medicine, National Coordinating Reference Centre for Rare Pulmonary Diseases, OrphaLung, Louis Pradel Hospital, University Hospital of Lyon, Lyon, France 2 Claude Bernard University Lyon 1, UMR754 INRAE, IVPC, Lyon, France 3 IQVIA, La Défense, France 4 Dept of Radiology, University Hospital of Lyon, Lyon, France 5 Dept of Pathology, University Hospital of Lyon, Lyon, France 6 CYPATH, Villeurbanne, France 7 Dept of Biostatistics, University Hospital of Lyon, Lyon, France | ||||
Eur Respir J . 2021 Feb 11;57(2):2002718. doi: 10.1183/13993003.02718-2020. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/32943410/ | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2021 | English | , Observational study, Population Based Study | |
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study) | ||||
Mouhamad Nasser, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed, Fabienne Bazin, Sébastien Marque, Jacques Massol, Françoise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Eric Hachulla, Stéphane Jouneau, Katell Le Lay & Vincent Cottin | ||||
1 Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Lyon, OrphaLung, RespiFil, ERN-LUNG, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Lyon Cedex, France. 2 UMR754, INRAE, Université Claude Bernard Lyon 1, Lyon, France. 3 IQVIA, RWS - La Défense, Paris, France. 4 Département de Radiologie, Hospices Civils de Lyon, Lyon, France. 5 CNRS, Inserm, CREATIS UMR 5220, Université de Lyon, INSA-Lyon, University Claude Bernard Lyon 1, UJM-Saint Etienne, Lyon, France. 6 AIXIAL, Boulogne-Billancourt, France. 7 Département d'anatomo-pathologie, Hospices Civils de Lyon, Lyon, France. 8 Université de Lyon, 69000, Lyon, France. 9 Université de Lyon 1, 69100, Villeurbanne, France. 10 Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Pôle Santé Publique, 69003, Lyon, France. 11 CNRS, UMR 5558, Équipe Biostatistique-Santé, Laboratoire de Biométrie et Biologie Évolutive, 69100, Villeurbanne, France. 12 Service de Médecine Interne et Immunologie Clinique, Hôpital Claude Huriez, Centre National de Référence des maladies auto‑immunes systémiques rare du Nord et Nord‑Ouest de France (CeRAINO), CHU de Lille, Lille, France. 13 Centre Hospitalier Universitaire de Rennes, Centre de Compétences pour les Maladies Pulmonaires Rares, Inserm, EHESP, IRSET (Institut de recherche en santé, environnement et travail), RespiFil, OrphaLung, Univ Rennes, Rennes, France. 14 Boehringer Ingelheim France SAS, Paris, France. 15 Hôpital Louis Pradel, Centre National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, Lyon, OrphaLung, RespiFil, ERN-LUNG, Claude Bernard University Lyon 1, 28 Avenue du Doyen Lepine, 69677, Lyon Cedex, France. vincent.cottin@chu-lyon.fr. 16 UMR754, INRAE, Université Claude Bernard Lyon 1, Lyon, France. vincent.cottin@chu-lyon.fr. | ||||
Respir Res . 2021 May 24;22(1):162. doi: 10.1186/s12931-021-01749-1. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34030695/ | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2021 | English | , Methodology, Observational study | |
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France | ||||
Vincent Cottin 1, Sophie Larrieu 2, Loic Boussel 3 4, Salim Si-Mohamed 3 4, Fabienne Bazin 2, Sébastien Marque 2, Jacques Massol 5, Françoise Thivolet-Bejui 6, Lara Chalabreysse 6, Delphine Maucort-Boulch 7 8 9 10, Stéphane Jouneau 11, Eric Hachulla 12, Julien Chollet 13, Mouhamad Nasser 1 | ||||
1 Hôpital Louis Pradel, Centre Coordonnateur National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, UMR754 INRAE and Université Claude Bernard Lyon 1, Member of ERN-LUNG, RespiFil, OrphaLung, Lyon, France. 2 IQVIA - RWS La Défense, Courbevoie, France. 3 Département de Radiologie, Hospices Civils de Lyon, Lyon, France. 4 Université Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS Inserm, CREATIS UMR 5220, Lyon, France. 5 AIXIAL - Paris, Paris, France. 6 Département d'anatomo-pathologie, Hospices Civils de Lyon, Lyon, France. 7 Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France. 8 Université de Lyon, Lyon, France. 9 Université Lyon 1, Villeurbanne, France. 10 CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France. 11 Centre Hospitalier Universitaire de Rennes, Centre de Compétences pour les Maladies Pulmonaires Rares, Univ Rennes, Inserm, EHESP, IRSET (Institut de recherche en santé, environnement et travail), RespiFil, OrphaLung, Rennes, France. 12 Hôpital Claude Huriez, Centre National de Référence des maladies auto-immunes systémiques rares (CeRAINO), CHU de Lille, Lille, France. 13 Boehringer Ingelheim France SAS, Paris, France. | ||||
Front Med (Lausanne) . 2021 Aug 30;8:699532. doi: 10.3389/fmed.2021.699532. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34552943/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2021 | English | , Observational study, Population Based Study | |
Impact des nouveaux traitements (AAD) de l’hépatite C dans la population générale et les populations à risque : étude réalisée en France à partir des données du SNDS sur la période 2015-2019 | ||||
PascalineRabiéga1, StanislasPol2, FayssoilFouad1, IngridRodriguez3, OlivierLada3, MagaliLemaitre1, EliasBenabadji3, FrançoiseRoudot-Thoraval4 | ||||
1 IQVIA, Courbevoie, France 2 Cochin (AP-HP), Paris, France 3 Gilead Sciences, Boulogne Billancourt, France 4 Henri-Mondor (AP-HP), Créteil, France | ||||
https://doi.org/10.1016/j.respe.2021.05.010 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S0398762021002455 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2021 | French | , Methodology, Population Based Study | |
Ability of primary care health databases to assess medicinal products discussed by the European Union Pharmacovigilance Risk Assessment Committee | ||||
Robert Flynn1,2,*, Karin Hedenmalm1, Tarita Murray-Thomas3, Alexandra Pacurariu1, Peter Arlett1, Hilary Shepherd3, Puja Myles3, Xavier Kurz1 | ||||
1 Pharmacovigilance and Epidemiology Department, European Medicines Agency, Amsterdam, The Netherlands 2 Medicines Monitoring Unit (MEMO), Division of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom 3 Clinical Practice Research Datalink (CPRD), MHRA, London, United Kingdom | ||||
First published: 18 January 2020 https://doi.org/10.1002/cpt.1775 |
||||
, Abstract, Article | ||||
, France, Germany, UK | ||||
Abstract: https://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.1775 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Drug safety, Health policy | 2020 | English | , Retrospective database analysis | |
The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study | ||||
Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain | ||||
IPVC, Barcelona, Spain, 23-27 March 2020 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Portugal, Spain | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Oncology | 2020 | English | , Burden of illness, Observational study, Retrospective Field Study | |
Real-world clinical outcomes for third-line standard of care regimens in deficient mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC) in France | ||||
Cohen R1, Thierry A1, Roset M2, Amonkar M3, Patel R3, Lara N2, Kothari S3, Tougeron D4 | ||||
1 Sorbonne Université, medical oncology department, AP-HP, hôpital Saint-Antoine, F-75012 Paris, France 2 IQVIA, Barcelona, Spain 3 Merck & Co, Inc., Kenilworth, NJ, US 4 Gastroenterology Department, Poitiers University Hospital and University of Poitiers, Poitiers, France | ||||
ESMO GI, Barcelona, Spain 1-4 July 2020 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Observational study, Population Based Study, Retrospective Field Study | |
The prevalence of polypharmacy and the use of potentially inappropriate medications (PIMs): a cross-national study in five European countries - Preliminary Results | ||||
Bennie M1, Elseviers M2, Schubert I3, Poluzzi E4, MacBride S5, Sermet C6, Jouaville Abrouk LS7, Menon S7, Trehony J7, Nasuti P7, Taxis K8 | ||||
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde / Information Services Division, NHS National Services Scotland, UK 2 Clinical Pharmacology, Ghent University, Belgium Centre for Innovation and Care, University of Antwerp, Belgium 3 PMV Research Group, Faculty of Medicine and University Hospital of Cologne, University for Cologne, Germany 4 University of Bologna, Italy 5 NHS Greater Glasgow and Clyde, Scotland 6 IRDES, Institut de Recherche en Economie de la Santé, France 7 IQVIA Real World Solutions, London, UK / France 8 University of Groningen, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands | ||||
European Drug Utilisation Resarch Group (EuroDURG) Conference 2020, Szeged, Hungary, 4-7 March 2020 |
||||
, Poster | ||||
, Belgium, France, Germany, Italy, UK | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Public Health | 2020 | English | , Population Based Study, Public Health, Retrospective database analysis | |
Investigation of factors considered in the health technology assessment conducted by regulatory authority in eight countries | ||||
Akira Yuasa 1, Naohiro Yonemoto 1, Sven Demiya 2, Chihiro Foellscher 2, Shunya Ikeda 3 (rwesheorj 2) | ||||
1) Pfizer Japan Inc., Tokyo, Japan 2) IQVIA Solutions Japan, Tokyo, Japan 3) Graduate School of Medicine, International University of Health and Welfare, Tokyo, Japan | ||||
ISPOR 2020 Conference |
||||
, Abstract | ||||
, Australia, Canada, France, Germany, Italy, Japan, Spain, UK | ||||
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/intl2020-3182/101019 | ||||
Condition | Year | Language | Analysis type | |
2020 | English | |||
Fardeau hospitalier du Virus respiratoire syncitial (VRS) chez l’enfant de moins de 5 ans entre 2010 et 2018 : utilisation des données du PMSI | ||||
N. Petrica a, M. Lemaitre a, I. Bardoulat a, L. Watier b, M. Lorrot c, A. Chosidow c, A. Kieffer d, C. Demont d | ||||
a IQVIA, Courbevoie, France b Biostatistique, biomathématique, pharmacoépidémiologie et maladies infectieuses (B2PHI), Inserm, UVSQ, Institut Pasteur, Université Paris-Saclay, Insermc, France c Département de pédiatrie, Hôpital Armand Trousseau (AP-HP), Paris, France d SanofiPasteur Lyon, Marcy-l’Etoile, France | ||||
Doi : 10.1016/j.respe.2020.04.041 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.em-consulte.com/article/1388418/fardeau-hospitalier-du-virus-respiratoire-syncitia | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2020 | French | , Observational study, Population Based Study | |
Estimation du fardeau direct et indirect de la grippe en France de la saison 2010/2011 à la saison 2017/2018 : analyse épidémiologique et économique à partir du Programme de médicalisation des systèmes d’information | ||||
F. Fouad a, A. Bessou a , F. Carrat b, P. Crépey c, d, M.-C. Levant e, M. Uhart e | ||||
a IQVIA, La Défense, France b Sorbonne Université, Inserm, Institut Pierre Louis d’épidémiologie et de santé publique ; Assistance publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Unité de santé publique, Paris, France c UMR Emergence des pathologies virales, Université Aix-Marseille - IRD 190 - Inserm 1207, Marseille, France d Ecole des hautes études en santé publique, Rennes, France e Sanofi Aventis, France | ||||
Doi : 10.1016/j.respe.2020.01.114 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.em-consulte.com/article/1352598/estimation-du-fardeau-direct-et-indirect-de-la-gri | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Respiratory disease | 2020 | French | , Methodology, Population Based Study | |
A RETROSPECTIVE COHORT STUDY OF THE NATIONAL HEALTHCARE RESOURCE UTILISATION (HCRU) AND COSTS OF TREATING MULTIPLE MYELOMA (MM) IN FRANCE USING THE SYSTÈME NATIONAL DES DONNÉES DE SANTÉ (SNDS) DATABASE | ||||
A. Bessou X. Colin J. De Nascimento W. Sopwith S.A. Ferrante B. Gorsh B. Gutierrez L. Sansbury J. Willson S. Sapra F. Wang | ||||
1 IQVIA, Paris, France 2 GlaxoSmithKline, Rueil Malmaison, 92, France, 3 IQVIA,La Defense Cedex, 75, France, 4 IQVIA, London, UK, 5 Value Evidence and Outcomes, GlaxoSmithKline, Upper Providence, PA, USA, 6 Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USA, 7 Value Evidence and Outcomes, GlaxoSmithKline, London, UK | ||||
DOI:https://doi.org/10.1016/j.jval.2020.08.250 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(20)32506-7/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2020 | English | , Observational study, Population Based Study | |
Prévalence et mortalité de la pneumopathie interstitielle diffuse associée à la sclérodermie systémique (PID-ScS) en France : données du Système National des Données de Santé (SNDS) | ||||
M.Nasser, P.Rabiega, L.Boussel, S.Si-Mohamed, V.Barbet, S.Marque, J.Massol, F.Thivolet-Bejui, L.Chalabreysse, D.Maucort-Boulch, S.Jouneau, E.Hachulla, J.Chollet, V.Cottin | ||||
1 Pneumologie, Hospices Civils de Lyon - HCL, Lyon 2 RWS, IQVIA, Courbevoie 3 Imagerie médicale, Hospices Civils de Lyon - HCL, Lyon 4 Consultant, Aixial, Boulogne-Billancourt 5 Anatomie et cytologie pathologiques, Hospices Civils de Lyon - HCL, Lyon 6 Biostatistiques, Hospices Civils de Lyon - HCL, Lyon 7 Pneumologie, CHU de Rennes, Rennes 8 Médecine interne, Centre Hospitalier Régional Universitaire de Lille, Lille 9 Heor department, Boehringer Ingelheim France, Paris 10 Pneumologie, Hopital Louis Pradel, Bron | ||||
https://doi.org/10.1016/j.rhum.2020.10.078 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1169833020302726 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2020 | French | , Methodology, Observational study, Population Based Study | |
Healthcare Resource Utilization and Associated Costs of Progressive Fibrosing Interstitial LUNG Disease (PF-ILD) and Systemic Sclerosis Associated Interstitial LUNG Disease (SSC-ILD) in France. | ||||
M. Nasser P. Rabiéga L. Boussel S. Si-Mohamed V. Barbet S. Marque J. Massol D. Revel F. Thivolet-Bejui L. Chalabreysse D. Maucort-Boulch S. Jouneau E. Hachulla V. Cottin | ||||
1 University Claude Bernard, Lyon, France, 2 IQVIA, La Défense, 92, France, 3 Hospices Civils de Lyon, Lyon, France, 4 IQVIA, La Défense, France, 5 AIXIAL, Paris, France, 6 Université de Rennes 1, CHU Rennes, INSERM, EHESP, Rennes, France, 7 Hôpital Claude Huriez, Centre National de Référence des maladies auto-immunes systémiques, CHRU de Lille, Lille, France, 8 National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University Claude Bernard, Lyon, France | ||||
DOI:https://doi.org/10.1016/j.jval.2020.08.1891 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(20)34147-4/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2020 | English | , Observational study, Population Based Study | |
Cohorte de patients présentant une pneumopathie interstitielle diffuse fibrosante chronique de phénotype progressif (PID-FP) autre qu’une fibrose pulmonaire idiopathique (FPI) et appariement des données au Système national des données de santé : étude PROGRESS | ||||
S. Larrieu, M. Nasser, S. Si-Mohamed, K. Ahmad, L. Boussel, M. Brevet, L. Chalabreysse, C. Fabre, S. Marque, D. Revel, F. Thivolet-Bejui, J. Traclet, S. Zeghmar, D. Maucort-Boulch, V. Cottin | ||||
a IQVIA, La Défense, France b Hospices Civils de Lyon, Pneumology Department, Lyon, France c Hospices Civils de Lyon, Radiology Department, Bron, France d Centre de recherche en applications et traitement de l’image pour la santé (CREATIS)–Université Claude Bernard Lyon 1, Hospices Civils de Lyon, Institut national des sciences appliquées, Inserm U1044, CNRS : UMR5220, Villeurbanne, France e Hospices Civils de Lyon, Radiology Department, France f Hospices Civils de Lyon, Anatomopathology Department, Lyon, France g Hospices Civils de Lyon, Biostatistics Department, Lyon, France | ||||
Doi : 10.1016/j.respe.2020.04.019 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.em-consulte.com/article/1388397/article/cohorte-de-patients-presentant-une-pneumopathie-in | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2020 | French | , Observational study, Population Based Study | |
Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France | ||||
Mouhamad Nasser, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed, Fabienne Bazin, Sébastien Marque, Jacques Massol, Didier Revel, Francoise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Eric Hachulla, Stéphane Jouneau, Vincent Cottin | ||||
1 Hospices Civils de Lyon, Lyon, France 2 IQVIA, Bordeaux, France 3 AIXIAL, Paris, France 4 CHU de Lille, Lyon, France 5 CHU de Rennes, Lyon, France | ||||
European Respiratory Journal 2020 56: 805; DOI: 10.1183/13993003.congress-2020.805 |
||||
, Article | ||||
, France | ||||
Abstract: https://erj.ersjournals.com/content/56/suppl_64/805.article-info | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2020 | English | , Observational study, Population Based Study | |
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data. | ||||
Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K | ||||
IQVIA, Eli Lilly | ||||
Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088. |
||||
, Article | ||||
, Belgium, Canada, France, Germany, Italy, Netherlands | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/31028689 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2019 | English | , Retrospective database analysis | |
Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe | ||||
Fife D, Waller J, Kaplan S, Hu P, Phillips S, Oliveria SA, Richarz U | ||||
Fife: Janssen Research and Development, LLC Waller: Adephi Real World Kaplan: Teva Pharmaceutical Indusries Ltd. Hu: Janssen Global Services Phillips: IQVIA Oliveria, IQVIA Richarz: Janssen Research and Development, LLC | ||||
Clin Drug Investig (2019). https://doi.org/10.1007/s40261-019-00831-3 |
||||
, Article | ||||
, Belgium, France, Germany, Spain, UK | ||||
Abstract: https://link.springer.com/article/10.1007/s40261-019-00831-3 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Drug Utlization Study | 2019 | English | , Population Based Study, Retrospective database analysis | |
European Multi-Country Drug Utilization Study of Dulaglutide | ||||
Ayad K. Ali1, Karen E. Wells2, Mathieu Ros3, Massoud Toussi3 | ||||
1Eli Lilly and Company, Indianapolis, IN, USA 2IQVIA, Oakland, MI, USA 3IQVIA, Courbevoie, France | ||||
ICPE, Philadelphia, USA, 24-28 August 2019 |
||||
, Abstract | ||||
, France, Germany, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Drug safety | 2019 | English | , Epidemiological study, Observational study, Retrospective cohort analysis, Retrospective database analysis | |
Adoption of immuno-oncology in NSCLC, a real-world study in EU5. | ||||
Alejandra Martinez De Pinillos,Isabel Ricote Lobera,Cristina Martinez,Caroline Anger,Filippo Guglielmetti,Roberto Jorge Bitton | ||||
IQVIA, London, United Kingdom; IQVIA, Madrid, Spain; IQVIA, Milan, Italy; IQVIA, Buenos Aires, Argentina | ||||
Journal of Clinical Oncology201937:15_suppl,e20631-e20631 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://ascopubs.org/doi/abs/10.1200/JCO.2019.37.15_suppl.e20631 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2019 | English | , Retrospective database analysis | |
EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE | ||||
Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi | ||||
Real World Evidence Solutions, IQVIA, France; Global Pharmacovigilance – Global Safety Sciences - Risk Management, Sanofi; Epidemiology and Benefit Risk Evaluation, Sanofi; Global Clinical Sciences; Vaccines & Anti-Infectives, Mylan, The Netherlands | ||||
Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019 |
||||
, Poster | ||||
, France, Greece, Italy, Portugal | ||||
Abstract: https://www.coodoc.com/pages/p1819-Thiocholchicoside-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Musculoskeletal disease | 2019 | English | , Survey research | |
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries | ||||
Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi | ||||
IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK | ||||
Presented at ISPE’s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24–28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA. |
||||
, Poster | ||||
, Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland | ||||
Abstract: https://www.coodoc.com/pages/p1822-Daratumumab-ICPE-2019 | ||||
Condition | Year | Language | Analysis type | |
, Hematology, Oncology | 2019 | English | , Public Health, Survey research | |
Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients | ||||
Goodall G1, Lamotte M2, Ramos M2, Maunoury F3, Pejchalova B1, de Pouvourville G4 | ||||
1 Edwards Lifesciences S.A., Nyon, Switzerland 2 IQVIA, Zaventem, Belgium 3 Statesia, Le Mans, France 4 ESSEC Business School, Cergy Pontoise, France | ||||
J Med Econ. 2019 Apr;22(4):289-296. doi: 10.1080/13696998.2018 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30547704 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2019 | English | , Cost effectiveness | |
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe | ||||
Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5 | ||||
1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium | ||||
Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157. |
||||
, Article | ||||
, Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30955367 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2019 | English | , Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study | |
Natural hisotry of oral human papillomavirus infection in healthy populations: Design of the Prevalence of Oral HPV infection, a Global assessment, THE PROGRESS STUDY | ||||
Pedros M1, Morais E2, Roset M1, Kothari S3, Alemany L5, Mirghani H6, Mehanna H7, Waterboer T8, Roberts C3, Vendetti N3, Walia A3, Drury R2, Luxembourg A3, Giuliano A9 | ||||
1 IQVIA, Barcelona, Spain 2 MSD, Lyon, France 3 Merck & Co, Inc., Kenilworth, NJ, US 5 Catalan Institute of Oncology, Cancer Epidemiology Research Program and IDIBELL i CIBERESP, Barcelona, Spain 6 Hôpital Européen Georges-Pompidou Université Paris-Descartes, Paris, France 7 Institute of Head & Neck Studies and Education (InHANSE), University of Birmingham, Birmingham, United kingdom 8 German Cancer Research Center (DKFZ), Heidelberg, Germany 9 Moffitt Cancer Center, Florida, US | ||||
EUROGIN, Monaco, France, 4-7 December 2019 |
||||
, Oral presentation | ||||
, China, France, Germany, Italy, Japan, Spain, UK, USA | ||||
Abstract: http://merck.creative.studios.s3-website-us-east-1.amazonaws.com/EUROGIN_2019/2019_EUROGIN_Pedros_NaturalHistory.pdf | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Infectious disease, Methodology | 2019 | English | , Epidemiological study, Observational study, Population Based Study | |
Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use | ||||
Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M | ||||
IQVIA | ||||
Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372 |
||||
, Article | ||||
, France, Greece, Italy, Portugal | ||||
Abstract: https://www.omicsonline.org/open-access/evaluation-of-the-effectiveness-of-risk-minimisation-measures-targeting-physicians-on-prescribing-practices-of-thiocolchicoside-co-2161-1165-1000372-108159.html | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease, Rheumatology, Risk Management & REMS | 2019 | English | , Survey research | |
PIN151 PATIENTS TREATED FOR HEPATITIS C: AN OBSERVATIONAL STUDY WITH THE FRENCH ADMINISTRATIVE HEALTH CARE DATABASE (SNDS) | ||||
Pol S,1 Rodriguez I,2 Fouad F,3 Lemaitre M,3 Ansolabehere X,4 Lada O,2 Roudot-Thoraval F | ||||
1 Hopital Cochin - APHP, Paris, France, 2 Gilead Sciences, Paris, France, 3 IQVIA, COURBEVOIE, France, 4 QuintilesIMS, Paris La Défense, France, 5 Henri Mondor hospital, Créteil, France | ||||
DOI:https://doi.org/10.1016/j.jval.2019.09.1391 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)33769-6/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2019 | English | , Observational study, Population Based Study, Predictive analytics | |
Évolution de la prise en charge de l’hépatite C en France : étude observationnelle réalisée à partir des données du Système national des données de santé | ||||
F. Fayssoil , M. Lemaitre , X. Ansolabehere , I. Rodriguez | ||||
a IQVIA, Courbevoie, France b Gilead Sciences, Boulogne Billancourt, France | ||||
Doi : 10.1016/j.respe.2019.04.025 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.em-consulte.com/article/1292586/article/evolution-de-la-prise-en-charge-de-l-hepatite-c-en | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2019 | French | , Methodology, Observational study, Population Based Study | |
Étude FRANTALGIC – Intensification du traitement par opioïde chez les utilisateurs douloureux chroniques : analyse des données de remboursement de l'assurance maladie. | ||||
C. Collin a, N. Coulombel a, A. Trouvin b, I. Bardoulat a, M. Lemaitre a, C. Le-Pen c, M. Maravic d | ||||
a IQVIA France, Innovation et croissance, Courbevoie, France b Centre d’évaluation et traitement de la douleur, hôpital Ambroise Paré, Boulogne Billancourt, Unité Inserm U987, Boulogne Billancourt, France c Université Paris Dauphine, LEDa/LEGOS, Paris, France d IQVIA France, Real World Insights, Courbevoie, hôpital Lariboisière (AP–HP), Rhumatologie, Paris, France | ||||
Doi : 10.1016/j.respe.2019.04.026 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.em-consulte.com/article/1292588/etude-frantalgic%C2%A0%E2%80%93%C2%A0intensification-du-traitement-p | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2019 | French | , Observational study, Population Based Study | |
SWITCH TO STRONG OPIOIDS IN CHRONIC OPIOID USERS: ANALYSIS OF THE FRENCH NATIONAL HEALTH INSURANCE DATABASE. THE FRANTALGIC STUDY | ||||
Anne-Priscille Trouvin, Cédric Collin, Nicolas Coulombel, Nadine Attal, Julien Nizard, Isabelle Bardoulat, Milka Maravic, Claude Le-Pen, Serge Perrot. | ||||
1 Hôpital Ambroise Paré APHP, Centre d'Etude et Traitement de la Douleur, Boulogne Billancourt, France, 2 INSERM U 987, Boulogne Billancourt, France 3 IQVIA France, Advanced analytics, Innovation & Growth, La Défense, France, 4 CHU Nantes, Centre d'Etude et Traitement de la Douleur, Nantes, France, 5 IQVIA France, Real World Insights, La Défense, France, 6 Hôpital Lariboisière APHP, Rhumatologie, Paris, France, 7 Université Paris Dauphine, LEDa/LEGOS, Paris, France, 8 Hôpital Cochin, APHP, Centre d'Etude et Traitement de la Douleur, Paris, France. | ||||
https://doi.org/10.26226/morressier.5d402f9e8f2158d25ec1247b |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.morressier.com/o/event/5d3f070f8f2158d25ec123c9/article/5d402f9e8f2158d25ec1247b | ||||
Condition | Year | Language | Analysis type | |
, Pain | 2019 | English | , Observational study, Population Based Study | |
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
Condition | Year | Language | Analysis type | |
2018 | English | |||
Patterns of care and of biomolecular characterization of Right, Transverse, and Left Colorectal Cancer from real-life evidence in Asia Pacific and European countries | ||||
Ettore M1, Mpima S2, Guglielmetti F1, Nasuti P2 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: ESMO 2018 Congress | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
CHALLENGES AND OPPORTUNITIES IN CLINICAL NUTRITION IN ONCOLOGY: AVAILABLE EVIDENCE, REAL WORLD PRACTICES, AND THE WAY FORWARD | ||||
Goldwasser F, Piaggio T, Lucas J, Zalcman G, Tilleul P, Schiefke I, Marschal O, Pedrazzoli P, Caccialanza R | ||||
Medical Oncology, Cochin Hospital, AP-HP, IQVIA Basel | ||||
ISPOR Europe 2018 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy | ||||
Condition | Year | Language | Analysis type | |
, Nutritional Disorders, Oncology | 2018 | English | , Clinical setting: Home care, Epidemiological study | |
Profiling and treatment patterns in NSCLC patients with CNS (brain) metastases in Europe and Asia | ||||
Mari E1, Mpima S2, Guglielmetti F1, Nasuti P2, Manuguid F2, Heitner Enschede S3 | ||||
1IQVIA , Milan, Italy 2IQVIA , London, UK 3IQVIA Inc, USA | ||||
JCO ( ASCO 2018) |
||||
, Abstract | ||||
, Asia Pacific, China, Europe, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e21085 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
COMPARING THE ROLE OF DIFFERENT SPECIALITIES IN THE MANAGEMENT OF PROSTATE CANCER IN FRANCE AND ITALY: INSIGHTS FROM A REAL-WORLD STUDY | ||||
Mpima S , Nasuti P , Casey V | ||||
IQVIA London , UK | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, France, Italy | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | , Clinical setting: Primary care | |
DESCRIPTIVE ANALYSIS OF THE USE OF TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKAEMIA IN EUROPE, A REAL-WORLD PERSPECTIVE | ||||
Martinez de Pinillos A1, Nasuti P1, Anger C1, Ricorte I2 | ||||
1 IQVIA London UK , 2IQVIA Madrid Spain | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Assessing and modeling organizational impact of tilmanocept in performing sentinel lymph node biopsy in France | ||||
Clément Le Dissez1, Pascal Paubel2, Frédéric Courbon3, Rémy Herve4, Mark Rance5, Marie-Aude Courteille6 | ||||
1IQVIA Opération France, Paris, La Défense ; 2Inserm UMR S 1145, Institut Droit et Santé, faculté de pharmacie de Paris, Université Paris Descartes, Sorbonne Paris Cité, 4 avenue de l’observatoire, 75006 Paris, France ; 3 Department of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France ; 4 Department of Pharmacy, Institute of Cancerology Gustave Roussy, University of Paris-Sud, Villejuif, France ; 5Norgine, Corporate ; 6Norgine, France | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Health economics, Oncology | 2018 | English | , Budget impact, Literature Review, Public Health | |
LIMITATIONS AND EXPECTED CHALLENGES OF CAR-T ECONOMIC EVALUATION. | ||||
Allou A*, Carette J*, Minacori R*, Touahmia S*, Bourguignon S*, Troubat A*, Maurel F* | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Health economics, Hematology | 2018 | English | , Cost effectiveness, Market impact, Review | |
WHAT INTERPRETATION OF ICERS IN ORPHAN DISEASES? A FRENCH EXAMPLE. | ||||
Moutier Hélène; Bourguignon Sandrine; Maurel Frédérique; Bodaghi Charles | ||||
RWI IQVIA France | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Health economics, Pricing and reimbursement, Rare Diseases | 2018 | English | , Cost effectiveness, Pricing & Reimbursement, Willingness to pay | |
A RETROSPECTIVE DATABASE STUDY TO DEFINE A PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENT COHORT AND EVALUATE THE ECONOMIC BURDEN OF ILLNESS IN FRANCE | ||||
Petrica N (1), Beaudier E(1),Exposto F (2), Beaudet A(3) | ||||
(1) IQVIA, Paris France (2) IQVIA, London UK (3) Actelion Pharmaceuticals Ltd, Switzerland | ||||
ISPOR 2018 |
||||
, Article, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2018 | English | , Cost analysis, Cost of illness, Retrospective database analysis | |
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe. | ||||
Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5 | ||||
1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France | ||||
European Society of Cardiology (ESC) Congress, 2018, Munich, Germany |
||||
, Poster | ||||
, Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
Abstract: https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-3-Health-economics/176943-patient-and-caregiver-productivity-loss-and-indirect-costs-associated-with-cardiovascular-events-in-europe | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Health economics | 2018 | English | , Burden of illness, Cost of illness | |
ECONOMIC IMPACT OF THE PATIENT BLOOD MANAGEMENT FROM A FRENCH NATIONAL PAYER AND HOSPITAL PERSPECTIVES IN FRANCE | ||||
Vasilescu L , Champs F-O1, Durand-Zaleski I | ||||
1 IQVIA France - RWI, 2 URCEco - Hôpital de l'Hôtel Dieu, Paris France | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2018 | English | , Budget impact, Economic evaluation | |
EXPLAINING THE DISPARITIES OF MARKET ACCESS FOR GLIFLOZINS IN FRANCE, SPAIN, GERMANY AND THE UNITED-KINGDOM | ||||
Bodaghi Charles, Benque Emma, Troubat Arnaud | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France, Germany, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Clinical setting: Home care, Pricing & Reimbursement | |
ASSESSMENT OF THE UNIT COSTS IN IMAGING ACTS: THE EXAMPLE OF MRI AND CT-SCAN ACTS IN France | ||||
Vasilescu L., Faller M., Allou A. | ||||
IQVIA France - RWI | ||||
ISPOR 2018 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Methodology | 2018 | English | , Literature Review, Public Health, Review | |
PATTERNS OF CARE OF ADVANCED SOFT TISSUE SARCOMAS (STS) NON-GIST IN FOUR EUROPEAN COUNTRIES (EU4) | ||||
Mari E1,Martinez de Pinillos A2, Nasuti P2,Guglielmetti F1, Anger C2 | ||||
1IQVIA Milan Italy , 2IQVIA London UK | ||||
CTOS 2018 Rome |
||||
, Poster | ||||
, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Patterns of Therapy in Regional Lymph Node Positive Prostate Cancer in Europe and Asia: An International Analysis | ||||
Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R, Payne H 1 | ||||
1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Abstract: ESMO 2018 Congress | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Drug treatment in melanoma: a real-world analysis across Europe and Japan | ||||
Martinez de Pinillos, Anger C, Nasuti P | ||||
IQVIA London UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Initial Management of localised prostate cancer in the Elderly: An International Data Review | ||||
Prentice M1, Mpima S2, Martinez de Pinillos A2, Nasuti P2, Davda R1, Payne H1 | ||||
1 University College Hospital, London, UK 2 IQVIA , London, UK | ||||
SIOG 2018 |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, South Korea, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Treatment algorithm for multiple myeloma: real-world insights across five European countries | ||||
Dr Rocci1, Bulger P1, Martinez de Pinillos A2 , Anger C2 , Nasuti P2, Manuguid F2 | ||||
1Manchester University NHS Foundation Trust, Manchester Royal Infirmary, 2 IQVIA London UK | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Clinical characteristics of Glioblastoma Multiforme (GBM) Patients Who Reached 400 Days Post Diagnostic from a Retrospective Real-World Data | ||||
Mitrofan L.M.1,Krukas-Hampel M.R.2, Mendoza L.A.3 | ||||
1 IQVIA, Paris, FR; 2IQVIA New York, US; 3IQVIA, Prague, CZ | ||||
ESMO 2018 |
||||
, Poster | ||||
, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Clinical Characteristics of 3,030 Glioblastoma Multiforme (GBM) Patients in High, Upper Middle and Lower Middle Economic Regions Based on Real-World Data (RWD) | ||||
Mitrofan L1 , M.R. Krukas-Hampel M.R2 , L.A. Mendoza L.A3 | ||||
IQVIA, Paris, FR; IQVIA New York, US; IQVIA, Prague, CZ | ||||
ESMO 2018 |
||||
, Poster | ||||
, Australia, Brazil, Canada, France, Germany, Italy, Mexico, Spain, Taiwan, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Verification of guideline conform mCRC treatment with EGFR inhibitors with real-world evidence data from EU5 countries | ||||
Hoyer L, Schmidt N | ||||
IQVIA Frankfurt Germany | ||||
ESMO 2018 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data | ||||
Maroun R1,2, Mitrofan L3, Benjamin L1 Nachbaur G1, Maunoury F4 Le Jeunne P3 Durand-Zaleski I2,5 | ||||
1GlaxoSmithKline, Health Economics and Outcomes Research,France 2INSERM, ECEVE, UMR 1123, Paris, France 3IQVIA, La Défense, France 4Statesia, Le Mans, France 5URC-ECO, APHP, Paris, France | ||||
BMC Cancer. 2018; 18: 214. |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822611/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2018 | English | ||
Real-World Use of Dulaglutide in Europe: A Multi-Country Drug Utilization Study | ||||
Ali AK, Toussi M, Phillips S, Roste M | ||||
Ali AK: Eli Lilly and Company; Toussi M: IQVIA; Phillips S: IQVIA; Roste M: IQVIA | ||||
34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Abstract | ||||
, France, Germany, Spain, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Drug Utlization Study, Drug Utlization Study | 2018 | English | , Database Study, Epidemiological study | |
TREATMENT AND DOSING PATTERNS AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) INITIATING GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) IN SEVERAL COUNTRIES | ||||
Norrbacka K, Divino V, Boye K, Lebrec J, Dekoven M | ||||
Eli Lilly, IQVIA | ||||
ISPOR Europe 2018 |
||||
, Poster | ||||
, Belgium, Canada, France, Germany, Italy, Netherlands | ||||
Abstract: https://tools.ispor.org/ScientificPresentationsDatabase/Presentation/84796?pdfid=57383 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2018 | English | , Retrospective database analysis | |
Télémédecine et dépenses de santé – une modélisation économique évaluant l’impact d’une intervention en télémédecine dans trois pathologies chroniques : diabète de type 2, hypertension artérielle et cancer de la prostate. | ||||
S. Sclison, C. Le Pen, I. Bardoulat, A. Gayon, C. Kolahi, M. Belhassen, F. Depont, E. Van Ganse | ||||
a IQVIA, Courbevoie, France b Pharmaco-épidémiologie Lyon (PELyon), Lyon, France | ||||
Doi : 10.1016/j.respe.2018.04.053 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.em-consulte.com/article/1215540/telemedecine-et-depenses-de-sante-%E2%80%93%C2%A0une-modelisati | ||||
Condition | Year | Language | Analysis type | |
, Drug Utlization Study | 2018 | French | , Observational study, Population Based Study | |
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective | ||||
Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J6. | ||||
Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2 Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. 3 Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. 4 Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. 5 Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. 6 AstraZeneca, London, United Kingdom. | ||||
Breast. 2017 Apr;32:247-255. |
||||
, Article | ||||
, France, Germany, Italy, Spain | ||||
Abstract: http://www.sciencedirect.com/science/article/pii/S0960977616302648 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , clinical setting: Secondary care, Retrospective database analysis | |
Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model. | ||||
Gerlier L1, Lamotte M1, Grenèche S2, Lenne X3, Carrat F4,5, Weil-Olivier C6, et al. | ||||
1 QuintilesIMS, Zaventem, Belgium 2 AstraZeneca, Rueil-Malmaison, France 3 University Lille Nord de France, Lille, France 4 Sorbonne Universités, Paris, France 5 Saint-Antoine Hospital, Paris, France 6 University Paris VII, Paris, France | ||||
Appl Health Econ Health Policy, 2017, Apr, 15(2): 261-276 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/27943165 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2017 | English | ||
Multicenter evaluation of Time, Operational and Economic Efficiencies of a New Pre-loaded IOL delivery system vs manual IOL delivery | ||||
Mendicute J1, Pablo L2, Vélasque L3, Martinez A4, Asmar J5, Schweitzer C6 | ||||
1.Hospital Universitario Donostia Servicio de Oftalmología 2.Hospital Universitario Miguel Servet Servicio de Oftalmología 3.Centre Retine Gallien Bordeaux 4.Alcon Laboratories, Inc., Fort Worth, TX 5.IMS Health Information Solutions France 6.Department of Ophthalmology, Bordeaux University Hospital, France | ||||
ASCRS (cataract congress) |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2017 | English | , Cost effectiveness, Observational study, Prospective study | |
Etude DISCOVER France - étude enrichie visant à décrire la prise en charge des patients diabétiques de type 2 | ||||
Harmand S.1, Maillard C.1, Thomas F.2 | ||||
1. QuintilesIMS, La Défense, France. 2. Astra Zeneca, La Défense, France | ||||
ADELF-SFSP congress (l'Association des épidémiologistes de langue française - Société française de santé publique) June 2017 in France |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | French | , Clinical setting: Primary care, Longitudinal study, Observational study, Patient questionnaire, Quality of life, Real World Data | |
Regional Differences in Insulin Therapy Regimens in 5 European Countries | ||||
Rathmann W, Czech M, Franek E, Kostev K | ||||
Int J Clin Pharmacol Ther. 2017 May;55(5):403-408. |
||||
, Article | ||||
, France, Germany, Hungary, Poland, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | ||
CONVERSION OF A FRENCH ELECTRONIC MEDICAL RECORD (EMR) DATABASE INTO THE OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP COMMON DATA MODEL. | ||||
Schwalm MS 1, Raoul T 1 ,Chu D 2 , Shah U 3, Potdar M 4, Van Zandt M 5,Coffin G 1, Jouaville SL1 | ||||
1 QuintilesIMS, 90-92 Route de la Reine 92773 Boulogne-Billancourt, France 2 QuintilesIMS, One IMS Drive Plymouth Meeting, PA 19462 USA 3 QuintilesIMS, 100 IMS Drive Parsippany, NJ 07054 USA 4 QuintilesIMS, 291 King George Road, Warren, NJ 07059Warren, NJ USA 5 QuintilesIMS, 425 Market, San Francisco, CA 94105 San Francisco, CA USA | ||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Database Validity and methodology | 2017 | English | , Clinical setting: Primary care, Methodology | |
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
JHEOR 2017;5(1):89-108 |
||||
, Article | ||||
, Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
L’observance médicamenteuse des patients diabétiques de type 2 en île-de-france : état des lieux et priorités d’actions [Drug adherence in patients with type 2 diabetes in Île-de-France: state of play and priorities for action]. | ||||
Bardoulat I1, Chauvin F1, De Saunière A2, Le Jeunne P1, Perrot D1, Collet C2 | ||||
1 QuintilesIMS, La Défense, France 2 ARS Île-de-France, Paris, France | ||||
9ème Colloque données de santé en vie réelle / AFCROs (Cité Universitaire, Paris, 13 juin 2017) |
||||
, Oral presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Medication compliance | 2017 | French | , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis | |
Evaluation of the effectiveness of risk minimisation measures: a survey among health care professionals to assess their knowledge and attitudes on prescribing conditions of Instanyl® in France and the Netherlands. | ||||
Toussi M1, Garofano A1, Jouaville L1, Bardoulat I1, Mitrofan L1 | ||||
1 QuintilesIMS, La Défense, France | ||||
33rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2017, August 26-30, Montreal, Canada |
||||
, Poster | ||||
, France, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Pain, Risk Management & REMS | 2017 | English | , Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Public Health, Survey research | |
L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions [Drug adherence in patients with type II diabetes in the Île-de-France region: study results and priorities for action]. | ||||
Collet C1, De Saunière A1, Perrot D2, Bardoulat I2 | ||||
1 ARS Ile de France, Paris, France 2 Quintiles IMS, Paris, France | ||||
Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Medication compliance | 2017 | French | , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis | |
Long-term impact of grass-pollen (GP) sublingual immunotherapy tablet (SLIT) on allergic rhinitis (AR) and on allergic asthma (AA) onset and progression. | ||||
Devillier P1, Molimard M2, Demoly P3, Ansolabehere X4, Bardoulat I4, Coulombel N4, Maurel F4, Le Jeunne P4 | ||||
1 UPRES EA 220, Department of Airway Diseases, Hospital Foch, University Versailles Saint Quentin, Suresnes, France 2 Pharmacology Department, CHU of Bordeaux-University, INSERM CR1219 unit, Bordeaux, France 3 Departement of Pneumology and Addictology, Arnaud de Villeneuve Hospital- CHRU of Montpellier, Montpellier, France 4 QuintilesIMS, Real-World Insights (RWI) Department, La-Défense, France. | ||||
ISPOR 20th Annual European Congress, 2017, 4-8 November, Glasgow, Scotland |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Otolaryngology, Respiratory disease | 2017 | English | , Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Retrospective cohort analysis, Retrospective database analysis | |
Comparison of incremental cost-utility ratios and sales of direct oral anticoagulants across EU-5 countries. | ||||
Viayna E, Planellas L | ||||
Quintiles IMS | ||||
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual European Congress, 2017, Nov 4 - 8, Glasgow, Scotland, United Kingdom |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/Event/index/2017Glasgow | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Cost utility, Literature Review | |
Modelización del comportamiento de fármacos biosimilares en 5 países de europa [Modeling of the behavior of biosimilar drugs in 5 European countries]. | ||||
Manganelli AG1, Solozabal M2, Planellas L2, Rebollo P2, Puig-Junoy J1 | ||||
1 CRES - Universitat Pompeu Fabra, Barcelona, Spain 2 QuintilesIMS, RWI, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.aes.es/jornadas/es/#comunicaciones | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Drug Utlization Study | 2017 | Spanish | , Clinical setting: hospital | |
Clonal selection of TP53MUT and/or Del (p17) in CLL: evaluation of 3,373 CLL patients, A Real World Data story | ||||
Mpima S1, Moehler T2, Kanter S3, Mitrofan L4 | ||||
1 QuintilesIMS Health, Paris, France 2 QuintilesIMS Health, London, UK 3 QuintilesIMS Health, Frankfurt, Germany 4 QuintilesIMS Health, Durham, USA | ||||
ASCO 2017, Journal of Clinical Oncology, 2017, 35(Suppl no. 15):e19004-e19004 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.e19004 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Treatment paradigm shift in NSCLC: patient data analysis from 2005 to 2016. | ||||
Mitrofan L1, Sahni MK2, Dhingra D2, Mistry H3, Anger C3 | ||||
1 Quintiles IMS, Paris, France 2 Quintiles IMS, Gurgaon, India 3 Quintiles IMS, London, United Kingdom | ||||
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
Changing treatment patterns in metastatic colorectal cancer in EU5 countries from 2014 to 2016. | ||||
Hoyer L, Schmidt N | ||||
QuintilesIMS Global Oncology, Central, East & South Europe | ||||
ESMO 2017 Annual meeting, 2017, 8-12 September, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | , Retrospective database analysis | |
GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries. | ||||
Divino V., DeKoven M., Khan FA., Boye KS., Sapin H., Norrbacka K. | ||||
Lilly. IMS authors: Divino V, DeKoven M | ||||
Diabetes Ther. |
||||
, Article | ||||
, Belgium, France, Germany, Netherlands, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28070733 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
Cinacalcet Persistence and Adherence in France, Germany, and Italy | ||||
Dionne M. Hines1, Catherine B. McGuiness1, Rolin L. Wade1, Bruno Fouqueray2, Paul Dluzniewski2 | ||||
1QuintilesIMS, 2Amgen | ||||
54th ERA-EDTA Congress |
||||
, Poster | ||||
, France, Germany, Italy | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Nephrology | 2017 | English | , Retrospective database analysis | |
L’observance médicamenteuse des patients diabétiques de type II en Île-de-France : Résultats de l’étude et priorités d’actions | ||||
Catherine Collet(1) – Anne de Saunière (1) – Dominique Perrot (2) – Isabelle Bardoulat (2) | ||||
(1) ARS Ile de France, Paris, France – (2) Quintiles IMS, Paris, France | ||||
Congrés annuel de la Société Francophone du Diabète du 28 au 31 mars 2017, Lille, France |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Medication compliance | 2017 | French | , Clinical setting: Primary care, clinical setting: Secondary care, Compliance, Retrospective database analysis | |
Real World analysis for immune related side effects in 3000 patients | ||||
Mitrofan L 1, Moehler T 2, Ruiz M 3 | ||||
1IQVIA Paris , France 2IQVIA , Frankfurt, Germany, 3IQVIA, Madrid, Spain | ||||
ESMO - ImmunoOncology |
||||
, Poster | ||||
, Europe, France, Germany, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2017 | English | ||
A COST-EFFECTIVENESS ANALYSIS COMPARING THE ORIGINATOR RECOMBINANT HUMAN ALFA TO THEIR BIOSIMILARS FOLLITROPIN ALFA FOR THE TREATMENT OF INFERTILITY. | ||||
Ravonimbola H(1), Petrica N (1), Maurel F(1), Murphy C(2), Doré C(2), Fresneau L(2), | ||||
(1) QuintilesIMS, Paris France (2) Merck Serono, France | ||||
ISPOR 2017 |
||||
, Poster | ||||
, France | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(17)31033-1/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment | 2017 | English | , Cost effectiveness, Literature Review, Randomised controlled trial | |
HEALTH-ECONOMICS EVALUATIONS IN FRANCE, ENGLAND, CANADA AND AUTRALIA: COMPARISON OF METHODOLOGIES AND IMPACT ON DRUGS | ||||
Bucher D*, Abalan M-E*, Allou A*, Dumon L*, Vialard L *, Troubat A*, Maurel F* | ||||
IQVIA France - RWI | ||||
ISPOR 2017 |
||||
, Poster | ||||
, Australia, Canada, France, UK | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment | 2017 | English | , Cost effectiveness, Literature Review, Pricing & Reimbursement, Review | |
SCHÉMAS THÉRAPEUTIQUES ET POSOLOGIQUES CHEZ DES PATIENTS AVEC UN DIABÈTE DE TYPE 2 (DT2) INITIANT UN TRAITEMENT PAR AGONISTE DU RÉCEPTEUR DU GLUCAGON-LIKE PEPTIDE 1 (AR GLP-1) EN EUROPE | ||||
Norrbacka K, Divino V, Dekoven M, Boye KS | ||||
Eli Lilly, IQVIA | ||||
Societé Francophone du Diabete 2017 |
||||
, Poster | ||||
, Belgium, Canada, France, Germany, Italy, Netherlands | ||||
Abstract: https://www.sfdiabete.org/sites/www.sfdiabete.org/files/files/evenements/17sfd_final_v12.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2017 | English | , Retrospective database analysis | |
Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings | ||||
Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H | ||||
Policlinic of Rheumatology, Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany. Department of Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy. Department of Rheumatology, Complexo Hospitalario Universitario de Vigo, Ourense y Pontevedra, Spain. Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden. HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La Défense, France. Global Specialty Pharma Franchise, GlaxoSmithKline; Services Unlimited, Brentford, UK. Immunology Medical Department, GlaxoSmithKline spa, Verona, Italy. Department of Internal Medicine and Systemic Diseases, University Hospital of Dijon, 5bis INSERM U866 5ter INSERM CIC-EC 1432, Dijon, France. | ||||
Rheumatology (Oxford). 2017 May 1;56(5):818-828 |
||||
, Article | ||||
, France, Germany, Italy, Spain, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28204765 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Rheumatology | 2017 | English | , Retrospective Field Study | |
Do intra-articular hyaluronic acid injections delay total knee replacement in patients with osteoarthritis - A Cox model analysis | ||||
Angélique Delbarre 1, Bernard Amor 2, Isabelle Bardoulat 3, Aymeric Tetafort 3, Nathalie Pelletier-Fleury 1 | ||||
1INSERM, Center for research in Epidemiology and Population Health, Université Paris-Saclay, Université Paris-Sud, UVSQ, Villejuif, France. 2Université Paris Descartes, Paris, France. 3QuintilesIMS, Paris La Défense 2, France. | ||||
PLoS One . 2017 Nov 20;12(11):e0187227. doi: 10.1371/journal.pone.0187227. eCollection 2017. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/29155833/ | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics | 2017 | English | , Observational study, Public Health | |
Real-life cost of vitamin K antagonist treatment in patients with non-valvular atrial fibrillation in France in 2013 | ||||
Jean Dallongeville 1, Xavier Ansolabehere 2, Noëlla Karusisi 2, Frédérique Maurel 2, Eric Van Ganse 3, Jean-Yves Le Heuzey 4 | ||||
1a Institut Pasteur , Lille , France. 2b QuintilesIMS , Real-World Insights (RWI) , La Defense , France. 3c PELyon (Pharmacoepidemiology Lyon); HESPER 7425 , Health Services and Performance Research UCBL , Lyon , France. 4d Hôpital Européen George Pompidou , René Descartes University , Paris , France. | ||||
J Med Econ . 2017 Sep;20(9):974-981. doi: 10.1080/13696998.2017.1352508. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/28682153/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2017 | English | , Database Study, Observational study | |
TREATMENT PATTERNS OF METASTATIC MELANOMA IN FIVE EUROPEAN COUNTRIES | ||||
Burudpakdee C1, Zhao Z2, Seetasith A1, Ma Q2, Campos Tapias I3, Barber BL2 | ||||
1 MS Health, Fairfax, VA, USA, 2 Amgen Inc, Thousand Oaks, CA, USA, 3 Amgen SA, Barcelona, Spain | ||||
ISPOR 21st, May 2016 Washington, USA |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. | ||||
Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. | ||||
1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden. | ||||
Clinical Epidemiology |
||||
, Article | ||||
, Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK | ||||
Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/ | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Literature Review | |
TREATMENT INDICATIONS FOR ANTIDEPRESSANTS PRESCRIBED IN PRIMARY CARE IN FRANCE, 2006-2015 | ||||
Schwalm MS, Miotti H, Hellard C, Nounit L, Trehony J, Jouaville SL | ||||
IMS HEALTH, Boulogne Billancourt, France | ||||
ISPOR 19th Annual European Congress, 2016, 29 October-2 November, Vienna, Austria. |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Mental health | 2016 | English | , Clinical setting: Primary care, Retrospective database analysis | |
Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. | ||||
Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 | ||||
1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
, Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2016 | English | ||
Three-monthly long-acting formulation of paliperidone palmitateis a dominant treatment option, cost saving while adding QALYs, compared to the one-monthly formulation in the treatment of schizophrenia in France. | ||||
Arteaga Duarte C1, Colin X2, De Moor R1, Guillon P3, van Gils CW1 | ||||
1 QuintilesIMS, Zaventem, Belgium, 2 QuintilesIMS, La Défense, France, 3 Janssen-Cilag France, Issy-les-Moulineaux, Cedex, France | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2016 | English | , Methodology | |
METHODOLOGICAL REVIEW OF SURVIVAL MODELS: APPLICATION TO A PERSISTENCE ANALYSIS BASED ON LONG ACTING PARENTERAL ANTIPSYCHOTIC IN RETAIL PHARMACIES IN FRANCE | ||||
Harmand S, El Mouaddin N | ||||
IMS Health France | ||||
19th ISPOR COngress 2016 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Medication compliance, Methodology | 2016 | English | , Compliance, Database Study, Methodology | |
IMPACT OF POST-INSCRIPTION STUDIES ON REASSESSMENT IN FRANCE: A CASE STUDY ON ORPHAN DRUGS | ||||
Jubert H, Ouali I, Kolahi C | ||||
IMS Health France | ||||
19th ISPOR congress 2016 |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PHP311.pdf | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2016 | English | , Clinical setting: Primary care, Literature Review, Pricing & Reimbursement, Review | |
COSTS EVOLUTION OF CANCER THERAPIES IN EUROPE FROM 2004 TO 2014 | ||||
Tetafort A, Aubert JM, Perrot D, Brigot G, Kolahi C, Ansolabehere X | ||||
IMS Health France | ||||
19th ISPOR Congress 2016 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN82.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology, Pricing and reimbursement | 2016 | English | , Clinical setting: hospital, Cost analysis, Pricing & Reimbursement, Retrospective database analysis | |
USE OF REAL WORLD DATA IN IDENTIFYING RELEVANT COMPARATORS IN MEDICO ECONOMIC MODELS AT EU5 LEVEL: A CASE STUDY ON MULTIPLE MYELOMA | ||||
Jubert H, Kolahi C, Karusisi N, Mitrofan L | ||||
IMS Health France | ||||
19th ISPOR congress 2016 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2016 | English | , Clinical setting: hospital, Population Based Study, Real World Data, Retrospective database analysis | |
STATISTICAL MODELS TO PREDICT INDICATION OF RESPIRATORY PATIENTS BETWEEN ASTHMA AND COPD | ||||
Ilgin Y, Staus A, Chauvin F, Leheyda N, Wolk A, Witte M, Subramani S | ||||
19th ISPOR congress 2016 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health status & patient reported outcomes, Methodology, Respiratory disease | 2016 | English | , Methodology, Retrospective database analysis | |
BIOLOGICS USE IN CROHN’S DISEASE IN France | ||||
1-Morand F, 2-Gaudry JL, 3-Willemin L, 4-Lee XY, 5-Lelli F | ||||
1- IMS Health Paris France, 2- IMS Health Boulogne-Billancourt France, 3-Janssen-Cilag Issy-les-Moulineaux France, 4-Janssen-Cilag Birkerod Denmark, Janssen-Cilag Colgno Monzese Italy | ||||
19th ISPOR Congress 2016 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Gastrointestinal disorders | 2016 | English | , Retrospective database analysis, Survey research | |
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based study. | ||||
Peyrin-Biroulet L1, Van Assche G2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. | ||||
1Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. Electronic address: peyrinbiroulet@gmail.com. 2Division of Gastroenterology, University Hospitals Leuven, Leuven Belgium. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. 10IMS Health, Real World Evidence Solutions, Spain. 11Merck & Co., Inc., Kenilworth, NJ, United States | ||||
Dig Liver Dis. 2016 Jun;48(6):601-7. |
||||
, Article | ||||
, Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2016 | English | , Burden of illness, Patient questionnaire, Survey research | |
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study | ||||
Van Assche G1, Peyrin-Biroulet L2, Sturm A3, Gisbert JP4, Gaya DR5, Bokemeyer B6, Mantzaris GJ7, Armuzzi A8, Sebastian S9, Lara N10, Lynam M10, Rojas-Farreras S10, Fan T11, Ding Q11, Black CM11, Kachroo S11. | ||||
1Division of Gastroenterology, University Hospitals Leuven, Leuven, Belgium. Electronic address: gert.vanassche@uzleuven.be. 2Department of Hepato-Gastroenterology and Inserm U954, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France. 3Department of Gastroenterology, DRK Kliniken Berlin I Westend, Berlin, Germany. 4Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP) and Centro de Investigación Biomédica and Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain. 5Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK. 6Gastroenterology Practice, Minden, Germany. 7Department of Gastroenterology, Evangelismos Hospital, Athens, Greece. 8IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. 9Gastroenterology and IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK. 10IMS Health, Real World Evidence Solutions, Barcelona, Spain. 11Merck & Co., Inc., Rahway, NJ, United States. | ||||
Dig Liver Dis. 2016 Jun;48(6):592-600 |
||||
, Article | ||||
, Belgium, France, Germany, Greece, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, UK | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2016 | English | , Burden of illness, Patient questionnaire | |
Validité et limites de la base de données Longitudinal Patient Database France pour les études pharmacoépidémiologiques et pharmacoéconomiquesv | ||||
Sophie L. Jouaville, Hakima Miotti, Gabriel Coffin, Bruno Sarfati, Adeline Meilhoc | ||||
QuintilesIMS, Boulogne-Billancourt, France | ||||
Rev Epidemiol Sante Publique, 2016 ; 64 (5) : s280-S281 |
||||
, Abstract | ||||
, France | ||||
Abstract: http://www.sciencedirect.com/science/article/pii/S0398762016302395 | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2016 | French | , Retrospective database analysis | |
L’épidémiologie de la gale en France métropolitaine de 2000–2014 : accélération de la recrudescence à partir de 2009. | ||||
: D.J. Slade, M.J. Campbell, S.L. Jouaville C.E. Bennett. | ||||
QuintilesIMS, Boulogne Billancourt, France | ||||
Rev Epidemiol Sante Publique, 2016 ; 64 (6) : S302-S303 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease, Public Health | 2016 | French | , Retrospective database analysis | |
Patient database analysis of fulvestrant 500 mg in the treatment of metastatic breast cancer: A European perspective | ||||
Marchetti P1, Maass N2, Gligorov J3, Berger K4, MacDougall F5, Montonen J6, Lewis J7. | ||||
1Department of Clinical and Molecular Medicine, Sapienza University of Rome and IDI-IRCCS, Rome, Italy. Electronic address: paolo.marchetti@ospedalesantandrea.it. 2Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein, Kiel, Germany. Electronic address: Nicolai.Maass@uksh.de. 3Department of Medical Oncology, INSERM U938, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, France. Electronic address: joseph.gligorov@aphp.fr. 4Real World Evidence Solutions and HEOR, IMS Health, Munich, Germany. Electronic address: KBerger@de.imshealth.com. 5Real World Evidence Solutions and HEOR, IMS Health, London, United Kingdom. Electronic address: FMacDougall@uk.imshealth.com. 6AstraZeneca, London, United Kingdom. Electronic address: jukka.montonen@astrazeneca.com. 7AstraZeneca, London, United Kingdom. Electronic address: Jan.Lewis@astrazeneca.com. | ||||
Breast. 2016 Dec 20. pii: S0960-9776(16)30264-8. |
||||
, Article | ||||
, France, Germany, Italy, Spain | ||||
Abstract: https://linkinghub.elsevier.com/retrieve/pii/S0960-9776(16)30264-8 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis. | ||||
Nyberg F1,2, Horne L3, Morlock R4, Nuevo J5, Storgard C4, Aiyer L4, Hines DM6, Ansolabehere X7, Chevalier P8 | ||||
1 AstraZeneca, Mölndal, Sweden 2 University of Gothenburg, Gothenburg, Sweden 3 AstraZeneca, Wilmington, USA 4 Ardea Biosciences, San Diego, USA 5 AstraZeneca, Madrid, Spain 6 IMS Health, Alexandria, USA 7 IMS Health, Paris, France 8 IMS Health, Vilvoorde, Belgium | ||||
Advances in Therapy, 2016, 33(7): 1180–1198 |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
2016 | English | |||
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. | ||||
Morlock R1, Chevalier P2, Horne L3, Nuevo J4, Storgard C1, Aiyer L1, Hines DM5, Ansolabehere X6, Nyberg F7,8 | ||||
1 Ardea Biosciences, San Diego, CA, USA 2 IMS Health HEOR, Zaventem, Belgium 3 AstraZeneca, Wilmington, DE, USA 4 AstraZeneca, Madrid, Spain 5 IMS Health HEOR, Fairfax, VA, USA, 6 IMS Health HEOR, Paris, France, 7 AstraZeneca, Mölndal, Sweden 8 University of Gothenburg, Gothenburg, Sweden | ||||
Rheumatol Ther., 2016, 3(1): 53-75 |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2016 | English | ||
Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. | ||||
Morlock R, Chevalier P, Horne L, Nuevo J, Storgard C, Aiyer L, Hines DM, Ansolabehere X, Nyberg F. | ||||
Rheumatol Ther. 2016 Jun;3(1):53-75. |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health policy, Metabolic Disorders , Public Health | 2016 | English | , Retrospective cohort analysis | |
Prasugrel Use in Real Life: A Report From the Outpatient Setting in France. | ||||
Sabouret P, Taiel-Sartral M, Chartier F, Akiki S, Cuisset T. | ||||
Clin Cardiol. 2016 Jul;39(7):378-84. doi: 10.1002/clc.22553. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Drug Utlization Study | 2016 | English | ||
Novel therapy options for advanced & metastatic melanoma patients in EU5 countries result in a changing treatment pattern especially in BRAF mutant patients. | ||||
Bernhardt M, Schmidt N, Mambrini T | ||||
IMS Health Global Oncology, Central, East & South Europe | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32626 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Changing treatment patterns in advanced & metastatic melanoma towards targeted therapies in EU5 countries from 2011 to 2015. | ||||
Bernhardt M, Schmidt N, Mambrini T | ||||
IMS Health Global Oncology, Central, East & South Europe | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32287 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Brain metastasis in NSCLC in the era of precision Medicine. | ||||
Mpima S, Anger C, Mitrofan L | ||||
1 IMS Health, London, United Kingdom 2 IMS Health, La Defense, France | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2016/Brain-metastases-in-NSCLC-patients-in-the-era-of-precision-medicine | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Observational study | |
17P Deletion and TP53 Gene Mutation (17P/TP53) testing behaviour and treatment patterns for Chronic Lymphocytic Leukaemia (CLL) patients in France, Germany, Italy, Spain and U.K. (EU5). | ||||
Bermudez F, Karanais Y, Mistry H, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://poster-submission.com/esmo2016/visitors/eposter/32724 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Retrospective database analysis | |
Real Life Progression Free Survival and treatment Patterns for Patients with Metastatic Renal Cell Carcinoma treated with Targeted Therapies in France: Analysis of IMS RWD Oncology Cross-sectional Survey Data. | ||||
Maroun R, Mitrofan L, Benjamin L, Nachbaur G, Maunoury F, Le Jeunne P, Durand Zaleski I | ||||
GlaxosmithKline, Health Economics and Outcome Research, Marly le Roi France, Eceve, Paris, France, Quintiles IMS, France Le Mans, France, URC Eco, Paris, France | ||||
ESMO 2016 Annual Meeting, 2016, 07 Oct - 11 Oct, Copenhagen, Denmark |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN47.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Longitudinal study | |
Understand the Role of dermatologists and Oncologists in the treatment of Melanoma in France and the UK. | ||||
Mpima S, Casey V, Nasuti P | ||||
QuintilesIMS, London, United Kingdom | ||||
IPSOR 2016 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(16)32943-6/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | , Observational study | |
Use of Real World Data in identifying relevant comparators in medico economic models at EU5 level: A case study on Multiple Myeloma. | ||||
Jubert H, Karusisi N, Kolahi C, Mitrofan L | ||||
QuintilesIMS, La Defense, France | ||||
IPSOR 2016 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.ispor.org/research_pdfs/54/pdffiles/PCN150.pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2016 | English | ||
Treatment and dosing patterns among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Europe. | ||||
Kirsi Norrbacka; Victoria Divino; Mitch DeKoven; Kristina Secnik Boye | ||||
Lilly. IMS authors: Divino V, DeKoven M | ||||
European Association for the Study of Diabetes 52nd annual meeting |
||||
, Poster | ||||
, Belgium, France, Germany, Netherlands, Sweden | ||||
Abstract: https://www.easd.org/virtualmeeting/home.html#!resources/treatment-and-dosing-patterns-among-patients-with-type-2-diabetes-initiating-glucagon-like-peptide-1-receptor-agonists-glp-1-ras-in-europe-5ef3fe71-7e5d-4bdd-8b32-b4187d2a9aac | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2016 | English | , Retrospective database analysis | |
Évaluation d’une base de données issue des dossiers médicaux informatisés d’un panel d’endocrinologues français | ||||
Christine Hellard, Sophie L. Jouaville, Simon Pilet, Adeline Meilhoc | ||||
IQVIA FRANCE | ||||
Rev Epidemiol Sante Publique |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2016 | French | , Observational study | |
Liver transplant associated with paracetamol overdose: results from the seven-country SALT study | ||||
Sinem Ezgi Gulmez,1 Dominique Larrey,2 Georges- Philippe Pageaux,2 Jacques Bernuau,3 Franco Bissoli,4 Yves Horsmans,5 Douglas Thorburn,6 P. Aiden McCormick,7 Bruno Stricker,8 Massoud Toussi,9 Séverine Lignot-Maleyran,1 Sophie Micon,1 Fatima Hamoud,1 Régis Lassalle,1 Jérémy Jové,1 Patrick Blin1 & Nicholas Moore1 | ||||
1CIC Bordeaux CIC1401 Pharmaco-épidémiologie, Université de Bordeaux, F-33076 Bordeaux, France, 2CHU St Eloi Hospital, Liver Unit, Montpellier, France, 3Beaujon Hospital, Liver Unit, Clichy, France, 4Department of Internal Medicine, Clinica San Gaudenzio, Novara, Italy, 5Department of Gastroenterology, Louvain Catholic University, Louvain, Belgium, 6Liver Unit, Royal Free NHS Trust, London, UK, 7Liver Unit, St Vincent’s University Hospital and University College Dublin, Dublin, Ireland, 8Department of Epidemiology, Erasmus University, Rotterdam, Netherlands and 9IMSHealth, Real World Evidence Solutions, France | ||||
British Journal of Clinical Pharmacology 2015 |
||||
, Article | ||||
, France, Greece, Ireland, Italy, Netherlands, Portugal, UK | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Public Health | 2015 | English | , Epidemiological study | |
The daily cost of ICU patients: A micro-costing study in 23 French Intensive Care Units. | ||||
Lefrant JY1, Garrigues B2, Pribil C3, Bardoulat I4, Courtial F4, Maurel F4, Bazin JÉ5; CRREA Study Group; AzuRea Group. | ||||
1Division anesthésie réanimation douleur urgences, faculté de médecine, université Montpellier 1, CHU de Nîmes, place du Professeur-Robert-Debré, 30029 Nîmes cedex 9, France. Electronic address: jean.yves.lefrant@chu-nimes.fr. 2Service de réanimation et de surveillances médico-chirurgicales polyvalentes, centre hospitalier du Pays d'Aix, Aix-en-Provence, France. 3Health Outcomes Department, GlaxoSmithKline, 100, route de Versailles, 78163 Marly-le-Roi cedex, France. 4IMS Health, Health Economics and Outcomes Research Department, Tour Ariane, 5-7, place de la Pyramide, 92088 La Défense cedex, France. 5Service anesthésie réanimation, CHU de Clermont-Ferrand, 1, place Lucile-Aubrac, 63003 Clermont-Ferrand cedex, France. | ||||
Anaesthesia Critical Care and Pain Medicine 2015 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25986476 | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2015 | English | , Cost analysis, Economic evaluation, Observational study | |
High prevalence of co-morbidities and complex polypharmacy with drug-drug interaction (DDI) potential in patients with chronic Hepatitis C (CHC). Consistent findings from large primary care databases in the United Kingdom, Germany, and France | ||||
Fiona Marra1, 10, Werner Leber3, Stephen T. Barclay2, Stefan Christensen 5, Denis Ouzan7, Valerie Oules8, Peter McMahon4, Karel Kostev6, Xavier Ansolabehere9 | ||||
1. NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. 2. Walton Liver Clinic, Glasgow, United Kingdom. 3. Centre for Primary Care and Public Health, London, United Kingdom. 4. IMS Health UK, London, United Kingdom. 5. Center for Interdisciplinary Medicine (CIM) Infectious Diseases, Münster, Germany. 6. IMS Health Germany, Frankfurt, Germany. 7. Institut Arnault Tzanck, Saint-Laurent-du-Var, France. 8. Hôpital Saint Joseph, Marseille, France. 9. IMS Health France, Paris, France. 10. University of Liverpool, Glasgow, United Kingdom. | ||||
AASLD - Congress of American Association for the Study of Liver Diseases |
||||
, Abstract, Poster | ||||
, France, Germany, UK | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2015 | English | , Database Study, Real World Data | |
Treatment maintenance duration of dual therapy with metformin and sitagliptin in type 2 diabetes: The ODYSSEE observational study | ||||
Valensi P1, de Pouvourville G2, Benard N3, Chanut-Vogel C3, Kempf C4, Eymard E5, Moisan C3, Dallongeville J6. | ||||
1Department of Endocrinology-Diabetology-Nutrition, Jean-Verdier Hospital, AP-HP, Paris Nord University, CRNH-IdF, CINFO, Bondy, France.2ESSEC, Cergy-Pontoise, France.3MSD France, Courbevoie, France.4CSD, Boulogne, France.5MSD France, Courbevoie, France 6INSERM U744, Institut Pasteur, Lille, France. | ||||
Diabetes Metab. 2015 Jun;41(3):231-8 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Prospective study | |
Public health and budget impact of probiotics on common respiratory tract infections: a modelling study. | ||||
Lenoir-Wijnkoop I 1,2, Gerlier L3, Bresson JL4, Le Pen C5, Berdeaux G3 | ||||
1 Utrecht University, Utrecht, The Netherlands 2 Danone Company, Paris, France 3 IMS, Vilvoorde, Belgium 4 Université Descartes, Hôpital Necker, Paris, France 5 Université Paris Dauphine, Paris, France | ||||
PLoS One. 2015 Apr 10;10(4):e0122765. doi: 10.1371/journal.pone.0122765. eCollection 2015. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25859849 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2015 | English | , Budget impact | |
Increased Treatment Cost Associated with Mantle Cell Lymphoma Disease Progression | ||||
Wade R1, Hu X2, Chen Y3, Mahmoud D4, Le Gouill S3 | ||||
IMS Health Global Market Access, Celgene, Summit, NJ, USA, Haematology Department, CHU Nantes and UMR892 INSERM, Nantes, France | ||||
EHA 2015, Congress of the European Hematology Association, June 2015 |
||||
, Abstract, Poster | ||||
, France, USA | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Cost analysis | |
DISCOVERing treatment of type 2 diabetes in real world settings using electronic medical record databases | ||||
Charbonnel B1, Gomes MB2, Khunti K3, Nicolucci A4, Pocock S5, Shestakova MV6, Shimomura I6, Fenici P7, García-Álvarez L8, Hammar N9, Hashigami K10, Hiller J8, Medina J11, Surmont FA12, Ji L13 | ||||
1University of Nantes, Nantes, France; 2Rio de Janeiro State University, Rio de Janeiro, Brazil; 3University of Leicester, Leicester, UK; 4Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy; 5London School of Hygiene and Tropical Medicine, London, UK; 6Endocrinology Research Center, Moscow, Russian Federation; 7Osaka University, Osaka, Japan; 8AstraZeneca, Cambridge, UK; 9IMS Health, London, UK; 10AstraZeneca, Mölndal, Sweden; 11AstraZeneca, Tokyo, Japan; 12AstraZeneca, Madrid, Spain; 13AstraZeneca, Shanghai, China; 14Diabetes Center, Peking University People’s Hospital, Beijing, China | ||||
EASD - 51st Annual Meeting of the European Association for the Study of Diabetes, 14–18 September 2015, Stockholm, Sweden |
||||
, Poster | ||||
, Canada, France, Germany, UK | ||||
Abstract: http://www.easdvirtualmeeting.org/resources/discovering-treatment-of-type-2-diabetes-in-real-world-settings-using-electronic-medical-record-databases--3 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Real World Data, Retrospective database analysis | |
An assessment of chemotherapy-induced nausea and vomiting direct costs in three EU countries. | ||||
Turini M1, Piovesana V1, Ruffo P1, Ripellino C2, Cataldo N2. | ||||
1 Helsinn S A., Lugano, Switzerland, 2 IMS Health Information Solutions Medical Research srl, Milan, Italy. | ||||
Drugs Context. 28;4:212285. |
||||
, Article | ||||
, France, Germany, Italy | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4544273/pdf/dic-4-212285.pdf | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Oncology | 2015 | English | , Survey research | |
Prescription of antibiotics and anxiolytics/hypnotics to asthmatic patients in general practice : a cross-sectional study based on Franch and Italian prescribing data | ||||
Darmon D1, Laforest L2, Van Ganse E3, Petrazzuoli F4,5, van Weel C6,7, Letrilliart L8. | ||||
1Département d'enseignement et de recherche en médecine générale, Faculté de médecine, Université de Nice Sophia-Antipolis,2Unité de Pharmaco épidémiologie, Faculté d'Odontologie, UMR 5558 CNRS - Université Claude-Bernard Lyon, 3Unité de Pharmaco épidémiologie, Faculté d'Odontologie, UMR 5558 CNRS - Université Claude-Bernard Lyon, CHU, 4SNAMID Caserta (Italian Society of General,Caserta, 5Department of Clinical Sciences in Malmö, Centre for Primary Health Care Research, Lund University, Malmö, Sweden. 6Department of Primary and Community Care, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. 7Australian Primary Health Care Research Institute, Australian National University, Canberra, ACT, Australia.8Département de médecine générale, Faculté de médecine, Université Claude-Bernard Lyon I | ||||
BMC Family Practice (2015) 16:14 |
||||
, Article | ||||
, France, Italy | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2015 | English | , Retrospective database analysis | |
Prevention of venous thromboembolic events by fondaparinux 2.5mg in general practice. ArchiMed Ville | ||||
Mahé I1, Daurès JP2, Pouchain D3, Quéré I4, Aubin C5, Doussaint J6, Schück S6, Leroyer C7 | ||||
1EA 7334 méthodologies et société (REMES), hôpital Louis-Mourier, université Paris 7, AP-HP, 178, rue des Renouillers, 92700 Colombes, France. 2IURC de Montpellier, 641, avenue du Doyen-Gaston-Giraud, 34093 Montpellier cedex, France; CHU de Nîmes, 30029 Nîmes, France. 3Département de médecine générale, UFR Tours, 10, boulevard Tonnellé, BP 3223, 37032 Tours cedex 1, France. 4Hôpital Saint-Eloi, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France. 5Laboratoire GlaxoSmithKline, 100, route de Versailles, 78160 Marly-le-roi, France. 6Kappa Santé, 4, rue de Cléry, 75002 Paris, France. 7Département de médecine interne et de pneumologie, université européenne de Bretagne, CHU de la Cavale-Blanche, boulevard Tanguy-Prigent, 29609 Brest cedex, France | ||||
J Mal Vasc. 2015 Jul 20. pii: S0398-0499(15)00121-3 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Drug Utlization Study, Orthopedics, Regulatory, Vascular disease | 2015 | English | , Prospective study | |
Patterns of use of oral anticancer treatments in France: a Retrospective Analysis of Cancer Treatments given ORally from 2004 to 2012 (Re-ACTOR study) | ||||
Benjamin L1, Maroun R, Maurel F, Bardoulat I, Ricarte C | ||||
1GlaxoSmithKline, Health Economics and Outcomes Research , Marly-le-Roi , France;2 IMS Health, La defense, Paris | ||||
Curr Med Res Opin. 2015 Feb;31(2):323-32 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26005879 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Database Study | |
Durée de maintien d'une bitherapie par Metformine-Sitagliptine chez les diabétiques de type 2 - Etude observationelle ODYSSEE | ||||
C. Moisan 1,, P. Valensi 2, G. De Pouvourville 3, N. Benard 4, C. Chanut-Vogel 4, J. Dallongeville 5 | ||||
1 MSD France, Paris, France, 2 Service d’endocrinologie, diabétologie, nutrition, Hôpital Jean-Verdier, CRNH-IdF, CINFO, Bondy, Paris, France, 3 ESSEC, Paris, France, 4 MSD France, Paris, France, 5 INSERM U744, Institut Pasteur, Paris, France. | ||||
SFD 2015 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Retrospective database analysis | |
A DESCRIPTION OF REAL-WORLD TREATMENT WITH ABIRATERONE ACETATE IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS IN THE POST-CHEMOTHERAPY SETTING IN FRANCE AND THE NETHERLANDS | ||||
Dearden L1, Musingarimi P2, Shalet N3, Demuth D4, Garcia Alvarez L4, Muthutantri A4, Venerus A4, Lasry R4, Hankins M4, Maher T3 | ||||
1Janssen EMEA HEMAR, High Wycombe, UK, 2Janssen-Cilag Ltd., High Wycombe, UK, 3Janssen, High Wycombe, UK, 4IMS Health, London, UK | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, France, Netherlands | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | ||
LISTE-EN-SUS REFORM IN FRANCE - WHAT ARE THE CONSEQUENCES? | ||||
Mitrano M, Flostrand S | ||||
IMS Consulting Group, Paris, France | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2015 | English | , Market impact | |
EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France. | ||||
Polack B1, Calvez T2, Chambost H3, Rothschild C4, Goudemand J5, Claeyssens S6, Borel-Derlon A7, Bardoulat I8, Maurel F8, Woronoff-Lemsi MC9; EQOFIX Study Group. | ||||
1Department of Hematology, University Hospital, and CNRS UMR5525, Grenoble-Alpes University, Grenoble, France. 2Sorbonne University, UPMC University of Paris 06, INSERM, UMR-S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France. 3APHM, Department of Pediatric Hematology, Children Hospital La Timone, and INSERM, UMR 1062, Aix-Marseille University, Marseille, France. 4Regional Hemophilia Center, Department of Hematology, University Hospital Necker Enfants Malades, Paris, France. 5Department of Hematology-Transfusion, University Hospital, Lille, France. 6Regional Hemophilia Center, Purpan Hospital, Toulouse, France. 7Regional Hemophilia and VWD Center, University Hospital, and INSERM U919, Caen, France. 8Department of Health Economics and Outcome Research, IMS Health, La Défense, France. 9Pharmacy, University Hospital, and INSERM UMR1098, Franche-Comté University, Besançon, France. | ||||
Transfusion (2015) |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25652955 | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2015 | English | , Economic evaluation, Observational study, Quality of life | |
DOES CONDITIONAL MARKETING AUTHORISATION INFLUENCE MARKET ACCESS IN FRANCE, ENGLAND, AND GERMANY? | ||||
Kaaniche A1, Troubat A1, Sherwood A2 | ||||
1IMS, PARIS, France, 2IMS Health, La Défense, France | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Abstract, Poster | ||||
, France, Germany, UK | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Pricing and reimbursement | 2015 | English | , Market impact | |
A CROSS-SECTIONAL STUDY ON INSULIN TREATMENTS AND GLYCEMIC CONTROL IN TYPE 2 DIABETES IN FRANCE, ITALY, GERMANY, UK AND SPAIN | ||||
Phan T1, Boutmy E2, Coulombel N2 | ||||
1Novo Nordisk Health Care AG, Zürich, Switzerland, 2IMS Health, Boulogne-Billancourt, France | ||||
ISPOR 18th Annual European Congress Milan, Italy November, 2015 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.ispor.org/research_pdfs/51/pdffiles/PDB13.pdf | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Retrospective database analysis | |
Validity and limitations of the Longitudinal Patient Database France for use in pharmacoepidemiological and pharmacoeconomics studies | ||||
Jouaville SL, Miotti H, Coffin G, Sarfati B, Meilhoc A | ||||
IMS HEALTH Information Solutions France, Boulogne-Billancourt, FRANCE | ||||
ISPOR 20th Annual International Meeting Philadelphia, PA, USA May, 201 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/ | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology | 2015 | English | , Longitudinal study | |
Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey | ||||
Sabouret P1, Bricard M2, Hermann MA2, Cotté FE2, Deret-Bixio L2, Rushton-Smith S3. | ||||
Heart Institute, Department of Cardiology, Pitié-Salpétrière Hospital, Pierre-and-Marie-Curie University, 75013 Paris, France. Electronic address: pierre.sabouret@psl.aphp.fr. 2Bristol-Myers Squibb, 92500 Rueil-Malmaison, France. 3Thrombosis Research Institute, SW3 6LR London, UK. | ||||
Arch Cardiovasc Dis. 2015 Nov;108(11):544-53. doi: 10.1016/j.acvd.2015.05.005. Epub 2015 Jun 22. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Guidelines, Public Health | 2015 | English | , Retrospective database analysis | |
Limited treatment adaptation despite poor asthma control in asthma patients treated with inhaled corticosteroids. | ||||
Roche N1, Pribil C2, Devillier P3, Van Ganse E4, Schück S5, Doussaint J5, Martin J5, Nachbaur G2, Boucot I2. | ||||
1a Respiratory and Intensive Care Medicine, Hôpital Cochin - Site Val de Grâce, Université Paris-Descartes , AP-HP, Paris , France . 2b GlaxoSmithKline , Marly-le-Roi , France . 3c Laboratory of Pulmonary Pharmacology UPRES EA220 , Hôpital Foch, University of Versailles-Saint Quentin en Yvelines , Suresnes , France . 4d Pharmacoepidemiology Unit, UMR CNRS 5558, University of Lyon , Lyon , France , and 5e Kappa Santé , Paris , France | ||||
J Asthma. 2016 Feb;53(1):76-85. doi: 10.3109/02770903.2015.1065421. Epub 2015 Oct 29. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2015 | English | , Prospective study | |
ASSESSMENT OF A FRENCH ENDOCRINOLOGIST ELECTRONIC MEDICAL RECORD DATABASE FOR USE IN OBSERVATIONAL STUDIES | ||||
Hellard C, Jouaville SL, Pilet S, Meihoc A | ||||
Cededim Strategic Data, Boulogne-Billancourt, France | ||||
ISPOR 20th Annual International Meeting Philadelphia, PA, USA May, 2015 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes | 2015 | English | , Retrospective database analysis | |
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database. | ||||
Detournay B1, Halimi S2, Robert J1, Deschaseaux C3, Dejager S4. | ||||
1Cemka-Eval, Bourg-la Reine, France. 2Department of Diabetology, Endocrinology and Nutrition, Grenoble University Hospital Center, Grenoble, France ; University Joseph Fourier, Grenoble, France. 3Novartis Pharma SAS, Market Access Department, Rueil-Malmaison, France. 4Novartis Pharma SAS, Medical and Scientific Affairs, Rueil Malmaison, France ; Department of Diabetology, Metabolism and Endocrinology, Pitié-Salpétrière Hospital, Paris, France. | ||||
Vasc Health Risk Manag. 2015 Jul 17;11:417-25. doi: 10.2147/VHRM.S84507. eCollection 2015. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Pricing and reimbursement | 2015 | English | , Prospective study, Retrospective database analysis | |
Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. | ||||
Fourcade RO1, Lacoin F, Rouprêt M, Slama A, Le Fur C, Michel E, Sitbon A, Cotté FE. | ||||
1Department of Urology, Centre Hospitalier Auxerre, Auxerre, France. | ||||
World J Urol. 2012 Jun;30(3):419-26 Epub 2011 Sep 3. |
||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2015 | English | , Prospective study, Quality of life, Retrospective database analysis | |
USE OF A FRENCH CLAIMS DATABASE TO ESTIMATE REAL-WORLD TREATMENT COSTS OF BENIGN PROSTATIC HYPERPLASIA | ||||
Jouaville SL1, DiNicola S2, Boutmy E1 | ||||
1Cededim Strategic Data, Boulogne-Billancourt, France, 2Inferential, Paris, France | ||||
ISPOR 20th Annual International Meeting Philadelphia, PA, USA |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/research_study_digest/details.asp | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2015 | English | , Cost of illness, Retrospective database analysis | |
Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. | ||||
Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14. | ||||
1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland. | ||||
Ann Rheum Dis. 2015 Jun;74(6):979-84 |
||||
, Article | ||||
, Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/ | ||||
Condition | Year | Language | Analysis type | |
, Comparative Effectiveness & Health Technology Assessment, Rheumatology | 2015 | English | , Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles | |
Hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the French health insurance database. | ||||
Detournay B1, Halimi S2, Robert J1, Deschaseaux C3, Dejager S4. | ||||
1Cemka-Eval, Bourg-la Reine, France. 2Department of Diabetology, Endocrinology and Nutrition, Grenoble University Hospital Center, Grenoble, France ; University Joseph Fourier, Grenoble, France. 3Novartis Pharma SAS, Market Access Department, Rueil-Malmaison, France. 4Novartis Pharma SAS, Medical and Scientific Affairs, Rueil Malmaison, France ; Department of Diabetology, Metabolism and Endocrinology, Pitié-Salpétrière Hospital, Paris, France. | ||||
Vasc Health Risk Manag. 2015 Jul 17;11:417-25 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514348/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2015 | English | , Retrospective database analysis | |
Clinical attributes, treatment, and control in hypertension (CATCH)-a French and Italian longitudinal patient database study | ||||
Wu D1, Mansoor G2, Kempf C3. | ||||
1Merck &Co., Inc., Kenilworth, NJ USA ; Global Health Outcomes, Merck & Co., Inc., 600 Corporate Drive, CRB-205, Cokesbury, NJ 08833 USA. 2Merck &Co., Inc., Kenilworth, NJ USA. 3Cegedim Strategic Data, Paris, France. | ||||
Clin Hypertens. 2015 Aug 10;21:18 |
||||
, Article | ||||
, France, Italy | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750805/pdf/40885_2015_Article_29.pdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2015 | English | , Retrospective database analysis | |
Évaluation d’une base de données issue des dossiers médicaux informatisés d’un panel d’endocrinologues français | ||||
Christine Hellard, Sophie L. Jouaville, Simon Pilet, Adeline Meilhoc | ||||
QuintilesIMS, Boulogne-Billancourt, France | ||||
Rev Epidemiol Sante Publique, 2016 ; 64 (5) : S280-S281 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Database Validity and methodology, Diabetes | 2015 | French | , Retrospective database analysis | |
Quality of life in patients suffering from active exudative age-related macular degeneration: the EQUADE study. | ||||
Matamoros E, Maurel F, Léon N, Solomiac A, Bardoulat I, Joubert M, Hermans M, Moser E, Le Picard S, Souied EH, Leveziel N | ||||
Department of Ophthalmology, University Hospital of Poitiers, Poitiers, France. IMS Health, Puteaux, France | ||||
Ophthalmologica. 2015; 234(3):151-9 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26337381 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2015 | English | , clinical setting: Secondary care, Cost analysis, Observational study, Patient questionnaire, Quality of life | |
Dose variation in metastatic breast cancer: Are European Medicines Agency summary of product characteristics (SmPC) being followed? | ||||
Charnock J, Bruce A, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e11581 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | ||
Evolution of RAS testing in colorectal cancer, in France, Germany, Italy, Spain and UK (EU5). | ||||
Bruce A, Anger C, Gajeperia C | ||||
IMS Health, London, United Kingdom | ||||
ASCO 2015 Annual Meeting, 2015, May 29-June 2, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2015.33.15_suppl.e14679 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Standards of care for first-line HER2+ metastatic breast cancer (mBC): Russia vs. EU5 (France, Germany, Italy, Spain, and UK). | ||||
Bruce A, Hurlock J | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2015 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29740 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Stratification of high risk HER2-/HR+ patients following AI therapy. | ||||
Mitrofan L, Gajperia C, Charnock J, Anger C | ||||
IMS Health, London, United Kingdom | ||||
ESMO 2015 Annual Meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.poster-submission.com/ecc2015/visitors/eposter/29751 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2015 | English | , Retrospective database analysis | |
Quality of Life in Patients Suffering from Active Exudative Age-Related Macular Degeneration: The EQUADE Study. | ||||
Matamoros E, Maurel F, Léon N, Solomiac A, Bardoulat I, Joubert M, Hermans M, Moser E, Le Picard S, Souied EH, Leveziel N. | ||||
Department of Ophthalmology, University Hospital of Poitiers, Poitiers, France. IMS Health, Puteaux, France | ||||
Ophthalmologica. 2015;234(3):151-9. |
||||
, Article | ||||
, France | ||||
Abstract: https://www.karger.com/Article/FullText/433448 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2015 | English | , clinical setting: Secondary care, Cost analysis, Observational study, Patient questionnaire, Quality of life | |
Patterns of systemic lupus erythematosus expression in Europe | ||||
Cervera R1, Doria A2, Amoura Z3, Khamashta M4, Schneider M5, Guillemin F6, Maurel F7, Garofano A7, Roset M8, Perna A9, Murray M10, Schmitt C11, Boucot I12 | ||||
1. Departmeent of Autoimmune Diseases, Hospital Clinic, Barcelona Spain, 2. Division of Rheumatology, University of Padova, Italy, 3. Internal medecine Department 2, la pitié Salpetrière Hospital, Paris France, 4. Lupus research Unit, The Rayne inistitue Lambeth Wing, St Thomas 'Hospital London, England, 5. Policlinic of Rheumatology, Heinrich-Heine University, Germany, 6. INSERM CIC-EC, CHU Nancy, France, 7. IMS HEOR, Paris La Défense France, 8. IMS HEOR, Barcelona Spain, 9. Immuno Inflammation & infectious diseases Global Franchise, GSK, UK, 10. Access to Medicine Centre of Excellence GSK, UK, 11. Global Health Outcomes GSK, UK, 12. Medical Dpt GSK, Marly-le-Roi France | ||||
Autoimmunity Reviews - Volume 13, Issue 6, June 2014, Pages 621-629 |
||||
, Article, Manuscript in preparation | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Dermatology, Immunology and Vaccination, Musculoskeletal disease, Neurological disorders | 2014 | English | , Epidemiological study, Observational study, Prospective study | |
Association of diabetes and cancer diagnosis in primary care practices in France | ||||
Grandfils N, Ricarte C, Solomiac A | ||||
IMS Health, Paris La Défense, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Oncology | 2014 | English | , Retrospective database analysis | |
Persistence of treatment of chronic hepatitis B virus (HBV) infection : a study based on the French IMS Lifelink(TM) treatment dynamics (LTD) database | ||||
El Mouaddin N1, Grandfils N1, Le Jeunne P1, Beaupère B2, Pol S3 | ||||
1- IMS Health, Paris, France ; 2- Médecin généraliste, France ; 3- Head of Liver department at Cochin Hospital, Paris | ||||
17th European Congress of ISPOR |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2014 | English | , Compliance, Retrospective database analysis | |
Public health and economic impact of vaccinating children with a quadrivalent live attenuated influenza vaccine in France using a dynamic transmission model. | ||||
Gerlier L1, Weil-Olivier C2, Carrat F3, Lenne X4, Lamotte M1, Greneche S5, Eichner M6,7 | ||||
1IMS Health, Vilvoorde, Belgium 2Professor of pediatrics, University Paris VII, France 3AP–HP, UMR-S 707, Paris, France 4Department of Medical Information, University Lille Nord de France, Lille, France 5AstraZeneca, Rueil-Malmaison, France 6Epimos Gmbh, Dusslingen, Germany 7Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Germany | ||||
ISPOR 17th Annual European Congress, 8-12 November, Amsterdam, The Netherlands |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Respiratory disease | 2014 | English | , Cost effectiveness, Cost utility | |
Progression of physiological parameters over time in type 1 diabetes mellitus patients in France | ||||
Beaudet A, Ong RC | ||||
IMS Health, Basel, Switzerland | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Economic evaluation | |
Burden of non-adherence to type 1 diabetes mellitus therapeutic guidelines in France | ||||
Beaudet A, Ong RC | ||||
IMS Health, Basel, Switzerland | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Burden of illness | |
Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in France | ||||
Granados D1, Maurel F2, Knudsen M3, Troelsgaard A4, Hemels M4 | ||||
1Janssen, Paris, France, 2IMS Health, Paris, France, 3IMS Health, Hellerup, Denmark, 4Janssen A/S, Birkerød, Denmark | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Cost effectiveness, Economic evaluation | |
The cost-effectiveness of canagliflozin compared with liraglutide in patients with type 2 diabetes inadequately controlled with metformin and sulfonylurea in France | ||||
Troelsgaard A1, Pitcher A2, Granados D3, Hemels M1, Lloyd A | ||||
1Janssen A/S, Birkerød, Denmark, 2IMS Health, London, UK, 3Janssen, Paris, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Economic evaluation | |
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study | ||||
Selle F1, Wittnebel S2, Biron P3, Gravis G4, Roubaud G5, Bui BN5, Delva R6, Bay JO7, Fléchon A3, Geoffrois L8, Caty A9, Soares DG10, de Revel T11, Fizazi K2, Gligorov J12, Micléa JM13, Dubot C10, Provent S10, Temby I10, Gaulet M14, Horn E15, Brindel I16, Lotz JP12 | ||||
1Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En Cancérologie), Hôpital Tenon (Hôpitaux Universitaires de l'Est-Parisien, AP-HP), Paris Sorbonne Universités, Université Pierre et Marie Curie (UPMC Univ Paris 06), Paris frederic.selle@tnn.aphp.fr. 2Department of Medicine, Institut Gustave Roussy, Villejuif. 3Department of Medical Oncology, Centre Léon Bérard, Lyon. 4Department of Medical Oncology, Institut Paoli Calmette, Marseille. 5Department of Medicine, Institut Bergonié, Bordeaux. 6Department of Chemotherapy, Centre Paul Papin, Angers. 7Department of Medicine, Centre Hospitalier Universitaire, Clermont-Ferrand. 8Department of Medicine, Centre Alexis Vautrin, Nancy. 9Department of Medicine, Centre Oscar Lambret, Lille. 10Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En Cancérologie), Hôpital Tenon (Hôpitaux Universitaires de l'Est-Parisien, AP-HP), Paris. 11Department of Hematology, Hôpital D'Instruction des Armées Percy, Clamart. 12Department of Medical Oncology and Cellular Therapy, APREC (Alliance Pour la Recherche En Cancérologie), Hôpital Tenon (Hôpitaux Universitaires de l'Est-Parisien, AP-HP), Paris Sorbonne Universités, Université Pierre et Marie Curie (UPMC Univ Paris 06), Paris. 13Cytapheresis and Cell Therapy Unit, Hôpital St Louis (AP-HP), Paris. 14Statistic, 3ES-Cegedim Strategic Data, Boulogne, France. 15Department of Internal Medicine, Brown University, Rhode Island Hospital, Providence, Rhode Island, USA. 16Department of Clinical Research, Hôpital St Louis (AP-HP), Paris, France | ||||
Ann Oncol. 2014 Sep;25(9):1775-82. |
||||
, Article | ||||
, France | ||||
Abstract: http://annonc.oxfordjournals.org/content/25/9/1775.full.pdf+html | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Prospective study | |
Cardiovascular risk and lifestyle habits of consumers of a phytosterol-enriched yogurt in a real-life setting. | ||||
Paillard F1, Bruckert E2, Naelten G3, Picard P4, van Ganse E5. | ||||
1Cardiovascular Prevention Center, CHU Pontchaillou, Rennes, France. 2Service Endocrinologie et Prévention des Maladies Cardiovasculaires, Hôpital Pitié Salpêtrière, Paris, France. 3Danone Research, Palaiseau, France. 4Aixial Pharma, Levallois Perret, France. 5Pharmacoepidemiology, UMR CNRS 5558, Claude-Bernard Lyon 1 University, Lyon, France. | ||||
J Hum Nutr Diet. 2014 Apr 19. doi: 10.1111/jhn.12236 |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24750351 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Nutritional Disorders | 2014 | English | , Prospective study, Retrospective database analysis | |
Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational study | ||||
Roche N1, Pribil C, Van Ganse E, Serrier P, Housset B, Poirier D, Texier N, Schück S, Boucot I. | ||||
1Respiratory and Intensive Care Medicine, Cochin Hospital Group, AP-HP, University Paris Descartes, HIA du Val de Grâce 4e C, Paris, France. | ||||
BMC Pulmonary Medicine 2014, 14:56 doi:10.1186/1471-2466-14-56 |
||||
, Article | ||||
, France | ||||
Abstract: http://www.biomedcentral.com/1471-2466/14/56 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2014 | English | , Prospective study | |
Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database. | ||||
Sabouret P1, Depret-Bixio L, Cotte FE, Marie P, Bedira N, Blin P. | ||||
1Department of Cardiology, Pitié Salpétrière Hospital, Heart Institute, Pierre and Marie Curie University, Paris, France | ||||
Clin Res Cardiol. 2014 Nov;103(11):887-93. doi: 10.1007/s00392-014-0726-y. Epub 2014 May 15 |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24830515 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Retrospective database analysis | |
Vitamin K antagonist treatment in patients with atrial fibrillation and time in therapeutic range in four European countries. | ||||
Cotté FE1, Benhaddi H2, Duprat-Lomon I2, Doble A3, Marchant N4, Letierce A5, Huguet M5. | ||||
Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France. Electronic address: francois-emery.cotte@bms.com. 2Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France. 3Foxymed, Paris, France. 4Pfizer, Walton Oaks, United Kingdom. 5Cegedim Strategic Data, Boulogne-Billancourt, France | ||||
Clin Ther. 2014 Sep 1;36(9):1160-8. doi: 10.1016/j.clinthera.2014.07.016. Epub 2014 Aug 21. |
||||
, Article | ||||
, France, Germany, Italy, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/25151574 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Retrospective database analysis | |
Coût du Lupus Systémique (LS) en France des patients adultes avec une maladie active et traitée (étude LUCIE) | ||||
Amoura Z1, Deligny C2, Pennaforte JL3, Hamidou M4, Blanco P5, Hachulla E6, Pourrat J7, Queyrel V8, Garofano A9, Maurel F9, Levy-Bachelot L10, Boucot I10. | ||||
1Service de médecine interne 2, Centre national de référence lupus, hôpital La Pitié-Salpétrière, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. 2Service de médecine interne et rhumatologie, CHU de Fort-de-France, BP 63297261, Fort-de-France cedex, Martinique. 3Service de médecine interne, hôpital Robert-Debré, rue du Général-Koenig, 51090 Reims, France. 4Service de médecine interne, hôpital Hôtel-Dieu, place Alexis-Ricordeau, 44093 Nantes cedex 1, France. 5Service de médecine interne, hôpital Pèllegrin, place Amélie-Rabat-léon, 33076 Bordeaux cedex, France. 6Service de médecine interne, hôpital Huriez, 1, place de Verdun, 59037 Lille cedex, France. 7Service de néphrologie et immunologie clinique, hôpital Rangueil, 1, avenue du Professeur-Jean-Pouhlès TSA 50032, 31059 Toulouse cedex 9, France. 8Service de médecine interne, hôpital l'Archet, 151, route Saint-Antoine-Ginestière BP 79, 06202 Nice cedex 3, France. 9IMS Real-World Evidence Solutions, Health Economics & Outcomes Research, Tour Ariane, 5-7, place de la Pyramide, 92088 La Défense cedex, France. 10GlaxoSmithKline, 100, route de Versailles, 78163 Marly-le-Roi cedex, France. | ||||
Rev Med Interne. 2014 Nov;35(11):700-8 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Nephrology, Rheumatology | 2014 | French | , Cost of illness, Observational study, Retrospective Field Study | |
Tracking of adverse drug reactions in social media: Current status of requirements, best practices, methods and tools | ||||
Toussi M1, de Moor C1, Nadarajah S2, Breckenridge A3 | ||||
1 IMS Health, Paris, France 2 IMS Health, US 3 University of Liverpool, UK | ||||
30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Oct 24-27, 2014, Taipei International Convention Center |
||||
, Workshop | ||||
, France, UK | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2014 | English | , Database Study | |
Treatment maintenance duration of dual therapy with Metformin and Sitagliptin in type 2 Diabetes - Real-World data From ODYSEE Study | ||||
Leproust S1, Dallongeville J2, Valensi P3, Boutmy E4, Moisan C1, Chanut-Vogel C5, de Pouvourville G6 | ||||
1Merck (MSD France), Paris, France, 2INSERM U744, Lille, France, 3Service d’Endocrinologie-Diabétologie-Nutrition, Bondy, France, 4Cegedim Strategic Data, Boulogne-Billancourt, France, 5Laboratoires MSD France, Courbevoie, France, 6ESSEC, Cergy-Pontoise, France | ||||
Ispor 17th Annual European Congress, 8-12 November 2014, Amsterdam RAI, Amsterdam, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Prospective study, Retrospective database analysis | |
Understanding Real Life Treatment Patterns among Patients with Hypertension: A Markov Model. | ||||
Alexia LETIERCE, Emmanuelle BOUTMY and Laurence Sophie JOUAVILLE | ||||
Cegedim Strategic Data, Boulogne-Billancourt, France | ||||
ISPOR 17th Annual European Congress 8-12 November 2014 Amsterdam RAI Amsterdam, The Netherlands |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/ | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2014 | English | , Longitudinal study, Retrospective database analysis | |
Using data envelopment analysis (DEA) to rank GP's according to their P4P quality and efficiency scores | ||||
Perronnin M, Pichetti S, Sermet C | ||||
Irdes, Paris, France | ||||
ISPOR 17th Annual European Congress 8-12 November 2014 Amsterdam RAI Amsterdam, The Netherlands |
||||
, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2014 | English | ||
Do quality or efficiency indicators inside French p4p perimeter influence quality or efficiency indicators outside P4P? | ||||
Perronnin M, Pichetti S, Sermet C | ||||
Irdes, Paris, France | ||||
ISPOR 17th Annual European Congress 8-12 November 2014 Amsterdam RAI Amsterdam, The Netherlands |
||||
, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2014 | English | ||
Hépatite virale B : Etude du suivi des prescriptions des antiviraux par l’analyse des délivrances en pharmacies de ville | ||||
Beaupère B1 ; El Mouaddin N2 ; Grandfils N2 ; Le Jeunne P2 ; Machuron Thue V2 ; Pol S3 | ||||
(1) Médecin généraliste, Paris ; (2) IMS Depart. Health Economics , IMS Health, Puteaux ;(3) Service d'Hépatologie, Hôpital C ochin, Paris | ||||
75ème journées scientifiques de l'AFEF, 25-26 septembre 2014 |
||||
, Poster | ||||
, France | ||||
Abstract: http://afef2014.com/ | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2014 | French | ||
Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France | ||||
Bertin P1, Rannou F2, Grange L3, Dachicourt JN4, Bruel P5, Emery C6, Grandfils N7, Taieb C8 | ||||
1Service de Rhumatologie, C.H.U. Dupuytren, Limoges, France, 2Service de Rééducation, Pôle Ostéo-Articulaire, C.H.U Cochin, Paris, France, 3Clinique universitaire de Rhumatologie, Pôle Locomotion Rééducation et Physiologie CHU de Grenoble/ Hôpital Sud, Echirolles, France, 4Association Française de Lutte Anti-Rhumatismale, Paris, France, 5Département Médical, Pierre Fabre Santé, Castres, France, 6CEMKA-EVAL, Pôle Biostatistiques, Bourg-La-Reine, France, 7IMS Health,Puteaux, France, and 8Public Health, PFSA, Paris, France | ||||
Journal of Musculoskeletal pain, Early Online : 1-9, 2014 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | ||
Does P4P perimeter matters? Evidence from France | ||||
Perronnin M, Pichetti S, Rococo E, Sermet C | ||||
IRDES (Institute for research and information in health economics) | ||||
EuroDURG 2014 27-29 August Groninger, the Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2014 | English | ||
Polypharmacy as a quality indicator of prescribing for the elderly aged 75 or more | ||||
Monégat M,Jean-Baptiste M, Perronnin M, Rococo E, Sermet C | ||||
IRDES (Institute for research and information | ||||
EuroDURG 2014 27-29 August Groninger, the Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Public Health | 2014 | English | ||
A retrospective analysis of P4P indicators | ||||
Perronnin M, Pichetti S, Rococo E, Sermet C | ||||
IRDES (Institute for research and information | ||||
EuroDURG 2014 27-29 August Groningen, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2014 | English | ||
Polymédication chez les personnes âgées | ||||
Delannoy A, Monegat M, Perronnin M, Pichetti S, Rococo E et Sermet C | ||||
IRDES (Institute for research and information | ||||
Séminaire interne IRDES 13 mai 2014 |
||||
, Presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Public Health | 2014 | French | ||
Diabète de type 2 : quels objectifs thérapeutiques selon les nouvelles recommandations de l’HAS ? Analyse de 6 680 patients suivis par des médecins [Type 2 diabetes: which therapeutic objectives according to the new recommendations of the HAS? Analysis of 6,680 patients followed by doctors]. | ||||
Larger E1, Ansolabehere X2, Grandfils N2, Le Jeunne P2 | ||||
1 GH Cochin Hôtel-Dieu, Paris 2 IMS Health HEOR, La Défense | ||||
Congrès annuel de la Société Francophone du Diabète (SFD). 11-14 mars 2014 Paris |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Endocrinology, Metabolic Disorders | 2014 | French | , Retrospective database analysis | |
Nine-Year Follow-Up of Children with Atopic Dermatitis by General Practitioners. | ||||
Misery L1, Ansolabehere X2, Grandfils N2, Georgescu V3, Taieb C4 | ||||
1Department of Dermatology, University Hospital of Brest, Brest, France. 2PMA/HEOR Department, IMS Health,Paris La Défense, 3Medical Department, Eau thermale Avène, Lavaur, and 4Department of Public Health,Pierre Fabre Laboratories, Boulogne-Billancourt , France | ||||
Dermatology. 2014;228(4):344-9 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2014 | English | ||
Annual direct medical cost of active systemic lupus erythematosus in five European countries. | ||||
Doria A1, Amoura Z, Cervera R, Khamastha MA, Schneider M, Richter J, Guillemin F, Kobelt G, Maurel F, Garofano A, Perna A, Murray M, Schmitt C, Boucot I. | ||||
1Division of Rheumatology, University of Padova, , Padova, Italy. | ||||
Ann Rheum Dis. 2014 Jan;73(1):154-60 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Nephrology, Rheumatology | 2014 | English | , Observational study | |
Using data envelopment analysis (DEA) to rank GP's according to their P4P quality and efficiency scores | ||||
Perronnin M, Pichetti S, Sermet C | ||||
Irdes, Paris, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam |
||||
, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2014 | English | , Retrospective database analysis | |
Do quality or efficiency indicators inside French p4p perimeter influence quality or efficiency indicators outside P4P? | ||||
Perronnin M, Pichetti S, Sermet C | ||||
Irdes, Paris, France | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam |
||||
, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2014 | English | , Retrospective database analysis | |
Annual Cost of Patients with Osteoarthritis of the Hip and Knee in France | ||||
Bertin P1, Rannou F2, Grange L3, Dachicourt JN4, Bruel P5, Emery C6, Grandfils N7, Taieb C8 | ||||
1Service de Rhumatologie, C.H.U. Dupuytren, Limoges, France, 2Service de Rééducation, Pôle Ostéo-Articulaire, C.H.U Cochin, Paris, France, 3Clinique universitaire de Rhumatologie, Pôle Locomotion Rééducation et Physiologie CHU de Grenoble/ Hôpital Sud, Echirolles, France, 4Association Française de Lutte Anti-Rhumatismale, Paris, France, 5Département Médical, Pierre Fabre Santé, Castres, France, 6CEMKA-EVAL, Pôle Biostatistiques, Bourg-La-Reine, France, 7IMS Health,Puteaux, France, and 8Public Health, PFSA, Paris, France | ||||
Journal Of Musculoskeletal Pain, Early Online: 1–9, 2014 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2014 | English | , Retrospective database analysis | |
Does P4P perimeter matters? Evidence from France | ||||
Perronnin M, Pichetti S, Rococo E, Sermet C | ||||
"IRDES (Institute for research and information in health economics)" | ||||
EuroDURG 2014 27-29 August Groningen, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2014 | French | , Retrospective database analysis | |
A retrospective analysis of P4P indicators | ||||
Perronnin M, Pichetti S, Rococo E, Sermet C | ||||
"IRDES (Institute for research and information in health economics)" | ||||
EuroDURG 2014 27-29 August Groningen, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice | 2014 | English | , Retrospective database analysis | |
Polypharmacy as a quality indicator of prescribing for the elderly aged 75 or more | ||||
Monégat M,Jean-Baptiste M, Perronnin M, Rococo E, Sermet C | ||||
"IRDES (Institute for research and information in health economics)" | ||||
EuroDURG 2014 27-29 August Groningen, The Netherlands |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Public Health | 2014 | English | , Retrospective database analysis | |
Nine-Year Follow-Up of Children with Atopic Dermatitis by General Practitioners. | ||||
Misery L1, Ansolabehere X2, Grandfils N2, Georgescu V3, Taieb C4 | ||||
1Department of Dermatology, University Hospital of Brest, Brest, France. 2PMA/HEOR Department, IMS Health,Paris La Défense, 3Medical Department, Eau thermale Avène, Lavaur, and 4Department of Public Health,Pierre Fabre Laboratories, Boulogne-Billancourt , France | ||||
Dermatology. 2014 Mar 20. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2014 | English | , Retrospective database analysis | |
Description of GCSF usage in oncology in 5 European countries. | ||||
Anger C1, Schmidt N2, Ricarte C3 | ||||
1 IMS Health, London, United Kingdom 2 IMS Health, Frankfurt, Germany 3 IMS Health, La Defense, France | ||||
ASCO 2014 Annual Meeting, 2014, May 30 - June 03, Chicago, Illinois, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://meetinglibrary.asco.org/record/97923/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Observational study | |
Evaluation of treatment patterns in acute nausea and vomiting in EU5 countries. | ||||
Schmidt N, Ricarte C, Haas G | ||||
1 IMS Health CES Oncology, Central Europe; 2 Client Service Oncology, IMS Health France | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Evaluation-of-treatment-patterns-in-acute-nausea-and-vomiting-in-EU5-countries | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Comparing patterns of BRAF testing and treatment in Metastatic Melanoma (MeM) in France, Germany, Italy, Spain and UK with the US. | ||||
Charnock J, Bruce A, Murch L, Anger C | ||||
Client Service Oncology, IMS Health, UK | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: poster-submission.com/cdrom/download_poster/37/27774/1110P | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Patterns of patients stopping their anti-cancer drug due to its associated side effects in France, Germany, Italy, Spain and UK. | ||||
Khanna R, Anger C | ||||
Client Service Oncology, IMS Health, UK | ||||
ESMO 2014 Annual Meeting, 2014, 26 Sep - 30 Sep, Madrid, Spain |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://oncologypro.esmo.org/Meeting-Resources/ESMO-2014/Patterns-of-patients-stopping-their-anti-cancer-drug-due-to-its-associated-side-effects-in-France-Germany-Italy-Spain-and-UK-EU5 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Association of diabetes and cancer diagnosis in primary care practices in France. | ||||
Grandfils N, Ricarte C, Solomiac A | ||||
1IMS Health, La Defense, France | ||||
ISPOR 2014 Annual Meeting |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2014 | English | , Retrospective database analysis | |
Glucagon-like Peptide-1 receptor agonist treatment patterns among type 2 diabetes patients in six European countries. | ||||
Divino V., DeKoven M., Hallinan S., Varol N., Wirta SB., Lee WC., Reaney M. | ||||
Lilly. IMS authors: Divino V, DeKoven M | ||||
Diabetes Ther. |
||||
, Article | ||||
, Belgium, France, Germany, Netherlands, Sweden, UK | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/25366334 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2014 | English | , Retrospective database analysis | |
Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries | ||||
Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3,Margolis J.M.5 | ||||
VALUE IN HEALTH 17 ; A684 |
||||
, Abstract | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Immunology and Vaccination, Oncology | 2014 | English | , Cost of illness, Retrospective database analysis | |
Optimizing EMR database value using natural language processing | ||||
Toussi M1 | ||||
1IMS Health, France | ||||
AccessPoint, May 2013; Vol 3(6); 30-35 |
||||
, Article | ||||
, France | ||||
Abstract: http://issuu.com/ims_heor_publications/docs/rwe_accesspoint_6_-_080513f_epub | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2013 | English | , Methodology | |
Screening characteristics and diabetes biomarkers in French and UK patient-level databases | ||||
Cabrera C1, Le Jeunne P2, Lee A3, Thomas F4, Mian N3, McDonell A5 | ||||
1AstraZeneca, Mölndal, Sweden, 2IMS Health, Paris, France, 3AstraZeneca GMD UK, Cheshire, England, 4AstraZeneca France, GMD, Paris, France, 5IMS Health, London, England | ||||
ISPOR 16th Annual European Congress, 2-6 November 2013, Abstract #45156 |
||||
, Poster | ||||
, France, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Real World Data | |
Public health and budget impact of probiotics in controlling upper respiratory tract infections in France. | ||||
Irene Lenoir-Wijnkoop (1), Laetitia Gerlier (2), Jean-Louis Bresson (3), Claude Le Pen (4), Gilles Berdeaux (2) | ||||
1 University of Utrecht, Utrecht, The Netherlands 2 IMS HEOR, Vilvoorde, Belgium 3 Necker Hospital, France 4 Paris Dauphine University, Paris, France | ||||
7th Probiotics, Prebiotics & New Foods, 2013, September 8-10, Rome, Italy |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Public Health, Respiratory disease | 2013 | English | , Cost analysis | |
The CANARD Project (project CANARD) – Cost-effectiveness ANAlysis of Real-world outcomes in a Diabetic population The impact of baseline characteristics in France | ||||
Sutherland CS 1,2, Gillet M2, Brennan A2, Duran A1 , Ansolabehere, X3 | ||||
1- IMS Health, London, United Kingdom, 2 - University of Sheffield, Sheffield, United Kingdom, 3 - IMS Health, Paris, France | ||||
ISPOR 18th annual international meeting, New Orleans - May 2013 |
||||
, Poster | ||||
, France, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Diabetes | 2013 | English | , Cost effectiveness | |
Quality of life of patients suffering from exudative age-related macular degeneration and treated by intravitreal injections and its predictors: the EQUADE study | ||||
Leveziel N1, Joubert M2, Hermans M3, Moser E3, Le Picard S3, Maurel F4 | ||||
1. CHU POitiers, France; 2. Association DMLA, France; 3. retina France; 4. IMS Health, La Défense, France | ||||
Ispor 16th annual European congress, Nov 2013 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2013 | English | , Observational study, Quality of life | |
Current situation of oral anticancer treatments use in france: the actor study (analysis of cancer treatments given orally) | ||||
Benjamin L1, Maurel F2, Bardoulat I2, Ricarte C2 | ||||
1. GlaxoSmithKline, Marly-leRoi, France; 2. IMS Health, La Défense, France | ||||
ISPOR 16th anual European congress - 2013 Value Health November 2013 Volume 16, Issue 7, Page A425 |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: www.ispor.org/Events/Posters.asp | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Real World Data, Retrospective database analysis | |
Management costs of the first five years after diagnosis in breast cancer by stage in France made with the french National Cancer Institute | ||||
Atsou K1, Bardoulat I2, Colin X1, Lemasson H1, Ricarte C1, Maurel F1, Ajjouri R2, Lançon F2 | ||||
1.IMS Health, La Défense, France; 2. Institut national du Cancer, Boulogne-Billancourt, France | ||||
ISPOR 16th annual congress Value Health November 2013 Volume 16, Issue 7, Page A403 |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: www.ispor.org/Events/Posters.asp | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Economic evaluation, Retrospective database analysis | |
Comparison of drug assessments in France, Germany and UK: is European HTA a reality? | ||||
Perrin l1, Troubat A1 | ||||
1. IMS Health, La Défense, France | ||||
ISPOR 16th Annual European Congress - Nov2013 |
||||
, Poster | ||||
, France, Germany, UK | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2013 | English | , Pricing & Reimbursement | |
Evolution of oral anticancer treatments use in France from 2004-2012 : RE-ACTOR study (retrospective analysis of cancer treatments given orally) | ||||
Benjamin L1, Maurel F2, Bardoulat I2, Ricarte C2 | ||||
1. GlaxoSmithKline, Marly-le-Roi, France; 2. IMS Health, La Défense, France | ||||
Ispor 16th annual European congress - Nov2013 Value Health November 2013 Volume 16, Issue 7, Page A425 |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: www.ispor.org/Events/Posters.asp | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Consistency of current type 2 diabetes (T2DM) treatmeent patterns in general practice versus the 2013 French HAS T2DM guidelines : a transversal study based on the French IMS LifelinkTM prospective diabetes cohort | ||||
1. Larger E, 2.Ansolabehere X, 2.Le Jeunne P, 2.Grandfils N, 3.Briand Y, 3.Gibelin B | ||||
1. Hotel Dieu Paris, Paris France 2. IMS Health, Paris La Défense France, 3. Boehringer Ingelheim France, Paris France. | ||||
16th annual European ISPOR |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Real World Data, Retrospective cohort analysis | |
A price comparison study of recent drugs in EU5, 2008-2012 | ||||
1. Le Pen C, 2. Vigier D, 2. Grandfils N | ||||
1. Université Paris Dauphine, Paris France . 2. IMS Health, Paris La Défense France | ||||
16th annual European ISPOR |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2013 | English | , Pricing & Reimbursement | |
Do fixed-dose combinations improve antidiabetic treatment compliance? A study based on French IMS Lifelink disease analyszer database | ||||
1. Grandfils N, 1. Le Jeunne P, 1. maillard C, 1. Solomiac A, 1. Besson A | ||||
1. IMS Health, Paris La Défense France | ||||
16th Annual European ISPOR |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Compliance, Retrospective cohort analysis | |
Influence of macro- and microvascular comorbidity on time to insulin initiation in type 2 diabetes patients: a retrospective database analysis in Germany, France, and UK. | ||||
Kostev K1, Rathmann W2 | ||||
1 IMS Health, Frankfurt, Germany 2 Institute of Biometrics and Epidemiology, German Diabetes Center, Dusseldorf, Germany | ||||
Prim Care Diabetes., 2013, Jul;7(2):167-71 |
||||
, Article | ||||
, France, Germany, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=influence%20of%20macro%20and%20microvascular%20comorbidity%20on%20time%20to%20insulin%20initiation%20in%20type%202%20diabetes%20patients%20a%20retrospective%20database%20analysis%20in%20germany,%20france,%20and%20uk&cmd=correctspelling | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Retrospective database analysis | |
Glucose lowering therapeutic strategies for type 2 diabetic patients with chronic kidney disease in primary care setting in France: a cross-sectional study. | ||||
Grandfils N1, Detournay B2, Attali C3, Joly D4, Simon D5, Vergès B6, Toussi M1, Briand Y8, Delaitre O8 | ||||
1 IMS Health, Paris, France 2 Cemka-Eval, Bourg-la-Reine, France 3 Medical office, Epinay sous Senart, France 4 Hôpital Necker-Enfants Malades, Paris, France 5 Hôpital de la Pitié-Salpétrière, Paris, France 6 INSERM CESP, Villejuif, France 7 Hôpital du Bocage, Dijon, France 8 Boehringer-Ingelheim, Paris, France | ||||
International Journal of Endocrinology, 2013, 640-632. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638677/ | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Retrospective database analysis | |
Hypoglycemic treatment in type 2 diabetes patients suffering from moderate to severe renal failure in France. Aim of the study. | ||||
Bouée S1, Gaudin AF, Amelineau E, Bonnet F. | ||||
1Cemka-Eval, Bourg la Reine, France | ||||
Therapie. 2013 Jan-Feb;68(1):19-26. doi: 10.2515/therapie/2013002. Epub 2013 Mar 14 |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23484656 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes, Nephrology | 2013 | English | , Retrospective database analysis | |
[Incidence of rotavirus gastroenteritis among children under 5 years consulting a paediatrician or a general practitioner in France]. | ||||
Parez N1, Pozzetto B, Texier N, Mory O, Garbarg-Chenon A, Téhard B. | ||||
1Service de Pédiatrie, Hôpital Louis-Mourier, 178 rue des Renouillers, 92700 Colombes cedex, France | ||||
Pathol Biol (Paris). 2013 Jun;61(3):99-107. doi: 10.1016/j.patbio.2012.01.005. Epub 2012 Mar 22. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22445056 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders, Infectious disease, Pediatrics | 2013 | English | , Prospective study | |
Perceptions of benign prostatic hyperplasia according to the perspective of patients and general practitioners - the Trophée study | ||||
Lacoin F1, Fourcade RO, Rouprêt M, Slama A, Le Fur C, Michel E, Sitbon A, Cotté FE. | ||||
1Médecine générale, immeuble La Source, rue René-Cassin, 73410 Albens, France | ||||
Prog Urol. 2013 Jan;23(1):50-7. doi: 10.1016/j.purol.2012.10.003. Epub 2012 Nov 10. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23287484 | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2013 | English | , Prospective study | |
ADHERENCE TO TREATMENT AND PERSISTENCY IN PATIENTS TREATED WITH VKA IN FRANCE, ITALY, GERMANY, SPAIN AND UK | ||||
COTTÉ FE1, CARRASCO J1, DUPRATLOMON I1, MARCHANT N2, LETIERCE A3 & HUGUET M3 | ||||
(1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
ISPOR Annual European Congress, Dublin. 2013. |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Retrospective database analysis | |
Anticoagulation treatment with VKA in France, Italy, Germany, Spain and UK. Results from the REACT-AF study. | ||||
COTTÉ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M | ||||
(1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
ISPOR Annual European Congress, Dublin. 2013 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Retrospective database analysis | |
Comparaison entre la France et le Royaume-Uni des prescriptions des patients asthmatiques suivis en médecine générale à partir de bases de données de prescription. | ||||
Van Ganse E1, Laforest L1, Schwalm MS2, Bourke A3. | ||||
1 Unité de pharmaco-épidémiologie, CHU de Lyon, Lyon, France 2 Cegedim Strategic Data, Boulogne, France 3 EPIC, Cegedim Strategic Data, London, Royaume-Uni | ||||
Forum Scientifique de Pharmaco-épidémiologie 2013 Paris |
||||
, Poster | ||||
, France, UK | ||||
Abstract: http://www.em-consulte.com/article/872233/article/comparaison-entre-la-france-et-le-royaume-uni-des- | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2013 | French | , Retrospective database analysis | |
Failure to renew prescriptions for gastroprotective agents to patients on continuous nonsteroidal anti-inflammatory drugs increases rate of upper gastrointestinal injury. | ||||
Le Ray I1, Barkun AN, Vauzelle-Kervroëdan F, Bardou M. | ||||
1INSERM Centre d'Investigations Cliniques Plurithématique 803, Centre Hospitalier Universitaire du Bocage, Dijon, France. | ||||
Clin Gastroenterol Hepatol. 2013 May;11(5):499-504.e1. doi: 10.1016/j.cgh.2012.12.016. Epub 2013 Jan 11. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23313838 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2013 | English | , Retrospective database analysis | |
Modélisation des changements de traitement antihypertenseurs en France à l'aide de chaines de Markov. | ||||
LETIERCE A, KEMPF C | ||||
Cegedim Strategic Data, Boulogne-Billancourt, France | ||||
7ème Conférence Francophone d'Epidémiologie Clinique, / 6è FORUM SCIENTIFIQUE DE PHARMACO-EPIDEMIOLOGIE |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.sciencedirect.com/science/article/pii/S0398762013011383 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | French | , Methodology, Retrospective database analysis | |
Résultats intermédiaires d'une cohorte française de patients sous micafungine en réanimation (MYRIADE) | ||||
JF.Timsit , N.Milpied , B.Gachot , G.Leverger. | ||||
[1] CHU Michallon, La Tronche, France [2] CHU Haut-Lévêque, Pessac, France ; [3] IGR, Villejuif, France, [4] CHU Trousseau, Paris, France ; | ||||
Congrès International de la SRLF, Paris 2013 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.srlf.org/english/congress/abstracts/viewPresentation.phtml?about=rc%2F2013%2Fsrlf2013%2Fabstract%2F20121007-381059-5967%2F_container&SearchEventInput=&eventCommunication=&communicationClass=abstract&Intervenant=0&SearchIntervenant=&cp=1&rp=1 | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2013 | French | , Prospective study | |
The Use of Oral Anticoagulation Drugs for Stroke Prevention in Nonvalvular Atrial Fibrilation in France, Italy, Germany, Spain and the United Kingdom: Is Current Practice Consistent with the 2012 ESC Recommendations. | ||||
COTTÉ FE, CARRASCO J, DUPRAT-LOMON I, MARCHANT N, LETIERCE A & HUGUET M | ||||
(1) Health Economics & Outcomes Research, Bristol-Myers Squibb, Rueil-Malmaison, France; (2) Pfizer Global Access, Walton Oaks, United Kingdom ; (3) Cegedim Strategic Data, Paris, France | ||||
16th Annual European ISPOR Congress Dublin, Ireland |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03127-6/abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2013 | English | , Retrospective database analysis | |
Validation of the French Translated Version of the Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS) in France. | ||||
Tepie MF, Kempf C, Letierce A, Ferreira I, Khalil L, Roddam A and Guillemin F | ||||
16th Annual European ISPOR Congress Dublin, Ireland |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)03422-0/abstract | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics | 2013 | English | , Prospective study | |
The association between asthma control, health care costs, and quality of life in france and Spain. | ||||
Doz M1, Chouaid C, Com-Ruelle L, Calvo E, Brosa M, Robert J, Decuypère L, Pribil C, Huerta A, Detournay B. | ||||
1Cemka-Eval, 43 Boulevard du Maréchal Joffre, Bourg-la-Reine | ||||
BMC Pulmonary Medicine 2013, 13:15 |
||||
, Article | ||||
, France, Spain | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2013 | English | , Cost analysis, Prospective study, Retrospective database analysis | |
COPD and quality of life : impact of the disease in primary care in France | ||||
Perez a, P. Serrier b, C. Pribil c, A. Mahdad c | ||||
a Service de pneumologie, hôpital Albert-Calmette, CHRU de Lille, boulevard Jules-Leclercq, 59037 Lille cedex, France b Service de pneumologie-réanimation, hôpital Hôtel-Dieu, 75001 Paris, France c Laboratoire GlaxoSmithkline, 78163 Marly-Le-Roi, France | ||||
Rev Mal Respir, 2013 jan ; 30(1) : 22-32 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2013 | English | , Quality of life, Retrospective database analysis | |
Motifs de non intensification thérapeutique chez des patients DT2 non contrôlés par une monothérapie en Médecine Générale en France – Phase prospective étude DIAttitude | ||||
Halimi S, BlickleJF, Balkau B, Attali C, Avignon A, Tocque E, Geoffroy MA, Chartier I, Vergès B | ||||
Department of Endocrinology,Department of Diabetology Pole DIGIDUNE, Grenoble University Hospital, Grenoble, France. | ||||
Diabetes Metab. 2013 Mar;39 (S1):A32 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Retrospective database analysis | |
Impact de la baisse du taux de remboursement des anti-arthrosiques symptomatiques d’action lente (AASALs) sur la prescription des AINS par les médecins généralistes français | ||||
P Hilliquin (1); S Bouée (2); I Dardour (3); A Letierce (4); V Leblanc (3); - (1) Corbeil-Essonnes - France; (2) Bourg-la-Reine - France; (3) Courbevoie - France; (4) Boulogne-Billancourt - France | ||||
26ème congrès français de Rhumatologie |
||||
, Poster | ||||
, France | ||||
Abstract: http://poster.rhumatologie.asso.fr/ | ||||
Condition | Year | Language | Analysis type | |
, Pain, Pricing and reimbursement, Rheumatology | 2013 | French | , Retrospective database analysis | |
Anti-diabetic treatment compliance with regards to the fixed or free treatments combination | ||||
Grandfils N, Le Jeunne P, Maillard C, Solomiac A, Besson A | ||||
IMS Health, Paris La Défense France | ||||
Ispor 16th Annual European Congrès 2-6 Novembre 2013 the convention centre Dublin |
||||
, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | ||
Accessibility of Orphan Drugs in France, United Kingdom and Germany: Different Approaches with Regard to HTA and Prices | ||||
N. Grandfils, H. Hounkanlin, A. Troubat | ||||
IMS Health, PARIS LA DEFENSE, France | ||||
ISPOR 16th - Dublin 02-03 Novembre 2013 |
||||
, Poster | ||||
, France, Germany, UK | ||||
Abstract: http://www.ispor.org/ | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2013 | English | ||
A Cost-Utility Analysis of Ranibizumab in Age-Related Macular Degeneration Based on Real-Life Observational Data in France | ||||
De Pouvourville G1 ; Lafuma A2 ; Moeremans K3 ; Nivelle E3 ; Umuhire D4 ; Gerlier L3 ; Maurel F5 ; Ponthieux A6. | ||||
1ESSEC Chair of Health Systems, Cergy, France ; 2Cemka Eval, Bourg La Reine, France ; 3IMS Health HEOR, Vilvoorde, Belgium ; 4IMS Health, Paris La Défense, France ; 5IMS Health, Paris La Défense, France ; 6Novartis Pharma S.A.S., Rueil-Malmaison Cedex, France. | ||||
ISPOR 16th - 02/03 novembre 2013 Dublin |
||||
, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology, Pricing and reimbursement | 2013 | English | ||
Impact du déremboursement des produits de phytothérapie sur les prescriptions : étude longitudinale sur base de données | ||||
L. Riou França a, C. Vidal b, N. Bourechak c, P. Le Jeunne c, G. Sainte-Claire Deville a, J. Massol a, d | ||||
a Institut Phisquare – fondation transplantation, Paris, France b CIC (Inserm CBT506), CHU de Besançon, Besançon, France c IMS Health, Puteaux, France d Département de thérapeutique, CHU de Besançon, Besançon, France | ||||
6ème Forum de Pharmaco-épidémiologie : 27, 28 juin « Médicaments et Dispositifs Médicaux » |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.e-liberal.pro/ | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2013 | French | , Retrospective database analysis | |
La diffusion des nouveaux antidiabétiques : une comparaison internationale | ||||
Pichetti S1, Sermet C1, Saskia van der Erf2 | ||||
1IRDES, 2CNAMTS | ||||
Points de repère n° 40 - mai 2013 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | French | ||
The CANARD Project (project CANARD) – Cost-effectiveness ANAlysis of Real-world outcomes in a Diabetic population | ||||
Sutherland CS 1,2, Gillet M2, Brennan A2, Duran A1 , Ansolabehere, X3 | ||||
1IMS Health, London, United Kingdom, 2University of Sheffield, Sheffield, United Kingdom, 3IMS Health, Paris, France | ||||
ISPOR 18th Annual International Meeting , New Orleans, 18th – 22nd May, 2013. Poster ID: PCV74 |
||||
, Poster | ||||
, France, UK | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Cost effectiveness | |
Anti-diabetic treatment compliance with regards to the fixed or free treatments combination | ||||
Grandfils N, Le Jeunne P, Maillard C, Solomiac A, Besson A | ||||
IMS Health, Paris La Défense France | ||||
ISPOR 16th Annual European Congress, 2-6 November 2013 |
||||
, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2013 | English | , Retrospective database analysis | |
"Impact du déremboursement des produits de phytothérapie sur les prescriptions :étude longitudinale sur base de données. " | ||||
"Riou França La, Vidal Cb, Bourechak Nc, Le Jeunne Pc, Sainte-Claire Deville Ga, Massol Ja,d " | ||||
a- Institut Phisquare – Fondation Transplantation, Paris, France ; b- CIC (INSERM CBT506), CHU de Besançon, Besançon, France ; c- IMS Health, Puteaux, France ; d- Département de Thérapeutique, CHU de Besançon, Besançon, France | ||||
6e forum scientifique de pharmaco-épidémiologie, 27-28 juin 2013 – Paris |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2013 | French | , Retrospective database analysis | |
Prescription of compression stockings in France in primary care. | ||||
Benigni JP1, Ansolabehere X2, Saudez X3, Toussi M2, Branchoux S4, Taieb C4 | ||||
1Cardiology Unit, HIA Begin, Saint Mandé, France; 2IMS Health, France; 3Pierre Fabre Laboratories, Castres, France; 4Public Health Department, Pierre Fabre Laboratories, Paris, France. | ||||
Phlebology. 2013 May 9;29(6):390-396 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Vascular disease | 2013 | English | , Retrospective database analysis | |
Prescription of compression stockings in France in primary care. | ||||
Benigni JP1, Ansolabehere X2, Saudez X3, Toussi M2, Branchoux S4, Taieb C4. | ||||
1Cardiology Unit, HIA Begin, Saint Mandé, France benigni.jp@orange.fr. 2IMS Health, Boulogne, France. 3Pierre Fabre Laboratories, Castres, France. 4Public Health Department, Pierre Fabre Laboratories, Paris, France. | ||||
Phlebology. 2014 Jul;29(6):390-6. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Vascular disease | 2013 | English | , Retrospective database analysis | |
A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security | ||||
Lionel Riou França1, Chrystelle Vidal2, Nadia Bourechak3, Philippe Le Jeunne3, Geoffroy Sainte-Claire Deville1 and Jacques Massol1,4 | ||||
1Phisquare Institute – Fondation Transplantation, Paris, France, 2Clinical Investigation Center, University Hospital of Besançon, France, 3IMS Health, Puteaux, France, 4Therapeutic Department, University Hospital of Besançon, France | ||||
Pharmacoepidemiology and drug safety 2013; 22: 760–768 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2013 | English | , Retrospective database analysis | |
Current emesis Patterns of chemotherapy and antiemetic treatments in Western Europe. | ||||
Ricarte C, Anger C | ||||
1 IMS Health, France 2 IMSHealth, UK | ||||
ESMO 2013 |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
2013 | English | , Retrospective database analysis | ||
Management costs of the first five years after diagosis in Breast Cancer by Stage in France. | ||||
Atsou L, Bardoulat I, Colin X, Lemasson H, Ricarte C, Maurel F, Ajjouri R, Lancon F | ||||
1 IMS Health, La Defense, France, 2 French National Cancer Institute, Boulogne-Billancourt France Cedex, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02369-3/abstract | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective cohort analysis | |
Evolution of oral anticancer treatments use in France from 2004 to 2012: the Re-ACTOR Study. | ||||
Benjamin L, Maurel F, Bardoulat I, Ricarte C | ||||
1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02489-3/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Current situation of oral anticancer treatments use in France: the ACTOR Study. | ||||
Benjamin L, Maurel F, Bardoulat I, Ricarte C | ||||
1 Glaxosmithkline, 2 Health Economics and Outcomes Research, Marly le Rol, France, 3 IMS Health, La Defense, France | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Abstract | ||||
, China, France, Germany, Italy, Japan, Korea, Spain, Taiwan, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02492-3/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | ||
Evolution of Molecular Diagnostic test Usage in Solid tumours in EU5 (Analysis of Molecular Biomarker Tests in Oncology). | ||||
Ricarte C, Bruce A, Anger C | ||||
1 IMS Health, La Defense, France 2 IMS Health, London, United Kingdom | ||||
ISPOR Europe 2013 Annual meeting |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(13)02310-3/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2013 | English | , Retrospective database analysis | |
Major surgery in patients with metastatic colorectal cancer in western Europe. | ||||
Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Klingman D3, Gao S1 | ||||
1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA | ||||
J Gastrointest Cancer. 2012 Sep;43(3):456-61 |
||||
, Manuscript in preparation | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22125088 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Patterns of treatment with chemotherapy and monoclonal antibodies for metastatic colorectal cancer in Western Europe. | ||||
Zhao Z1, Pelletier EM2, Barber B1, Bhosle M3, Wang S1, Gao S1, Klingman D3 | ||||
Amgen Inc., Thousand Oaks, CA, USA1, IMS Consulting Group, Watertown, MA, USA2, IMS Consulting Group, Alexandria, VA, USA3 | ||||
Curr Med Res Opin 2012; 28(2):221-229; 2012 Jan 27 [Epub ahead of print] |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
Cost analysis: treatment of chemotherapy-induced anemia with erythropoiesis-stimulating agents in five European countries | ||||
Duran A1, Spaepen E2,Lamotte M3, Walter E4, Umuhire D5, Lucioni C6, Pinheir B7, Brosa M8, Pujol LKB9, Van Belle S10, Annemans L11 | ||||
1 IMS Health, London, UK 2 SBD Analytics BVBA/SPRL, Bekkevoort, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Pharmaeconomic Research, Health Economics, Vienna, Austria 5 IMS Health, Paris, France 6 Wolters Kluwer Health Italy, Milan, Italy 7 CISEP, Research Centre on the Portuguese Economy, Lisbon, Portugal 8 Oblikue Consulting, Barcelona, Spain 9 Amgen (Europe) GmbH, Zug, Switzerland 10 Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium 11 I-CHER, Ghent University, Brussels University (VUB), Ghent, Belgium | ||||
Journal of Medical Economics Vol. 15, No. 3, 2012, 1–10 |
||||
, Article | ||||
, Austria, Belgium, France, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Cost analysis | |
Assessing the cost-effectiveness of the recommended antihypertensive drug classes in France using a lifetime Markov model. | ||||
Gerlier L1, Midy F2, Lièvre M3, Maurel F4, Cohn E2, Vellopoulou K1, Lamotte M1 | ||||
1 IMS HEOR, Vilvoorde, Belgium 2 Haute Autorité de Santé, Saint-Denis La Plaine, France 3 Université Claude Bernard, Lyon, France 4 IMS HEOR, Puteaux, France | ||||
ISPOR US conference, 2012, June 3-8, Washington DC, USA |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2012 | English | , Cost effectiveness | |
Assessing the budget impact of using ScanBag® in CT in 6 European countries. | ||||
Nivelle E1, Mathou F2, Lamotte M1 | ||||
1 IMS Health, Vilvoorde, Belgium 2 Guerbet SA, Villepinte, France | ||||
15th ISPOR Annual European Congress, 2012, November 3-7, Berlin, Germany |
||||
, Abstract, Poster | ||||
, Belgium, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2012 | English | , Budget impact | |
Gastroesophageal reflux disease : impact on work productivity and daily life activities of daytime workers. A French cross sectional study (ACTA) | ||||
Bruley des Varannes S 1, Ducrotté P 2, Vallot T 3, Maurel F 4, Bardoulat I 4, Garaofano A 4, Carrois F 5, Ricci L 5 | ||||
1 Institut des maladies de l'appareil digestif (IMAD), CHU Hôtel-Dieu, Nantes, France - 2 Hôpital Charles Nicolle, Rouen, France - 3 Clinique Claude Bernard, Ermont, France - 4 IMS Health HEOR, Puteaux, France - 5 Janssen, Medical Affairs, Issy-les-Moulineaux, France | ||||
15th European ISPOR in 2012 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2012 | English | , Cost consequence, Observational study | |
Health-related quality of life and annual direct medical costs of patients with haemophilia B in France : the EQOFIX study | ||||
Polack B 1, Calvez T 2, Claeyssens S 3, Chambost H 4, Derlon A 5, Goudemand J 6, Rotshild C 7, Maurel F 8, Woronoff-Lemsi MC 9 | ||||
1 Department of hematology, CHU Grenoble, Grenoble, France - 2 Inserm & UPMC, Paris, France - 3 Regional Haemophilia Treatment center, Toulouse, France - 4 Regional Haemophilia Treatment center, Marseille, France - 5 Regional Haemophilia Treatment center, Caen, France - 6 Regional Haemophilia Treatment center, Lille, France - 7 Regional Haemophilia Treatment center, Paris cedex 1, France - 8 IMS health, Puteaux, France - 9 Department of Pharmacy, Besançon, France | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Cost of illness, Prospective study, Quality of life | |
The sharp decrease of drug's access to reimbursement in France in 2011 | ||||
Hounkanlin H, Troubat A, Morlet-Vigier D | ||||
IMS Health, Puteaux, France | ||||
15th European ISPOR in 2012 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2012 | English | , Pricing & Reimbursement | |
Drug reimbursement maintenance : a French challenge in 2011 | ||||
Hounkanlin H, Troubat A, Morlet-Vigier D | ||||
Ims health, Puteaux, France | ||||
15th European Ispor in 2012 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Pricing and reimbursement | 2012 | English | , Market impact | |
Relationship between comorbidities, blood pressure control and therapeutic schemes in real-life setting hypertensive patients | ||||
Ansolabehere X, Grandfils N, Morlet-Vigier D | ||||
IMS Health, Puteaux, France | ||||
15th European ISPOR in 2012 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Vascular disease | 2012 | English | , Retrospective database analysis | |
How hypoglycaemicn events can influence diabetic patients'weight and affect HBA1C control | ||||
Ansolabehere X, Grandfils N, Le Jeunne P, Morlet-Vigier D | ||||
IMS Health, Puteaux, France | ||||
ISPOR 15th Annual European Congress, 3-7 November 2012, Berlin, Germany |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Retrospective cohort analysis | |
Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases. | ||||
S Ng-Mak D, Ya-Ting C, Who T, Standford B, Roset M. | ||||
Global Health Outcomes, Merck Sharp & Dohme Corp., West Point, PA, USA, IMS Health, Barcelona. | ||||
Cephalalgia. 2012 Sep;32(12):875-87. |
||||
, Article | ||||
, France, Germany, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Results%20of%20a%202-year%20retrospective%20cohort%20study%20of%20newly%20prescribed%20triptan%20users%20in%20European%20nationwide%20practice%20databases. | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2012 | English | , Retrospective cohort analysis | |
Clinical Attributes, Treatment, and Control In Hypertension (CATCH) Study - Italy | ||||
David W1, David D, Vasalisa S | ||||
1Merck &Co., Inc., Kenilworth, NJ, USA | ||||
ESH Annual Meeting London. 2012. |
||||
, Poster | ||||
, France, Italy | ||||
Abstract: http://www.tuttocongressi.it/website/congresses/CongressDetail2.aspx?idc=1966&cont=110&in=W | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2012 | English | , Retrospective cohort analysis, Retrospective database analysis | |
A Cross-Sectional Assessment of Atrial Fibrillation Management Among French Patients in Primary Care. | ||||
SABOURET P., WILLEMS C., COTTE FE., MARIE MERCIER F., BLIN P | ||||
15th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Berlin, Germany |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)02673-3/abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2012 | English | , Retrospective database analysis | |
An observational study of the initial management of hypothyroidism in France: the ORCHIDÉE study. | ||||
Delemer B, Aubert JP, Nys P, Landron F, Bouée S. | ||||
Eur J Endocrinol. 2012 Dec;167(6):817-23. doi: 10.1530/EJE-11-1041. Epub 2012 Oct 3. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23034782 | ||||
Condition | Year | Language | Analysis type | |
, Metabolic Disorders | 2012 | English | ||
Antithrombotic Therapy Prescription and Persistence in Patients With Atrial Fibrillation in France and Spain. | ||||
Huguet M, Shakespeare A, Haug HM, Miadi-Fargier H, Restovic G, Rafols C, Kempf C | ||||
ISPOR Annual European Congress, Berlin, Germany |
||||
, Poster | ||||
, France, Spain | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(12)02765-9/abstract | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2012 | English | , Pricing & Reimbursement | |
Clinical Attributes, Treatment, and Control In Hypertension (CATCH) Study - France | ||||
David W, David D, Vasalisa S | ||||
ESH Annual Meeting London. 2012. |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.tuttocongressi.it/website/congresses/CongressDetail2.aspx?idc=1966&cont=110&in=W | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2012 | English | , Retrospective database analysis | |
Disability in patients consulting for anxiety or mood disorders in primary care : response to antidepressant treatment. | ||||
Gérard A1, Liard F, Crochard A, Goni S, Millet B. | ||||
1Rue des Marronniers' Psychiatry Clinic, Paris. | ||||
Neuropsychiatr Dis Treat. 2012;8:605-14. doi: 10.2147/NDT.S34132. Epub 2012 Dec 13. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23271910 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2012 | English | , Prospective study | |
Evaluation de la prévalence de la distension pulmonaire et de sa réversibilité immédiate chez des patients asthmatiques persistants insuffisamment contrôlés et/ou dyspnéiques- Enquête Distair 2 | ||||
T. Perez1,P. Chanez2, D. Dusser3, D. Vesque4, Ph. Devillier5 | ||||
1Hôpital Calmette, Lille, France 2 Hôpital Nord, Marseille, France 3 Hôpital Cochin, Paris, France 4 Laboratoire Chiesi, Courbevoie, France 5 Hôpital Foch, Suresnes, France | ||||
16th Congrès de Pneumologie de Langue Française (CPLF), Lyon, France |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.em-consulte.com/es/revue/RMR/29/S1/table-des-matieres/ | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2012 | French | , Retrospective database analysis | |
Evaluation of long-acting somatostatin analog injection devices by nurses: a quantitative study. | ||||
Adelman DT1, Burgess A, Davies PR. | ||||
1Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. | ||||
Med Devices (Auckl). 2012;5:103-9. doi: 10.2147/MDER.S37831. Epub 2012 Dec 14. |
||||
, Article | ||||
, France, Germany, UK, USA | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/23293542 | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous | 2012 | English | , Survey research | |
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program. | ||||
Van Ganse E1, Letrilliart L, Borne H, Morand F, Robain M, Siegrist CA | ||||
1Pharmacoepidemiology, CHU-Lyon, Lyon, France | ||||
Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):261-8. doi: 10.1002/pds.2243. Epub 2011 Nov 3 |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22052698 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Womens Health | 2012 | English | , Retrospective database analysis | |
Mixed dyslipidemias in primary care patients in France. | ||||
Laforest L1, Ambegaonkar BM, Souchet T, Sazonov V, Van Ganse E. | ||||
1Lyon University, Lyon, France | ||||
Vasc Health Risk Manag. 2012;8:247-54. doi: 10.2147/VHRM.S27668. Epub 2012 Apr 19. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22566746 | ||||
Condition | Year | Language | Analysis type | |
, Vascular disease | 2012 | English | , Prospective study, Retrospective database analysis | |
Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia. | ||||
Fourcade RO1, Lacoin F, Rouprêt M, Slama A, Le Fur C, Michel E, Sitbon A, Cotté FE. | ||||
1Department of Urology, Centre Hospitalier Auxerre, Auxerre, France. | ||||
World J Urol. 2012 Jun;30(3):419-26. doi: 10.1007/s00345-011-0756-2. Epub 2011 Sep 3. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21892656 | ||||
Condition | Year | Language | Analysis type | |
, Urology | 2012 | English | , Retrospective database analysis | |
Résultats intermédiaires d’une cohorte française de patients sous micafungine (MYRIADE). | ||||
Gachot B1., Leverger G2., Milpied N3., Timsit JF4. | ||||
[1] IGR, Villejuif, France [2] CHU Trousseau, Paris, France ; [3] CHU Haut-Lévêque, Pessac, France ; [4] CHU Michallon, La Tronche, France | ||||
JNI Tours, France 2012 32e Réunion Interdisciplinaire de Chimiothérapie Anti-infectieuse |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.em-consulte.com/article/733757/article/gh05-resultats-intermediaires-dune-cohorte-francai | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2012 | French | , Prospective study | |
Résultats intermédiaires d'une cohorte française de patients sous micafungine en onco-hématologie (MYRIADE. | ||||
Gachot B1, Leverger G2, Milpied N3, Timsit JF4. | ||||
[1] IGR, Villejuif, France [2] CHU Trousseau, Paris, France ;[3] CHU Haut-Lévêque, Pessac, France ; [4] CHU Michallon, La Tronche, France | ||||
CONGRES DE LA SFGM-TC, Paris |
||||
, Poster | ||||
, France | ||||
Abstract: https://www.cegedimstrategicdata.com/SiteCollectionDocuments/Medical%20Research%20Scientific%20Publications/CSDScientificPublications_2014.pdf | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2012 | French | , Prospective study | |
Severe hypertriglyceridaemia in patients treated with lipid-modifying agents. | ||||
Désaméricq G1, Van Ganse E1, Schwalm MS2, Bourke A3, Moulin P4. | ||||
1Unité de pharmaco-épidémiologie, faculté d’odontologie UCBL, CHU de Lyon, 69372 Lyon, France 2Cegedim Strategic Data, 92100 Boulogne-Billancourt, France 3The Health Improvement Network, SW8 3QJ London, UK 4Université de Lyon, 69003 Lyon, France Inserm, U870, IFR62, 69008 Lyon, France Inra, UMR1235, 69008 Lyon, France INSA-Lyon, RMND, 69621 Villeurbanne, France Hospices Civils de Lyon, 69008 Lyon, France | ||||
Diabetes & Metabolism Volume 38, n° 3 pages 277-279 (juin 2012) |
||||
, Article | ||||
, Belgium, France, Germany, Italy, UK | ||||
Abstract: http://www.em-consulte.com/en/article/735594 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders , Vascular disease | 2012 | English | , Retrospective database analysis | |
Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010: the DIAttitude Study. | ||||
Halimi S1, Balkau B, Attali C, Detournay B, Amelineau E, Blickle JF. | ||||
1CHU Grenoble - Clinique Diabétologie Nutrition Pôle DigiDUNE University Hospital Grenoble University Joseph Fourier | ||||
Diabetes Metab. 2012 Mar;38 Suppl 3:S36-46. doi: 10.1016/S1262-3636(12)71533-1. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22541601 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Prospective study, Retrospective database analysis | |
Type 2 diabetes treatment intensification in general practice in France in 2008-2009: the DIAttitude Study. | ||||
Balkau B1, Bouée S, Avignon A, Vergès B, Chartier I, Amelineau E, Halimi S. | ||||
1Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease Over the Lifecourse and Determinants of Early Nutrition, Villejuif, France | ||||
Diabetes Metab. 2012 Mar;38 Suppl 3:S29-35. doi: 10.1016/S1262-3636(12)71532-X. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22541600 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Prospective study, Retrospective database analysis | |
Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire of osteoporotic post-menopausal women. | ||||
Breuil V1, Cortet B, Cotté FE, Arnould B, Dias-Barbosa C, Gaudin AF, Regnault A, Roborel de Climens A, Legrand E | ||||
1Rheumatology Department, Nice University Hospital, Nice, France. | ||||
Osteoporos Int. 2012 Feb;23(2):445-55. doi: 10.1007/s00198-011-1555-8. Epub 2011 Apr 6 |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21625889 | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Womens Health | 2012 | English | , Prospective study | |
First-line sunitinib in type I and II papillary renal cell carcinoma (PRCC): SUPAP, a phase II study of the French Genito-Urinary Group (GETUG) and the Group of Early Phase trials (GEP). | ||||
Ravaud A1, Oudard S2, De Fromont M3, Chevreau C4, Gravis G5, Zanetta S6, Theodore C7, Jimenez M8, Sevin E9, Laguerre B10, Rolland F11, Ouali M12, Culine S13, Escudier B14. | ||||
1Department of Medical Oncology, Bordeaux University Hospital, Bordeaux alain.ravaud@chu-bordeaux.fr. 2Department of Medical Oncology, Paris Rene Descartes University, Paris. 3Pathology Department, SCP Pathology, Marseille. 4Department of Medical Oncology, Institut Claudius Régaud/Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse. 5Department of Medical Oncology, Institut Paoli Calmettes, Marseille. 6Department of Medical Oncology, Centre Georges-François Leclerc, Dijon. 7Department of Medical Oncology, Hôpital Foch, Suresnes. 8Research and Development Department, Unicancer, Paris. 9Department of Medical Oncology, Centre François Baclesse, Caen. 10Department of Medical Oncology, Centre Eugène Marquis, Rennes. 11Department of Medical Oncology, Institut de Cancérologie de L'Ouest, Nantes. 12Department of Biostatistics, Institut Claudius Régaud/Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse. 13Medical Oncology, Hôpital Saint-Louis, Paris. 14Department of Medical Oncology, Gustave Roussy, Villejuif, France. | ||||
2009 ASCO Annual Meeting Abstract Number: 5146 |
||||
, Poster | ||||
, France | ||||
Abstract: http://meetinglibrary.asco.org/content/30779-65 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Prospective study | |
Better analyze the determinants of therapeutic inertia to overcome it | ||||
Halimia S, Balkaub B. | ||||
Department of Diabetology,Grenoble University Hospital Center, Grenoble, France | ||||
Diabetes Metab. 2012 Mar;38 Suppl 3:S27-8. doi: 10.1016/S1262-3636(12)71531-8. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.em-consulte.com/en/article/709573 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Prospective study, Retrospective database analysis, Survey research | |
Ims LifeLinkTM cohorte diabète : validité et utilité | ||||
Le Jeunne P1 | ||||
1IMS Health, Paris La Défense France | ||||
Le revue du Praticien médecine générale 2012 Nov; 26: n° 889 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | French | ||
Ims LifeLinkTM cohorte diabète : validité et utilité | ||||
Le Jeunne P1 | ||||
1IMS Health, Paris La Défense France | ||||
Le revue du Praticien médecine générale 2012 Nov; 26: n° 889 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2012 | English | , Retrospective database analysis | |
A lifetime cost-effectiveness analysis of the recommended antihypertensive drug classes in France. | ||||
Midy F 1, Lièvre M2, Maurel F3, Cohn E4, Vellopoulou K5, Lamotte M5 | ||||
1 Haute Autorité de Santé, Saint-Denis La Plaine, France 2 Université Claude Bernard, Lyon, France 3 IMS Health, Puteaux, France 4 Haute Autorité de Santé, Saint-Denis La Plaine, Belgium 5 IMS Health Consulting, Vilvoorde, Belgium | ||||
HTAi Bilbao 2012 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
2012 | English | , Economic evaluation | ||
Health-related quality of life and annual direct medical cost of patients with haemophilia B in France: the eqofix study. | ||||
Polack B1, Calvez T2, Chambost H3, Rothschild C4, Goudemand J5, Claeyssens S6, Borel-Derlon A7, Bardoulat I8, Maurel F8, Woronoff-Lemsi MC9 | ||||
1 Department of Hematology, University Hospital, and CNRS UMR5525, Grenoble-Alpes University, Grenoble, France 2 Sorbonne University, UPMC University of Paris 06, INSERM, UMR-S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France 3 APHM, Department of Pediatric Hematology, Children Hospital La Timone, and INSERM, UMR 1062, Aix-Marseille University, Marseille, France 4 Regional Hemophilia Center, Department of Hematology, University Hospital Necker Enfants Malades, Paris, France 5 Department of Hematology-Transfusion, University Hospital, Lille, France 6 Regional Hemophilia Center, Purpan Hospital, Toulouse, France 7 Regional Hemophilia and VWD Center, University Hospital, and INSERM U919, Caen, France 8 Department of Health Economics and Outcome Research, IMS Health, La Défense, France 9 Pharmacy, University Hospital, and INSERM UMR1098, Franche-Comté University, Besançon, France | ||||
ISPOR 15th Annual European Congress, 2012, 3-7 November, Berlin, Germany |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2012 | English | , Clinical setting: hospital, Cost analysis, Observational study, Patient questionnaire, Prospective study, Quality of life | |
Treatment pattern by hormone receptors and HER2 status in patients with metastatic breast cancer in the United Kingdom, Germany, France, Spain, and Italy (EU-5): Results from a physician survey. | ||||
DeKoven M, Bonthapally V, Lee W, Pathak P, Jiao X, Ray S, Alexandria | ||||
IMS Health; Abbott Laboratories, Abbott Park, IL; IMS Health, Collegeville, PA | ||||
ASCO 2012; J Clin Oncol 30, 2012 (suppl; abstr 570) |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://ascopubs.org/doi/abs/10.1200/jco.2012.30.15_suppl.570 | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2012 | English | , Retrospective database analysis | |
The patterns of treatment persistence with antihypertensive medications in France. | ||||
Breitscheidel L1, Sandberg A2, Kostev K1, Holz B1, Oberdiek A2 | ||||
1 IMS Health GmbH & Co, Munich, Germany 2 Daiichi Sankyo, Munich, Germany | ||||
The ESH 21st European Meeting on Hypertension, Milan, Italy. 2011. |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Retrospective database analysis | |
Analysis of the impact of removing mucolytics and expectorants from the list of reimbursable drugs on prescription rates: a time-series analysis for France 1998-2010. | ||||
Pichetti S, Sorasith C, Sermet C | ||||
"IRDES (Institute for research and information in health economics)" | ||||
Health Policy. 2011 Oct;102(2-3):159-69. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2011 | English | ||
Retrospective chart review study of the cost of care of systematic lupus erythematousus (SLE)in 5 European coutries | ||||
Doria A1, Amoura Z 2, Richter J3, Cervera R4, Khamashta M5, Guillemin F6, Garofanno A7, Maurel F7, Roset M8, Perna A9, Schmitt C10, Ager M9, Boucot I11, Gonzalez MC Quire S10, Birch H10. | ||||
1. University of Padova, Padova, Italy, 2. Université Paris VI Pierre et Marie Courie, Paris, France, 3. Heinrich-Heine-University, Düsseldorf, Germany, 4. Hospital Clinic, Barcelona, Spain, 5. The Rayne Institute, London, United Kingdom, 6. Centre d'épidémiologie clinique, Vandoeuvre-les-Nancy, France, 7. IMS Health, Paris, France, IMS Health, Barcelona, Spain, 9. GlaxoSmithKline, Brentford, United Kingdom, 10. GlaxoSmithKline, Uxbrige, United Kingdom, 11. GlaxoSmithKline, Marly-le-Roi, France | ||||
Abstract - Presentation PSY17 for the 14th European congress of ISPOR 2011 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2011 | English | , Cost analysis, Cost of illness, Epidemiological study, Observational study, Retrospective cohort analysis | |
The annual direct medical cost of systemic lupus erythematosus (SLE)patients and costs drivers (LUCIE study): French results. | ||||
Amoura Z1, Pennaforte JL2, Hamidou M3, Arfi S4, Lazaro E5, Hachulla E6, Pourrat J7, Queyrel V8, Aubin C9, Garofano A10, Levy-Bachelot L9, Maurel F10, Boucot I9 | ||||
1. Internal Medecine Department, La Pitié Salpetrière Hospital, Paris, France, 2. Internal Medecine Department, Robert Debré Hospital, Reims, France, 3. Internal Medecine Department, Hôtel Dieu Hospital, Nantes, France, 4. Internal Medecine and Rheumatology Department, Fort de France Hospital, Fort de France, France, 5. Internal Medecine Departmeent, Pellegrin Hospital, Boredeaux, France, 6. Internal Medecine Department, Hurriez Hospital, Lille, France, 7. Nephrology and Clinical Immunology Department, Rangueil Hospital, Toulouse, France, 8. Internal Medecine Department, l'Archet Hospital, Nice, France, 9. GlaxoSmithKline, Marly-le-Roi, France, 10. IMS Health, Puteaux, France | ||||
Abstract - Presentation PSY20 for the 14th European congress of Ispor 2011 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2011 | English | , Cost of illness, Economic evaluation, Observational study | |
Cost-effectiveness of ganulocyte colony stimulating factor (G-CSF) in primary (PP) and secondary prophylaxis (SP) of febrile neutropenia (FN) in patients with stages 2 and 3 breast cancer (BC) undergoing cytotoxic chemotherapy in France. | ||||
Perrier L1, Bachelot T2, Leon N3, Maurel F3, Cohen-Nizard S4, De Liège F4 | ||||
1 Cancer Centre Léon Bérard, Lyon, France 2 Centre Léon Bérard - Inserm U590, Lyon Cedex 08, France 3 IMS Health, Puteaux, France 4 Amgen France SAS, Neuilly-sur-Seine, France | ||||
Abstract - Presentation PCN77 for the 14th European Congress of ISPOR 2011 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
The cost per day of intensive care units (ICU) in France : the CRRéa study. | ||||
Garrigues B1, Lefrant JY2, Bazin JE3, Bardoulat I4, Tagdichti K4, Courtial F4, Maurel F4, Pribil C5 | ||||
1 CH du Pays d'Aix, Aix-en6provence, France 2 CHU de Nîmes , Nîmes, France 3 CHRU de Clermont-Ferrand, Clermont-Ferrand, France 4 IMS Health, Puteaux, France 5 GSK France, Marly-le-Roi, France. | ||||
Abstract - Presentation PHP75 for the 14th European congress of Ispor 2011 |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2011 | English | , Cost analysis, Economic evaluation, Prospective study | |
Anti-diabetic therapeutic strategies for type 2 diabetes patients with chronic kidney disease in France. | ||||
Amalric F1, Attali C2, Joly D3, Simon D4, Vergès B5, Grandfils N1, Briand Y6 | ||||
1 IMS Health, Paris, France 2 Epinay-sous-Dénart, France 3 Hôpital Necker, Paris, France 4 Hôpital Robert Debré, Paris, France 5. Hôpital du Bocage, Dijon, France 6. Boehringer Ingelheim France, Paris, France | ||||
Abstract - Presentation PDB63 for the 14th European congress of Ispor 2011 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Diabetes | 2011 | English | , Retrospective database analysis | |
Economic model of granulocyte-colony stimulating factor (G-CSF) in primary (PP) and secondary prophylaxis (SP) of febrile neutropenia (FN) in Non-Hodgkin's Lymphoma (NHL) patients undergoing chemotherapy in France. | ||||
Perrier L1, Sebban C1, Leon N2, Maurel F2, Cohen-Nizard S3, De Liège F3 | ||||
1 Cancer Centre Léon Bérard, Lyon, France 2 IMS Health, Puteaux, France 4 Amgen France SAS, Neuilly-sur-Seine, France | ||||
Abstract - Presentation PCN88 for the 14th European congress of Ispor 2011 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Cost effectiveness | |
Surgery in patients with metastatic colorectal cancer in western Europe. | ||||
Z. Zhao, E. M. Pelletier, B. Barber, M. Bhosle, S. Wang, D. Klingman, S. K. Gao; Amgen Inc., Thousand Oaks, CA; IMS Health, Inc., Watertown, MA; IMS Health, Inc., Falls Church, VA | ||||
1Amgen Inc., Thousand Oaks, CA, USA, 2IMS Consulting, Watertown, MA, USA, 3IMS Consulting, Alexandria, VA, USA | ||||
2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 2011, Chicago, IL, USA |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2011 | English | , Retrospective database analysis | |
Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. | ||||
Jose´ R. Banegas 1,2*, Esther Lo´pez-Garcı´a 1,2, Jean Dallongeville3, Eliseo Guallar 4,5,6,7, Julian P. Halcox8, Claudio Borghi 9, Elvira L. Masso´-Gonza´lez 10, Francisco J. Jime´nez 11, Joep Perk12, Philippe Gabriel Steg13, Guy De Backer 14,and Fernando Rodrı´guez-Artalejo1,2 | ||||
1 Department of Preventive Medicine and Public Health, School of Medicine, Universidad Auto´noma de Madrid/IdiPAZ, Avda Arzobispo Morcillo, 2, 28029 Madrid, Spain; 2 CIBER of Epidemiology and Public Health, Madrid, Spain; 3 Inserm U 744, Institut Pasteur de Lille, 59019 Lille Cedex, France; 4 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 5 Department of Medicine, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 6 Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA; 7 Department of Cardiovascular Epidemiology and Population Genetics, National Center for Cardiovascular Research (CNIC), Madrid 28029, Spain; 8 Wales Heart Research Institute, Cardiff University, Heath Park, Cardiff CF14 4XN, UK; 9 Department of Internal Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy; 10Medical Department, AstraZeneca Farmace´utica Spain, S.A., 28003 Madrid, Spain; 11Medical Department, AstraZeneca Europe, 1935 Zaventem, Belgium; 12School of Health and Caring Sciences, Linnaeus University, 391 82 Kalmar, Sweden; 13INSERM U 698, Assistance Publique–Hoˆpitaux de Paris and Universite´ Paris-Diderot, Paris, France; and 14Department of Public Health, University of Gent, 9000 Gent, Belgium | ||||
Eur Heart J. 2011 Sep;32(17):2143-52 |
||||
, Article | ||||
, Austria, Belgium, France, Germany, Greece, Norway, Spain, Sweden, Switzerland, Turkey, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21471134 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Observational study, Prospective study | |
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France. | ||||
Cotté FE1, De Pouvourville G. | ||||
1CERMES, IFR, INSERM U, National Institute of Health and Medical Research, Villejuif, France | ||||
BMC Health Services Research 2011, 11:151 |
||||
, Article | ||||
, France | ||||
Abstract: http://www.biomedcentral.com/1472-6963/11/151 | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics | 2011 | English | , Retrospective database analysis | |
Epidemiologic Evaluation of Cardiovascular Risk in Patients Receiving Milnacipran, Venlafaxine, or Amitriptyline: Evidence from French Health Data (February). | ||||
Mease PJ, Zimetbaum PJ, Duh MS, Vekeman F, Guerin A, Boerstoel-Streefland M, Jiang W, Lefebvre P. | ||||
Ann Pharmacother. 2011 Feb 8. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21304035 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2011 | English | ||
Etude Hb-One day - Etude observationnelle évaluant la stabilité du taux d’hémoglobine (Hb) par Mircera® et Ferrisat® chez des patients présentant une insuffisance rénale chronique (IRC) en dialyse. | ||||
Baranger T, Bergé F, Bansal V, Frangié C, Rosier E, Seniuta P. | ||||
13th réunion commune SFD & SN, Bordeaux, France |
||||
, Poster | ||||
, France | ||||
Abstract: https://www.cegedimstrategicdata.com/Documents/Medical%20Research%20Public%20and%20Private/CSD%20Medical%20Research%20Scientific%20Publications%20Bibliography.pdf | ||||
Condition | Year | Language | Analysis type | |
, Nephrology | 2011 | French | , Prospective study | |
Excess risk attributable to traditional cardiovascular risk factors in clinical practice settings across Europe - The EURIKA Study. | ||||
Guallar E, Banegas JR, Blasco-Colmenares E, Jiménez FJ, Dallongeville J, Halcox JP, Borghi C, Massó-González EL, Tafalla M, Perk J, De Backer G, Steg PG, Rodríguez-Artalejo F. | ||||
BMC Public Health. 2011 Sep 18;11:704. doi: 10.1186/1471-2458-11-704. |
||||
, Article | ||||
, Austria, Belgium, France, Germany, Greece, Norway, Russian Federation, Spain, Sweden, Switzerland, Turkey, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21923932 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2011 | English | , Observational study, Prospective study | |
Les pratiques d’intensification thérapeutique dans le diabète de type 2, en France, en médecine générale. | ||||
Balkaua Ba,b, Avignonc Ac, Vergèsd Bd, Bouéee Se, Chartierf If, Amelineaug Eg, Halimih Sh | ||||
INSERM U1018, Center for Research in Epidemiology and Population Health, Villejuif, France Paris-South University, Villejuif, France University of Versailles Saint-Quentin-en-Yvelines, Versailles, France. | ||||
Diabetes & Metabolism 03/2011; 59. DOI: 10.1016/j.respe.2011.08.050 |
||||
, Oral communication | ||||
, France | ||||
Abstract: http://www.researchgate.net/publication/251590567_Les_pratiques_dintensification_thrapeutique_dans_le_diabte_de_type_2_en_France_en_mdecine_gnrale | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2011 | French | , Prospective study, Retrospective database analysis | |
Management of osteoporosis and associated quality of life in post menopausal women. | ||||
Cortet B1, Blotman F, Debiais F, Huas D, Mercier F, Rousseaux C, Berger V, Gaudin AF, Cotté FE. | ||||
1Laboratoire GlaxoSmithKline, Marly-le-Roi, France. | ||||
BMC Musculoskelet Disord. 2011; 12: 7. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034724/ | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Rheumatology, Womens Health | 2011 | English | , Prospective study | |
Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs. | ||||
Thiéfin G1, Schwalm MS | ||||
1Hepato-Gastroenterology, Reims University Hospital, Reims, France. | ||||
Dig Liver Dis. 2011 Mar;43(3):209-14. doi: 10.1016/j.dld.2010.09.009. Epub 2010 Nov 3. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21051300 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders, Pain | 2011 | English | , Prospective study | |
Use of antimigraine treatments by general practitioners. | ||||
Ducros A1, Romatet S, Saint Marc T, Allaf B | ||||
1Emergency Headache Centre, Head and Neck Clinic, Hôpital Lariboisière | ||||
Headache. 2011 Jul-Aug;51(7):1122-31. doi: 10.1111/j.1526-4610.2011.01939.x. Epub 2011 Jun 15. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/21675969 | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2011 | English | , Survey research | |
Psoriasis: an epidemiologic evaluation of disease burden of disease, economic and social impact in 590 patients. | ||||
N. Meyer, C. Paul, N. Grandfils, I. Bardoulat, C. Thiriet, D. Sid Mohand, C. Le Pen, JP Ortonne | ||||
J Eur Acad Dermatol Venereol. 2010 Mar 4. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2010 | English | , Burden of illness | |
Spectacle independence and subjective satisfaction of ReSTOR® multifocal intraocular lens after cataract or presbyopia surgery in two European countries | ||||
Cochener B1, Fernández-Vega L2, Alfonso JF2, Maurel F3, Meunier J4, Berdeaux G5,6 | ||||
1 Centre Hospitalier de Brest, Brest, France; 2 Instituto Oftalmologico Fernandez Vega, Oviedo, Spain; 3 IMS Health, Health Economics Department, Puteaux, France; 4 Mapi Values, Lyon, France; 5 Alcon France, Health Economics Department, Rueil-Malmaison, France; 6 Conservatoire National des Arts et Métiers, Paris, France | ||||
Clin Ophthalmol. 2010 Mar 4;4:81-9. |
||||
, Manuscript in preparation | ||||
, France, Spain | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed?term=Cochener+B%5Bfirst+author%5D+AND+spectacle&TransSchema=title&cmd=detailssearch | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2010 | English | , Retrospective cohort analysis, Survey research | |
Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France. | ||||
Lamotte M, Maugars Y, Le Lay K, Taïeb C | ||||
Clin Exp Rheumatol, 2010; 28 (Suppl. 63): S64-S70 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Musculoskeletal disease | 2010 | English | , Economic evaluation | |
Assessment of the workload real time dedicated to each patient in intensive care units (ICU): preliminary results of the CRREA study | ||||
Garrigues B (1), Lefrant JY (2), Bazin JE (3), Probil C (4), Maurel F(5) | ||||
1. CH du Pays d'Aix, Aix en Provence, France 2. CHU de Nïmes, Nïmes, France 3. CHRU de Clermont-Ferrand, Clermont-Ferrand, France 4. GSK France, Marly-Le-Roi, France 5. IMS Health, Puteaux, France | ||||
ISPOR 13th Annula European Congress to be held 6-9 November 2010 at the Prague Congress Centre in Prague, Czech Republic |
||||
, Abstract, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2010 | English | , Clinical setting: hospital, Cost analysis, Observational study, Prospective study | |
Quel est le temps réellement consacré à chaque patient en service de réanimation? résultats préliminaires de l'étude CRRéA | ||||
Lefrant JY (1), Bazin JE (2), Pribil C (3), Maurel F (4), Gariigues B (5) | ||||
1. CHU de Nîmes, Nîmes, France 2. CHRU de Clermont-Ferrand, Clermont Ferrand, France 3. GSK France, Marly-Le-Roi, France 4. IMS Health, Puteaux, France 5. CH du pays d’Aix, Aix-en-Provence, France | ||||
SFAR 2010, Congrès national d'anesthésie et de réanimation du 22 au 25 septembre 2010 - session Médecine d'urgence 2 |
||||
, Abstract, Oral presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2010 | French | , Cost analysis, Observational study | |
Comparison of Prescribing Patterns for Asthma in Five European Countries | ||||
Laforest L, Schwalm MS, Dufour M, Broquet M, Bourke A & Van Ganse E | ||||
Cegedim | ||||
ICPE 2010 Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/13 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2010 | English | , Retrospective database analysis | |
Cost-effectiveness model of using zoledronic acid once a year versus current treatment strategies in postmenopausal osteoporosis. | ||||
Fardellone P, Cortet B, Legrand E, Bresse X, Bisot-Locard S, Vigneron AM, Beresniak A. | ||||
Joint Bone Spine. 2010 Jan;77(1):53-7. doi: 10.1016/j.jbspin.2009.04.009. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20034831 | ||||
Condition | Year | Language | Analysis type | |
, Orthopedics, Womens Health | 2010 | English | ||
Characteristics and LDL-C Therapeutic Objectives of Patients Receiving Unusual Lipid-Modifying Therapy Regimen | ||||
Desamericq G, Laforest L, Schwalm MS, Bourke A, Broquet M, Van Ganse E & Moulin P | ||||
Cegedim | ||||
ICPE 2010 Pharmacoepidemiology and Drug Safety (19): S1-S347 |
||||
, Abstract, Poster | ||||
, France, UK | ||||
Abstract: https://www.yumpu.com/en/document/view/5337032/poster-session-international-society-for-pharmacoepidemiology/13 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders , Miscellaneous | 2010 | English | , Retrospective database analysis | |
Les pratiques d’intensification thérapeutique dans le diabète de type 2 en France en Médecine Générale | ||||
Halimi S, Balkau B, Blickle JF, Attali C, Vergès B, Avignon A, Andre l, Amelineau E, Detournay B | ||||
Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease Over the Lifecourse and Determinants of Early Nutrition, Villejuif, France | ||||
Bull Epidemiol Hebd (Paris). 2010 Nov;n° 42-43:436-40. [French |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective database analysis | |
Type 2 diabetes treatment intensification in general practice in France in 2008-2009 | ||||
Balkau B1, Bouée S, Avignon A, Vergès B, Chartier I, Amelineau E, Halimi S. | ||||
1Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, Epidemiology of Diabetes, Obesity and Chronic Kidney Disease Over the Lifecourse and Determinants of Early Nutrition, Villejuif, France. | ||||
Diabetes Metab. 2012 Mar;38 Suppl 3:S29-35. doi: 10.1016/S1262-3636(12)71532-X. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2010 | English | , Retrospective database analysis | |
Validation of the adherence evaluation of osteoporosis treatment (ADEOS) questionnaire for osteoporotic post-menopausal women. | ||||
Breuil V1, Cortet B, Cotté FE, Arnould B, Dias-Barbosa C, Gaudin AF, Regnault A, Roborel de Climens A, Legrand E. | ||||
1Rheumatology Department, Nice University Hospital, Nice, France. | ||||
Osteoporos Int. 2012 Feb;23(2):445-55 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology, Womens Health | 2010 | English | , Prospective study, Quality of life, Retrospective database analysis | |
Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. | ||||
Huas D1, Debiais F, Blotman F, Cortet B, Mercier F, Rousseaux C, Berger V, Gaudin AF, Cotté FE. | ||||
Department of General Practice, UFR Paris 7, Paris, France. | ||||
BMC Womens Health. 2010 Aug 20;10:26 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology, Womens Health | 2010 | English | , Prospective study | |
Assessment of the workload real time dedicated to each patient in intensive care units (icu): preliminary results of the crréa study. | ||||
Garrigues B1, Lefrant JY2, Bazin JE3, Pribil C4, Maurel F5 | ||||
1 CH du pays d’Aix, Aix-en-Provence, France 2 CHU de Nîmes, Nîmes, France 3 CHRU de Clermont-Ferrand, Clermont Ferrand, France 4 GSK France, Marly-Le-Roi, France 5 IMS Health, Puteaux, France | ||||
ISPOR 13th Annual European Congress, 2010, 6-9 November, Prague, Czech Republic |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2010 | English | , Clinical setting: hospital, Cost effectiveness, Observational study, Prospective study | |
A Review Of Treatment Patterns Of Patients With Pulmonary Arterial Hypertension In Three European Countries | ||||
Angalakuditi M1, Wright D2, Gaskin M2, Fakhoury W2 | ||||
1Eli Lilly and Company, Indianapolis, IN, USA, 2IMS Health, London, UK | ||||
ISPOR 14th Annual International Meeting, Orlando, Florida, USA 16 - 20 May 2009 |
||||
, Poster | ||||
, France, Germany, UK | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease | 2009 | English | , Review | |
Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries. | ||||
Gschwend MH1, Aagren M2, Valentine WJ1 | ||||
1 IMS Health, Basel, Switzerland, 2 Novo Nordisk Inc., New Jersey, United States | ||||
Journal of Medical Economics, 2009; 12(2): 114–123 |
||||
, Manuscript in preparation | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Abstract: http://informahealthcare.com/doi/abs/10.3111/13696990903080344 | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2009 | English | , Cost effectiveness | |
Psoriasis : une évaluation du fardeau de la maladie et de l’impact socio-économique de la maladie chez 590 patients. | ||||
N. Meyer, C. Paul, N. Grandfils, I. Bardoulat, C. Camara, C. Thiriet, D. Sid Mohand, C. Le Pen, JP Ortonne. | ||||
JDP 2009 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2009 | French | , Burden of illness | |
Psoriasis: an epidemiologic evaluation of disease burden in 590 patients | ||||
D. Fénéron, N. Meyer, I. Bardoulat, N. Grandfils, C. Thiriet, C. Camara, D. Sid-Mohand, C. Le Pen, JP Ortonne | ||||
ISPOR PARIS 2009 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2009 | English | , Burden of illness | |
Cost-effectiveness of Rituximab combined with fludarabine and cyclophosphamide in previously untreated patients with chronic lymphocytic leukemia in France | ||||
M. Roussel, X. Troussard, MD, A. Delmer, M. Poinso, H. Miadi Fargier | ||||
ISPOR PARIS 2009 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology | 2009 | English | , Cost effectiveness | |
Primary care and avoidable hospitalizations: A comparative analysis between France and the UK | ||||
Mansour E1, Le Pen C2, Nestrigue C3, Amalric F1 | ||||
1IMS Health, Puteaux, Ile de France, France, 2Dauphine University, Paris, France, 3IMS Health, Puteaux, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24 -27th October 2009 |
||||
, Poster | ||||
, France, UK | ||||
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2009 | English | ||
Verteporfin in neovascular AMD: real life confirms clinical trials results | ||||
SAMBUC R., LE PEN C., SOUBRANE G., QUENTEL G., ZEROUTA S., PONTHIEUX A. | ||||
ISPOR PARIS 2009 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2009 | English | , Observational study | |
Impact of Rheumatoid Arthritis (RA) on working conditions and income | ||||
Maurel F1, Fautrel B2, Maravic M3, Bardoulat I1, Preiss P4, Camara C5, Schadtler Law L6, Le Pen C7 | ||||
1 IMS Health, Puteaux, France 2 Groupe Hospitalier Pitié-Salpêtrière, Paris, France, 3 Hopital Leopold Bellan, Paris, France, 4 Association Française des Polyarthritiques, Paris, France, 5 Wyeth Pharmaceuticals France, Paris La Défense, France, 6 Wyeth Pharmaceuticals France, Paris La Défense Cedex, France, 7 Dauphine University, Paris, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24-27th October 2009 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/congresses/paris1009/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Burden of illness | |
Indirect costs of rheumatoid arthritis and their determinants | ||||
Maurel F1, Bardoulat I1, Camara C2, Schadtler Law L3, Le Pen C4 | ||||
1 IMS Health, Puteaux, France, 2 Wyeth Pharmaceuticals France, Paris La Défense , France, 3 Wyeth Pharmaceuticals France, Paris La Défense Cedex, France, 4 Dauphine University, Paris, France | ||||
EULAR 2009 ISPOR 12th Annual European Congress, Paris, France 24-27 October 2009 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/congresses/paris1009/Posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2009 | English | , Economic evaluation | |
Cost-effectiveness of Rituximab combined with Fludarabine and Cyclophosphamide in previously untreated patients with Chronic Lymphocytic Leukemia in France | ||||
Roussel M1, Troussard X2, Delmer A3, Poinso M4, Miadi-Fargier H5 | ||||
1 Roche, Neuilly-sur-Seine, France 2 Clémenceau Hospital, Haematology department, Caen, France 3 Robert Debré Hospital, Haematology department, Reims, France 4 IMS Health HEOR, Puteaux, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24-27 October 2009 |
||||
, Poster | ||||
, France | ||||
Abstract: http://www.ispor.org/congresses/paris1009/Posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2009 | English | , Cost effectiveness | |
Does pharmaceutical consumption improve healthcare status? | ||||
Grandfils N1, Hauser S1, Amalric F1, Le Pen C2 | ||||
1IMS Health, Puteaux, France, 2Paris Dauphine University, Paris, France | ||||
ISPOR 12th Annual European Congress, Paris, France, 24–27th October 2009 |
||||
, Abstract, Poster | ||||
, Denmark, France, Germany, Italy, Spain, Sweden, UK | ||||
Abstract: http://www.ispor.org/congresses/paris1009/posters1.aspx | ||||
Condition | Year | Language | Analysis type | |
, Health policy | 2009 | English | , Economic evaluation | |
Therapeutic management of uncomplicated gastroesophageal reflux disease in france in 2005: Potential cost savings of omeprazole substitution. | ||||
Mouly S, Charlemagne A, Le Jeunne P, Fagnani F. | ||||
Curr Ther Res Clin Exp. 2009 Aug;70(4):282-98. doi: 10.1016/j.curtheres.2009.07.001. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24683238 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2009 | English | ||
Can the relationship between age and cholesterol levels indicate effectiveness of lipid lowering therapy in primary care? France, Germany, Italy and UK | ||||
Blak BT, Hards M, Maguire A & Schwalm MS | ||||
Cegedim | ||||
ISPOR Orlando, USA Value in Health 12(3):A142-A143 |
||||
, Abstract, Poster | ||||
, France, Germany, Italy, UK | ||||
Abstract: https://www.infona.pl/resource/bwmeta1.element.elsevier-ef0c58f0-1c99-3554-8596-1bce21118531 | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
Comparison of prescription patterns of statins in primary care in five European countries: results from the LIPIDE observational survey | ||||
Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al | ||||
ICPE/ISPE, Providence. 2009 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
LDL-C goal attainment according to prescribed lipid-lowering therapy: results from the LIPIDE European survey | ||||
Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al | ||||
Université Paris Est, Faculté de Médecine, Créteil, France; | ||||
ICPE/ISPE, Providence. 2009 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
. Prise en charge des patients dyslipidémiques dans cinq pays européens: Résultats préliminaires de l’étude LIPIDE. | ||||
Desamericq G, Laforest L, Schwalm MS, Moulin P, Michel E, Eteve C, et al. | ||||
Université Paris Est, Faculté de Médecine, Créteil, France; | ||||
ADELF, Paris. 2009. [French] |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Endocrinology, Metabolic Disorders | 2009 | English | , Retrospective database analysis | |
The impact of insulin detemir compared to Neutral Protamine Hagedorn insulin on long-term diabetes-related complications: a modeling analysis in type 1 diabetes patients in Belgium, France, Germany, Italy and Spain | ||||
Gschwend M1, Aagren M2, Valentine WJ1 | ||||
1 IMS Health, Basel, Switzerland, 2 Novo Nordisk A/S, Bagsværd, Denmark | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Economic evaluation | |
Long-term cost-effectiveness of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with type 1 diabetes using a basal–bolus regimen in Belgium, France, Germany, Italy and Spain. | ||||
Gschwend M, Aagren M, Valentine WJ | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2008 | English | , Cost effectiveness | |
Impact of brain metastases on health care costs associated with the management of patients with metastatic breast cancer in France and Germany. | ||||
S Cottrell1, M Walker2, H Scheijbeler1, L Christova1, N Hertel3, B Hass3, M Behrens4, E Roux5, M Amonkar6, Aristides M1 | ||||
1 IMS HEOR, London, UK 2 GlaxoSmithKline, Greenford, UK 3 IMS HEOR, Nuremberg, Germany 4 GlaxoSmithKline, Munich, Germany 5 GlaxoSmithKline, Paris, France 6 GlaxoSmithKline, Philadelphia, USA | ||||
6th European Breast Cancer Conference (EBCC-6), 15-19 April 2008, Berlin, Germany |
||||
, Oral presentation | ||||
, France, Germany | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Budget impact | |
Comparison of real-world observed persistence for patients treated with Escitalopram and other antidepressants in a French setting: A database study. | ||||
Kostev K1, Jha A2, Verpillat P3, Milea D3 | ||||
1 IMS Health, Frankfurt, Germany 2 IMS Health, London, UK 3 Lundbeck, Copenhagen, Denmark | ||||
8th International Forum on Mood and Anxiety Disorders (IFMAD), 12 - 14 November 2008; Vienna, Austria 8th International Forum on Mood and Anxiety Disorders, 2008, November 12-14, Vienna, Austria |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2008 | English | , Compliance | |
Cross-cultural comparisons of the overweight/obese population in the US and Europe | ||||
Annunziata K, Gupta S, Chapnick J, Pokras S, Klingman D | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
, France, Germany, Italy, Spain, UK, USA | ||||
Condition | Year | Language | Analysis type | |
, Obesity | 2008 | English | , Retrospective database analysis | |
ECONOMIC EVALUATION OF ETANERCEPT AND EFALIZUMAB IN THE MANAGEMENT OF CHRONIC PLAQUE PSORIASIS | ||||
J. Ortonne, C. Le Pen, J. Daures, D. Fénéron | ||||
EADV |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Dermatology | 2008 | English | , Cost effectiveness | |
Assessment of the benefits of time savings achieved by once monthly injection of erythropoietin stimulating agents (ESA) on anaemia management in haemodialysis centres | ||||
Allard B., Grégoire M., Ferrandini C., Ollivier C., Vrtovsnik F., Zambrowski JJ., Lamure E, Baillon N | ||||
ISPOR congress. 8-11 November 2008 |
||||
, Abstract, Oral presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2008 | English | , Survey research | |
Impact de la mise sur le marché d’une nouvelle érythropoïétine à injection mensuelle en termes de gain de temps et d’optimisation organisationnelle pour les personnels impliqués dans le circuit de l’EPO dans les centres d’hémodialyse. | ||||
Allard B., Grégoire M., Ferrandini C., Ollivier C., Vrtovsnik F., Zambrowski JJ., Mouradian A. | ||||
les Journées Annuelles de la Société de Néphrologie et de la Société francophone de dialyse ». 26-29 novembre 2008 |
||||
, Abstract, Oral presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Hematology | 2008 | French | , Survey research | |
Serious adverse reactions of bupropion for smoking cessation: analysis of the French Pharmacovigilance Database from 2001 to 2004. | ||||
Beyens MN, Guy C, Mounier G, Laporte S, Ollagnier M. | ||||
Drug Saf. 2008;31(11):1017-26. |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/18840021 | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2008 | English | ||
Cost of initial prostate cancer treatment following diagnosis per patient by stage: estimates from the UK, France, Germany, Italy and Spain. | ||||
Benedict A, Black L, Stokes M, Dorval | ||||
1 United BioSource Corporation, Budapest, Hungary 2 GlaxoSmithKline, Research Triangle Park, NC, USA 3 United BioSource Corporation, Dorval, QC, Canada | ||||
ISPOR 11th Annual European Congress |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: http://www.valueinhealthjournal.com/article/S1098-3015(10)66210-9/pdf | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2008 | English | , Cost effectiveness | |
Cost-utility of insulin detemir versus NPH for type 1 diabetes patients treated with basal-bolus therapy in a French setting. A modeling evaluation based on results from a meta-analysis of three clinical trials | ||||
Scheijbeler H1, Aagren M2, Nielsen S2, Valentine WJ3, Goodall G3, Kotchie R1 | ||||
1 IMS Health, London, UK; 2 Novo Nordisk A/S, Bagsværd, Denmark; 3 IMS Health, Basel, Switzerland | ||||
ISPOR 2007 10th Annual European Congress, Dublin, Ireland, 20-23 October 2007 |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2007 | English | , Cost utility | |
The cost of zoster and post-herpetic neuralgia treatment in France. | ||||
Loock J, Le Pen C, Baptiste C, Bloch K, Valentin E, Bruxelle J, Berrut G, Gallais JL, Stahl JP | ||||
ISPOR ISPOR 2007 10th Annual European Congress |
||||
, Abstract, Oral presentation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics | 2007 | English | , Burden of illness | |
A cost-effectiveness analysis of a yearly Fibroscan® liver fibrosis assessment compared with a periodic liver biopsy in hepatitis c virus (HCV) infected individuals in a French setting. | ||||
Levesque K, de Lédinghen V, Bourlière M, Miadi-Fargier H, Billon S, LePen C. | ||||
ISPOR 2007 10th Annual European Congress |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2007 | English | , Cost effectiveness | |
Anxiety and depression prevalence rates in age-related macular degeneration. | ||||
Augustin A, Sahel JA, Bandello F, Dardennes R, Maurel F, Negrini C, Hieke K, Berdeaux G. | ||||
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1498-503. |
||||
, Manuscript in preparation | ||||
, France, Germany, Italy | ||||
Abstract: http://www.iovs.org/cgi/content/full/48/4/1498 | ||||
Condition | Year | Language | Analysis type | |
, Mental health | 2007 | English | ||
Cost-effectiveness and cost-utility of rituximab maintenance therapy for patients with relapsed/refractory follicular lymphoma in French setting. | ||||
Pacull A, Coudray-Omnes C, Brice P, Deconinck E, Le Pen C, Miadi-Fargier H | ||||
ISPOR 2007 10th Annual European Congress |
||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | , Cost effectiveness | |
Association Between Visual Acuity and Costs, Medical and Non-Medical, in Patients with Wet Age-Related Macular Degeneration in France, Germany and Italy. | ||||
Bandello F, Augustin A, Sahel JA, Benhaddi H, Maurel F, Negrini C, Hieke K, Berdeaux G. | ||||
Drugs & Aging, 2007. |
||||
, Manuscript in preparation | ||||
, France, Germany, Italy | ||||
Abstract: http://cat.inist.fr/?aModele=afficheN&cpsidt=20238855 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2007 | English | ||
Health-related quality of life and utility in patients with Age-Related Macular Degeneration. | ||||
Sahel JA, Bandello F, Augustin A, Maurel F, Negrini C, Berdeaux G for the MICMAC study group. | ||||
Arch Ophthalmol 2007;125(7:945-951. |
||||
, Manuscript in preparation | ||||
, France | ||||
Abstract: http://archopht.ama-assn.org/cgi/content/abstract/125/7/945 | ||||
Condition | Year | Language | Analysis type | |
, Ophthalmology | 2007 | English | , Quality of life | |
EVALUATION PHARMACO-ECONOMIQUE DU LANREOTIDE LORS DE LA PRISE EN CHARGE DE LA FISTULE DIGESTIVE POST-OPERATOIRE. | ||||
Tilleul P, Levesque K, Nestrigue C2, Maurel F2, Brignone M1, Ménégaux F, Buscail L, Levesque E, De Pouvourville G. | ||||
HOPIPHARM – 21-23 Mai 2008 – Bordeaux, France |
||||
, Abstract, Oral presentation, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Surgery | 2007 | French | , Budget impact, Economic evaluation | |
Classification of hyperlipidemia from automated primary care data in the UK and France | ||||
Maguire A, Schwalm MS, Douglas I & Smeeth L | ||||
Cegedim | ||||
Pharmacoepidemiology and Drug Safety 16:S1-S274 (424) |
||||
, Abstract | ||||
, France, UK | ||||
Abstract: http://researchonline.lshtm.ac.uk/8491/ | ||||
Condition | Year | Language | Analysis type | |
, Miscellaneous, Vascular disease | 2007 | English | , Retrospective database analysis | |
Differences in cholesterol levels between statin and fibrate treated patients in French, Italian and UK primary care | ||||
Blak BT, Maguire A & Schwalm MS | ||||
Cegedim | ||||
ISPOR - 10th Annual European Congress Dublin, Ireland Value in Health 10(6):A407 |
||||
, Abstract, Poster | ||||
, France, Italy, UK | ||||
Abstract: http://www.ispor.org/congresses/ireland0507/posters3.aspx | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Miscellaneous | 2007 | English | , Retrospective database analysis | |
Antipsychotics dosage and antiparkinsonian prescriptions | ||||
Acquaviva E1, Gasquet I, Falissard B. | ||||
1INSERM U669, PSIGIAM (Paris Sud Innovation Group in Adolescent Mental Health Methodology), 97 boulevard de Port-Royal, 75679 Paris cedex 14, France. | ||||
Clin Pract Epidemiol Ment Health. 2007 Sep 3;3:14. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | English | , Retrospective database analysis | |
Antipsychotics dosage and antiparkinsonian prescriptions. | ||||
Acquaviva E1, Gasquet I, Falissard B. | ||||
1INSERM U669, PSIGIAM (Paris Sud Innovation Group in Adolescent Mental Health Methodology), 97 boulevard de Port-Royal, 75679 Paris cedex 14, France. | ||||
Clin Pract Epidemiol Ment Health. 2007 Sep 3;3:14. |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2007 | English | , Retrospective database analysis | |
Diagnostic indicators of restless legs syndrome in primary care consultations: the DESYR study. | ||||
Crochard A1, El Hasnaoui A, Pouchain D, Huas D, Arnulf I, Krieger J, Lainey E, Le Jeunne P, Leger D, Schuck S, Texier N, Tison F, Montplaisir J | ||||
1Laboratoire GlaxoSmithKline, Marly-le-Roi, France. | ||||
Mov Disord. 2007 Apr 30;22(6):791-7 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Rheumatology | 2007 | English | , Prospective study, Retrospective database analysis | |
The effect of cancer drug vintage on cancer survival and mortality. | ||||
IMS Health | ||||
2007 European Society of Medical Oncology |
||||
, Article | ||||
, France, Germany, Italy, Spain, UK | ||||
Abstract: https://academic.oup.com/annonc/article/18/suppl_3/iii67/214317/The-effect-of-cancer-drug-vintage-on-cancer | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2007 | English | ||
Self monitoring of blood glucose in patients with type 2 diabetes: cost utility analysis in a French government payer setting | ||||
Palmer AJ, Minshall ME, Valentine WJ, Foos V, Tunis SL | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Diabetes | 2006 | English | , Cost utility | |
Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). | ||||
Amouretti M, Le Pen C, Gaudin AF, Bommelaer G, Frexinos F, Ruszniewski P, Poynard T, Maurel F, Priol G, El Hasnaoui A. | ||||
Gastroenterol Clin Biol. 2006 Feb;30(2):241-6. |
||||
, Manuscript in preparation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders | 2006 | English | , Quality of life | |
Economic advantages and time savings of using oxaliplatin concentrated solution versus osaliplatin lyophilised powder for infusion | ||||
Favier B, Spath HM, Anhoury P, Pacull A | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Health economics | 2006 | English | ||
Outcome validation of a succinct HPV infection model for France | ||||
Demarteau N, Detournay B, El Hansnaoui A Standaert B, Annemans L | ||||
ISPOR 9th Annual Euorpean Congress. 28-31 October 2006. Copenhagen, Denmark |
||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Infectious disease | 2006 | English | ||
Vers une convergence des modes de financement ? in Mondialisation et Santé. | ||||
Actes du Colloque du Cercle des Economistes, Paris, 27 avril, 2006. |
||||
, Manuscript in preparation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Methodology | 2006 | French | ||
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's disease. | ||||
Fraix V, Houeto JL, Lagrange C, Le Pen C, Krystkowiak P, Guehl D, Ardouin C, Welter ML, Maurel F, Defebvre L, Rougier A, Benabid AL, Mesnage V, Ligier M, Blond S, Burbaud P, Bioulac B, Destee A, Cornu P, Pollak P; SPARK Study Group. | ||||
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):443-9. |
||||
, Manuscript in preparation | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Neurological disorders | 2006 | English | ||
Cost-effectiveness of cetuximab (Erbitux®) in combination with radiotherapy versus radiotherapy alone in the treatment of locally advanced head and neck cancer in France | ||||
Brown B, Roninson P, Launois R, Griebsch I | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | , Cost effectiveness | |
Long term clinical effect of an HPV-vaccine for the prevention of cervical cancer in France in relation to age of vaccination: Results from a markov model | ||||
Demarteau N, Detournay B, El Hansnaoui A Standaert B, Annemans L | ||||
, Poster | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Oncology | 2006 | English | ||
Cost of scheduled and unscheduled asthma management in seven EU countries. | ||||
Williams AE1, Lloyd AC2, Watson L1, Rabe KF3. | ||||
1 GlaxoSmithKline R&D, Greenford, 2 Fourth Hurdle Consulting Ltd, London, UK. 3 Leiden University Medical Centre, Leiden, The Netherlands | ||||
European Respiratory Review 2006; 15:(98): 4–9 |
||||
, Manuscript in preparation | ||||
, France, Germany, Italy, Netherlands, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Respiratory disease | 2006 | English | , Burden of illness | |